Annual Statements Open main menu

TREDEGAR CORP - Annual Report: 2010 (Form 10-K)

Form 8-K
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-K

 

 

 

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2010

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission File Number 1-10258

 

 

TREDEGAR CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Virginia   54-1497771

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

1100 Boulders Parkway, Richmond, Virginia   23225
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: 804-330-1000

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Name of Each Exchange on Which Registered

Common Stock   New York Stock Exchange
Preferred Stock Purchase Rights   New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None

 

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ¨    No  x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ¨    No  x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.    Yes  ¨    No  ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   ¨    Accelerated filer   x
Non-accelerated filer   ¨  (Do not check if a smaller reporting company)    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ¨    No  x

Aggregate market value of voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 2010 (the last business day of the registrant’s most recently completed second fiscal quarter): $434,856,910*

Number of shares of Common Stock outstanding as of January 31, 2011: 31,884,723 (31,831,708 as of June 30, 2010)

 

* In determining this figure, an aggregate of 5,186,064 shares of Common Stock beneficially owned by John D. Gottwald, William M. Gottwald and the members of their immediate families has been excluded because the shares are held by affiliates. The aggregate market value has been computed based on the closing price in the New York Stock Exchange Composite Transactions on June 30, 2010.

 

 

Documents Incorporated By Reference

Portions of the Tredegar Corporation Proxy Statement for the 2011 Annual Meeting of Shareholders (the “Proxy Statement”) are incorporated by reference into Part III of this Form 10-K. We expect to file our Proxy Statement with the Securities and Exchange Commission (the “SEC”) and mail it to shareholders on or about April 13, 2011.

 

 

 


Table of Contents

Index to Annual Report on Form 10-K

Year Ended December 31, 2010

 

          Page  
Part I     

Item 1.

  Business      1-4   

Item 1A.

  Risk Factors      4-7   

Item 1B.

  Unresolved Staff Comments      None   

Item 2.

  Properties      8   

Item 3.

  Legal Proceedings      None   
Part II     

Item 5.

  Market for Tredegar’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities      9-12   

Item 6.

  Selected Financial Data      12-18   

Item 7.

  Management’s Discussion and Analysis of Financial Condition and Results of Operations      19-38   

Item 7A.

  Quantitative and Qualitative Disclosures About Market Risk      38   

Item 8.

  Financial Statements and Supplementary Data      43-78   

Item 9.

  Changes In and Disagreements With Accountants on Accounting and Financial Disclosure      None   

Item 9A.

  Controls and Procedures      38-39   

Item 9B.

  Other Information      None   
Part III     

Item 10.

  Directors, Executive Officers and Corporate Governance*      40-41   

Item 11.

  Executive Compensation      *   

Item 12.

  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters*      42   

Item 13.

  Certain Relationships and Related Transactions, and Director Independence      *   

Item 14.

  Principal Accounting Fees and Services      *   
Part IV     

Item 15.

  Exhibits and Financial Statement Schedules      43   

 

* Items 11, 13 and 14 and portions of Items 10 and 12 are incorporated by reference from the Proxy Statement.


Table of Contents

PART I

 

Item 1. BUSINESS

Description of Business

Tredegar Corporation (“Tredegar”), a Virginia corporation incorporated in 1988, is primarily engaged, through its subsidiaries, in the manufacture of plastic films and aluminum extrusions. The financial information related to Tredegar’s film products, aluminum extrusions and other segments and related geographical areas included in Note 3 to the Notes to Financial Statements is incorporated herein by reference. Unless the context requires otherwise, all references herein to “Tredegar,” “we,” “us” or “our” are to Tredegar Corporation and its consolidated subsidiaries.

Film Products

Tredegar Film Products Corporation and its subsidiaries (together, “Film Products”) manufacture plastic films, elastics and laminate materials primarily for personal and household care products and surface protection and packaging applications. These products are manufactured at locations in the United States (“U.S.”) and at plants in The Netherlands, Hungary, Italy, China, Brazil and India. Film Products competes in all of its markets on the basis of product innovation, quality, price and service.

Personal Care Materials. Film Products is one of the largest global suppliers of apertured, breathable, elastic and embossed films, and laminate materials for personal care markets, including:

 

 

Apertured film and nonwoven materials for use as topsheet in feminine hygiene products, baby diapers and adult incontinence products (including materials sold under the ComfortQuiltTM, ComfortAireTM, SoftAireTM and FreshFeelTM brand names);

 

 

Breathable, embossed and elastic materials for use as components for baby diapers, adult incontinence products and feminine hygiene products (including elastic components sold under the FabriFlexTM, StretchTabTM, FlexAireTM and FlexFeelTM brand names); and

 

 

Absorbent transfer layers for baby diapers and adult incontinence products sold under the AquiDryTM and AquiSoftTM brand names.

In 2010, 2009 and 2008, personal care products accounted for approximately 50%, 52% and 40% of Tredegar’s consolidated net sales from continuing operations, respectively.

Protective Films. Film Products produces single and multi-layer surface protection films sold under the UltraMaskTM and ForceFieldTM brand names. These films are used in high technology applications, most notably protecting components of flat panel displays, which include liquid crystal display (“LCD”) televisions, monitors, notebooks, smart phones, tablets, e-readers and digital signage, during the manufacturing process. In 2010, 2009 and 2008, protective films accounted for approximately 12%, 10% and 7% of Tredegar’s consolidated net sales from continuing operations, respectively.

Packaging Films and Films for Other Markets. Film Products produces a broad line of packaging films with an emphasis on paper products, as well as laminating films for food packaging applications. We believe these products give our customers a competitive advantage by providing cost savings with thin-gauge films that are readily printable and convertible on conventional processing equipment. Major end uses include overwrap for bathroom tissue and paper towels as well as retort pouches.

Film Products also makes apertured films, breathable barrier films and laminates that regulate fluid or vapor transmission. These products are typically used in industrial, medical, agricultural and household markets, including filter layers for personal protective suits, facial masks, landscaping fabric and construction applications.

Raw Materials. The primary raw materials used by Film Products are low density, linear low density and high density polyethylene and polypropylene resins, which are obtained from domestic and foreign suppliers at


Table of Contents

competitive prices. We believe there will be an adequate supply of polyethylene and polypropylene resins in the foreseeable future. Film Products also buys polypropylene-based nonwoven fabrics based on these same resins, and we believe there will be an adequate supply of these materials in the foreseeable future.

Customers. Film Products sells to many branded product producers throughout the world. Its largest customer is The Procter & Gamble Company (“P&G”). Net sales to P&G totaled $273 million in 2010, $253 million in 2009 and $283 million in 2008 (these amounts include film sold to third parties that converted the film into materials used with products manufactured by P&G).

P&G and Tredegar have had a successful long-term relationship based on cooperation, product innovation and continuous process improvement. The loss or significant reduction in sales associated with P&G would have a material adverse effect on our business.

Aluminum Extrusions

The William L. Bonnell Company, Inc. and its subsidiaries (together, “Aluminum Extrusions”) produce high-quality, soft-alloy aluminum extrusions primarily for building and construction, distribution, transportation, electrical, consumer durables and machinery and equipment markets. On February 12, 2008, we sold our aluminum extrusions business in Canada. All historical results for the Canadian business have been reflected as discontinued operations (see Note 17 to the notes to financial statements for more information).

Aluminum Extrusions manufactures mill (unfinished), anodized (coated) and painted aluminum extrusions for sale directly to fabricators and distributors that use our extrusions to produce architectural curtain walls, storefronts, windows and doors, hurricane shutters, tub and shower enclosures, heatsinks and components for LED (light emitting diode) lighting and automotive and light truck aftermarket parts, among other products. Sales are made primarily in the United States, principally east of the Rocky Mountains. Aluminum Extrusions competes primarily on the basis of product quality, service and price.

Aluminum Extrusions’ sales volume from continuing operations by market segment over the last three years is shown below:

% of Aluminum Extrusions Sales Volume

by Market Segment (Continuing Operations)

 

     2010      2009      2008  

Building and construction:

        

Nonresidential

     68         71         72   

Residential

     14         14         13   

Transportation

     8         6         4   

Distribution

     5         4         5   

Electrical

     2         2         2   

Consumer durables

     2         2         2   

Machinery and equipment

     1         1         2   
                          

Total

     100         100         100   
                          

Raw Materials. The primary raw materials used by Aluminum Extrusions consist of aluminum ingot, aluminum scrap and various alloys, which are purchased from domestic and foreign producers in open-market purchases and under short-term contracts. We believe there will be an adequate supply of aluminum and other required raw materials and supplies in the foreseeable future.

Other

In February 2010, we added a new segment, Other, comprised of the start-up operations of Bright View Technologies Corporation (“Bright View”) and Falling Springs, LLC (“Falling Springs”).

 

2


Table of Contents

We acquired the assets of Bright View, a late-stage development company, on February 3, 2010. Bright View is a developer and producer of high-value microstructure-based optical films for the LED and fluorescent lighting markets.

Falling Springs develops, owns and operates multiple mitigation banks. Through the establishment of perpetual easements to restore, enhance and preserve wetlands, streams or other protected environmental resources, these mitigation banks create saleable credits that are used by the purchaser of credits to offset the negative environmental impacts from private and public development projects.

With Bright View’s focus on the eco-efficient LED and fluorescent lighting markets and Falling Springs’ work in environmental restoration, the two businesses that comprise this segment address environmental sustainability issues, which are of growing significance to us.

General

Intellectual Property. We consider patents, licenses and trademarks to be of significance for Film Products and Bright View. We routinely apply for patents on significant developments in this business. As of December 31, 2010, Film Products held 222 issued patents (76 of which are issued in the U.S.) and 95 trademarks (6 of which are issued in the U.S.). Bright View held 39 issued patents (26 of which are issued in the U.S.). Aluminum Extrusions held two U.S. trademark registrations. Our patents have remaining terms ranging from 1 to 17 years. We also have licenses under patents owned by third parties.

Research and Development. Tredegar’s spending for research and development (“R&D”) activities in 2010, 2009 and 2008 was primarily related to Film Products. Film Products has technical centers in Richmond, Virginia; Terre Haute, Indiana; and Chieti, Italy. R&D spending was approximately $13.6 million in 2010, $11.9 million in 2009 and $11.0 million in 2008.

Backlog. Backlogs are not material to our operations in Film Products. Overall backlog for continuing operations in Aluminum Extrusions at December 31, 2010 increased by approximately 25% compared with December 31, 2009. Demand for extruded aluminum shapes improved slightly in 2010 after declining in most market segments in recent years. Aluminum extrusion volume from continuing operations, which we believe is cyclical in nature, increased 3.7% in 2010 compared to 2009 after decreasing 32.8% in 2009 compared to 2008 and 12.6% in 2008 compared to 2007.

Government Regulation. Laws concerning the environment that affect or could affect our domestic operations include, among others, the Clean Water Act, the Clean Air Act, the Resource Conservation Recovery Act, the Occupational Safety and Health Act, the National Environmental Policy Act, the Toxic Substances Control Act, the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”), as amended, regulations promulgated under these acts, and any other federal, state or local laws or regulations governing environmental matters.

The U.S. Environmental Protection Agency has adopted regulations under the Clean Air Act relating to emissions of carbon dioxide and other greenhouse gases (“GHG”), including mandatory reporting and permitting requirements. Additional regulations are anticipated. Several of our manufacturing operations result in emissions of GHG and are subject to these new GHG regulations. Compliance with the newly adopted regulations has yet to require significant expenditures. The cost of compliance with any future GHG legislation or regulations is not presently determinable, but it is not anticipated to have a material adverse effect on our financial condition or results of operation based on information currently available.

At December 31, 2010, we believe that we were in substantial compliance with all applicable environmental laws, regulations and permits. In order to maintain substantial compliance with such standards, we may be required to incur additional expenditures, the amounts and timing of which are not presently determinable but which could be significant, in constructing new facilities or in modifying existing facilities.

 

3


Table of Contents

Employees. Tredegar employed approximately 2,000 people at December 31, 2010.

Available Information and Corporate Governance Documents. Our Internet address is www.tredegar.com. We make available, free of charge through our website, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after such documents are electronically filed with, or furnished to, the SEC. Information filed electronically with the SEC can be accessed on its website at www.sec.gov. In addition, our Corporate Governance Guidelines, Code of Conduct and the charters of our Audit, Executive Compensation and Nominating and Governance Committees are available on our website and are available in print, without charge, to any shareholder upon request by contacting Tredegar’s Corporate Secretary at 1100 Boulders Parkway, Richmond, Virginia 23225. The information on or that can be accessed through our website is not, and shall not be deemed to be, a part of this report or incorporated into other filings we make with the SEC.

 

Item 1A. RISK FACTORS

There are a number of risks and uncertainties that could have a material adverse effect on the operating results of our businesses and our financial condition. The following risk factors should be considered, in addition to the other information included in the Form 10-K, when evaluating Tredegar and our businesses:

General

 

 

Our performance is influenced by costs incurred by our operating companies including, for example, the cost of raw materials and energy. These costs include, without limitation, the cost of resin (the raw material on which Film Products primarily depends), aluminum (the raw material on which Aluminum Extrusions primarily depends), natural gas (the principal fuel necessary for Aluminum Extrusions’ plants to operate), electricity and diesel fuel. Resin, aluminum and natural gas prices are extremely volatile as shown in the charts on pages 34-35. We attempt to mitigate the effects of increased costs through price increases and contractual pass-through provisions, but there are no assurances that higher prices can effectively be passed through to our customers or that we will be able to offset fully or on a timely basis the effects of higher raw material and energy costs through price increases or pass-through arrangements. Further, there is no assurance that our cost control efforts will be sufficient to offset any additional future declines in revenue or increases in raw material, energy or other costs.

 

 

Tredegar and its customers operate in highly competitive markets. Tredegar and its businesses compete on product innovation, quality, price and service, and our businesses and its customers operate in highly competitive markets. Recent economic volatility has exacerbated our exposure to margin compression due to competitive forces, especially as certain products move into the later stages of their product life cycles. We attempt to mitigate the effects of this trend through cost saving measures and manufacturing efficiency initiatives, but there is no assurance that these efforts will be sufficient to offset the impact of margin compression as a result of competitive pressure.

 

 

Noncompliance with any of the covenants in our $300 million credit facility could result in all debt under the agreement outstanding at such time becoming due and limiting our borrowing capacity, which could have a material adverse effect on our financial condition and liquidity. The credit agreement governing our revolving credit facility contains restrictions and financial covenants that could restrict our financial flexibility. While we had no outstanding borrowings on our $300 million credit facility at December 31, 2010, our failure to comply with these covenants in a future period when we have borrowings outstanding could result in an event of default, which if not cured or waived, could have a material adverse effect on our financial condition and liquidity if such borrowings are material. Renegotiation of the covenant(s) through an amendment to our revolving credit facility may effectively cure the noncompliance, but may have an effect on financial condition or liquidity depending upon how the covenant is negotiated.

 

4


Table of Contents
 

Loss of certain key officers or employees could adversely affect our businesses. We depend on our senior executive officers and other key personnel to run our businesses. The loss of any of these officers or other key personnel could have a materially adverse affect on our operations. Competition for qualified employees among companies that rely heavily on engineering and technology is intense, and the loss of qualified employees or an inability to attract, retain and motivate highly skilled employees required for the operation and expansion of our businesses could hinder our ability to improve manufacturing operations, conduct research activities successfully and develop marketable products.

 

 

Tredegar is subject to increased credit risk that is inherent with economic uncertainty and efforts to increase market share as we attempt to broaden our customer base. In the event of the deterioration of operating cash flows or diminished borrowing capacity of our customers, the collection of trade receivable balances may be delayed or deemed unlikely. The operations of our customers for Aluminum Extrusions generally follow the cycles within the economy, resulting in greater credit risk from diminished operating cash flows and higher bankruptcy rates when the economy is deteriorating or in recession. In addition, Film Products’ credit risk exposure could increase as efforts to expand its business may lead to a broader, more diverse customer base.

 

 

Tredegar may not be able to successfully execute its acquisition strategy. New acquisitions can provide meaningful opportunities to grow our business and improve profitability. Acquired businesses may not achieve the levels of revenue, profit, productivity, or otherwise perform as we expect. Acquisitions involve special risks, including, without limitation, diversion of management’s time and attention from our existing businesses, the potential assumption of unanticipated liabilities and contingencies and potential difficulties in integrating acquired businesses and achieving anticipated operational improvements. While our strategy is to acquire businesses that will improve our competitiveness and profitability, we can give no assurance that acquisitions will be successful or accretive to earnings.

 

 

Tredegar is subject to various environmental laws and regulations and could become exposed to material liabilities and costs associated with such laws. We are subject to various environmental obligations and could become subject to additional obligations in the future. In the case of known potential liabilities, it is management’s judgment that the resolution of ongoing and/or pending environmental remediation obligations is not expected to have a material adverse effect on our consolidated financial condition or liquidity. In any given period or periods, however, it is possible such obligations or matters could have a material adverse effect on the results of operations. Changes in environmental laws and regulations, or their application, including, but not limited to, those relating to global climate change, could subject us to significant additional capital expenditures and operating expenses. Moreover, future developments in federal, state, local and international environmental laws and regulations are difficult to predict. Environmental laws have become and are expected to continue to become increasingly strict. As a result, we will be subject to new environmental laws and regulations. However, any such changes are uncertain and, therefore, it is not possible for us to predict with certainty the amount of additional capital expenditures or operating expenses that could be necessary for compliance with respect to any such changes.

 

 

An inability to renegotiate one of our collective bargaining agreements could adversely affect our financial results. Some of our employees are represented by labor unions under various collective bargaining agreements with varying durations and expiration dates. Tredegar may not be able to satisfactorily renegotiate collective bargaining agreements when they expire, which could result in strikes or work stoppages or higher labor costs. In addition, existing collective bargaining agreements may not prevent a strike or work stoppage at our facilities in the future. Any such work stoppages (or potential work stoppages) could negatively impact our ability to manufacture our products and adversely affect results of operations.

 

 

Our investments (primarily $7.5 million of investments in a privately-held specialty pharmaceutical company and a $6.4 million net investment in Harbinger) have high risk. The value of our investment in a specialty pharmaceutical company can fluctuate, primarily as a result of its ability to meet its developmental and commercialization milestones within an anticipated time frame. The specialty pharmaceutical company may require additional rounds of financing to have the opportunity to complete product development and bring its

 

5


Table of Contents
 

technology to market, which may never occur. The estimated fair value of our investment was $16.0 million at December 31, 2010. There is no secondary market for selling our interests in the specialty pharmaceutical company. As a result, we may be required to bear the risk of our investment in the specialty pharmaceutical company for an indefinite period of time.

Harbinger Capital Partners Special Situations Fund, L.P. (“Harbinger”) is a private investment fund and an investment in the fund involves risk and is subject to limitations on withdrawal. We are withdrawing from the fund, and we received the first installments of withdrawal proceeds in the third and fourth quarters of 2010. The timing and amount of future withdrawal proceeds are not known.

Film Products

 

 

Film Products is highly dependent on sales associated with one customer, P&G. P&G comprised approximately 38% of Tredegar’s consolidated net sales from continuing operations in 2010, 40% in 2009 and 33% in 2008. The loss or significant reduction of sales associated with P&G would have a material adverse effect on our business. Other P&G-related factors that could adversely affect our business include, by way of example, (i) failure by P&G to achieve success or maintain share in markets in which P&G sells products containing our materials, (ii) operational decisions by P&G that result in component substitution, inventory reductions and similar changes, (iii) delays in P&G rolling out products utilizing new technologies developed by us and (iv) P&G rolling out products utilizing technologies developed by others that replace our business with P&G. While we have undertaken efforts to expand our customer base, there can be no assurance that such efforts will be successful, or that they will offset any delay or loss of sales and profits associated with P&G.

 

 

Growth of Film Products depends on our ability to develop and deliver new products at competitive prices. Personal care, surface protection and packaging products are now being made with a variety of new materials and the overall cycle for changing materials has accelerated. While we have substantial technical resources, there can be no assurance that our new products can be brought to market successfully, or if brought to market successfully, at the same level of profitability and market share of replaced films. A shift in customer preferences away from our technologies, our inability to develop and deliver new profitable products, or delayed acceptance of our new products in domestic or foreign markets, could have a material adverse effect on our business. In the long term, growth will depend on our ability to provide innovative materials at a price that meets our customers’ needs.

 

 

Continued growth in Film Products’ sale of protective film products is not assured. A shift in our customers’ preference to new or different products or new technology that displaces flat panel displays that currently utilize our protective films could have a material adverse effect on our sales of protective films. Similarly, a decline in the rate of growth for flat panel displays could have a material adverse effect on protective film sales.

 

 

Our substantial international operations subject us to risks of doing business in countries outside the U.S., which could adversely affect our business, financial condition and results of operations. Risks inherent in international operations include the following, by way of example: changes in general economic conditions, potential difficulty enforcing agreements and intellectual property rights, staffing and managing widespread operations and the challenges of complying with a wide variety of laws and regulations, restrictions on international trade or investment, restrictions on the repatriation of income, fluctuations in exchange rates, imposition of additional taxes on our income generated outside the U.S., nationalization of private enterprises and unexpected adverse changes in international laws and regulatory requirements.

 

 

Our inability to protect our intellectual property rights or our infringement of the intellectual property rights of others could have a material adverse impact on Film Products. Film Products operates in a field where our significant customers and competitors have substantial intellectual property portfolios. The continued success of this business depends on our ability not only to protect our own technologies and trade secrets, but also to develop and sell new products that do not infringe upon existing patents or threaten existing customer relationships. An unfavorable outcome in any intellectual property litigation or similar proceeding could have a materially adverse effect on results of operations in Film Products.

 

6


Table of Contents
 

An unstable economic environment could have a disruptive impact on our supply chain. Certain raw materials used in manufacturing our products are available from a single supplier, and we may not be able to quickly or inexpensively re-source to another supplier. The risk of damage or disruption to our supply chain has been exacerbated as different suppliers have consolidated their product portfolios or experienced financial distress due to recent uncertainty in the economy. Failure to take adequate steps to effectively manage such events, which are intensified when a product is sourced from a single supplier or location, could adversely affect our business and results of operations, as well as require additional resources to restore our supply chain.

 

 

Failure of our customers to achieve success or maintain market share could adversely impact sales and operating margins. Our products serve as components for various consumer products sold worldwide. Our customers’ ability to successfully develop, manufacture and market their products is integral to our success.

Aluminum Extrusions

 

 

Sales volume and profitability of Aluminum Extrusions is cyclical and highly dependent on economic conditions of end-use markets in the U.S., particularly in the construction sector. Our end-use markets can be subject to seasonal slowdowns. Because of the high degree of operating leverage inherent in our operations (generally constant fixed costs until full capacity utilization is achieved), the percentage drop in operating profits in a cyclical downturn will likely exceed the percentage drop in volume. Any benefits associated with cost reductions and productivity improvements may not be sufficient to offset the adverse effects on profitability from pricing and margin pressure and higher bad debts (including a greater chance of loss associated with defaults on fixed-price forward sales contracts with our customers) that usually accompany a downturn. In addition, higher energy costs can further reduce profits unless offset by price increases or cost reductions and productivity improvements.

Currently, there is uncertainty surrounding the extent and timing of recovery in the building and construction sector. There can be no assurance as to the extent and timing of the recovery of sales volumes and profits for Aluminum Extrusions, especially since there can be a lag in the recovery of its end-use markets in comparison to the overall economic recovery.

 

 

The markets for our products are highly competitive with product quality, service, delivery performance and price being the principal competitive factors. Aluminum Extrusions has approximately 805 customers that are in a variety of end-use markets within the broad categories of building and construction, distribution, transportation, machinery and equipment, electrical and consumer durables. No single customer exceeds 5% of Aluminum Extrusions’ net sales. Due to the diverse customer mix across many end-use markets, we believe the industry generally tracks the real growth of the overall economy. Future success and prospects depend on our ability to retain existing customers and participate in overall industry cross-cycle growth.

During improving economic conditions, excess industry capacity is absorbed and pricing pressure becomes less of a factor in many of our end-use markets. Conversely, during an economic slowdown, excess industry capacity often drives increased pricing pressure in many end-use markets as competitors protect their position with key customers. Because the business is susceptible to these changing economic conditions, Aluminum Extrusions targets complex, customized, service-intensive business with more challenging requirements in order to differentiate itself from competitors that focus on higher volume, standard extrusion applications.

Imports into the U.S., primarily from China, represent a portion of the U.S. aluminum extrusion market. Imports from China have the potential of further exacerbating a very competitive market, thereby amplifying market share and pricing pressures. While the industry submitted a petition to the Department of Commerce in March 2010 alleging Chinese extrusions are being imported through unfair trade practices, the results of this initiative and the impact that this may have on the volume of imports is unknown at this time.

 

7


Table of Contents
Item 1B. UNRESOLVED STAFF COMMENTS

None.

 

Item 2. PROPERTIES

General

Most of the improved real property and the other assets used in our operations are owned, and none of the owned property is subject to an encumbrance that is material to our consolidated operations. We consider the plants, warehouses and other properties and assets owned or leased by us to be in generally good condition.

We believe that the capacity of our plants is adequate to meet our immediate needs. Our plants generally have operated at 50-90% of capacity. Our corporate headquarters, which is leased, is located at 1100 Boulders Parkway, Richmond, Virginia 23225.

Our principal plants and facilities are listed below:

Film Products

 

Locations in the U.S.

  

Locations Outside the U.S.

  

Principal Operations

Lake Zurich, Illinois

Pottsville, Pennsylvania

Red Springs, North Carolina (leased)

Richmond, Virginia (technical center) (leased)

Terre Haute, Indiana (technical center and production facility)

  

Chieti, Italy (technical center) (leased)

Guangzhou, China

Kerkrade, The Netherlands

Pune, India

Rétság, Hungary

Roccamontepiano, Italy

São Paulo, Brazil

Shanghai, China

   Production of plastic films and laminate materials
Aluminum Extrusions      

Locations in the U.S.

       

Principal Operations

Carthage, Tennessee

Kentland, Indiana

Newnan, Georgia

      Production of aluminum extrusions, fabrication and finishing
Other      

Locations in the U.S.

       

Principal Operations

Morrisville, North Carolina (leased)

      Development and production of optical films for LED and fluorescent lighting

We also have various mitigation banking properties in Virginia, Georgia and Florida.

 

Item 3. LEGAL PROCEEDINGS

None.

 

8


Table of Contents

PART II

 

Item 5. MARKET FOR TREDEGAR’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Prices of Common Stock and Shareholder Data

Our common stock is traded on the New York Stock Exchange (“NYSE”) under the ticker symbol TG. We have no preferred stock outstanding. There were 31,883,173 shares of common stock held by 2,739 shareholders of record on December 31, 2010.

The following table shows the reported high and low closing prices of our common stock by quarter for the past two years.

 

     2010      2009  
     High      Low      High      Low  

First quarter

   $ 17.58       $ 14.93       $ 18.68       $ 14.43   

Second quarter

     18.03         15.26         17.99         12.79   

Third quarter

     19.34         15.84         15.82         13.07   

Fourth quarter

     20.19         18.38         15.93         13.40   

The closing price of our common stock on February 25, 2011 was $19.11.

Dividend Information

We have paid a dividend every quarter since becoming a public company in July 1989. During 2010, 2009 and 2008, our quarterly dividend was 4 cents per share.

All decisions with respect to the declaration and payment of dividends will be made by the Board of Directors in its sole discretion based upon earnings, financial condition, anticipated cash needs, restrictions in our credit agreement and other such considerations as the Board deems relevant. See Note 8 beginning on page 62 for the restrictions contained in our credit agreement related to minimum shareholders’ equity required and aggregate dividends permitted.

 

9


Table of Contents

Issuer Purchases of Equity Securities

On January 7, 2008, we announced that our board of directors approved a share repurchase program whereby management is authorized at its discretion to purchase, in the open market or in privately negotiated transactions, up to 5 million shares of Tredegar’s outstanding common stock. The authorization has no time limit. This share repurchase program replaced our previous share repurchase authorization announced on August 8, 2006.

Under these standing authorizations, we purchased approximately 2.1 million shares in 2010, 105,497 shares in 2009 and 1.1 million shares in 2008 of our stock in the open market at an average price of $16.54, $14.44 and $14.88 per share, respectively. The table below summarizes share repurchase activity under the current program by month beginning in January 2010:

 

Period

   Total
Number of
Shares
Purchased
     Average
Price Paid
Per Share
Before
Broker
Commissions
     Total
Number

of Shares
Purchased
Since
Inception of
Program (a)
     Maximum
Number of
Shares at
End of Period
that May Yet be
Purchased Under
Program (a)
 

January 2010

     201,600       $ 15.81         1,344,697         3,655,303   

February 2010

     548,900         16.48         1,893,597         3,106,403   

March 2010

     380,338         17.16         2,273,935         2,726,065   

April 2010

     171,630         17.20         2,445,565         2,554,435   

May 2010

     537,302         16.28         2,982,867         2,017,133   

June 2010

     284,930         16.28         3,267,797         1,732,203   

July 2010

     200         15.74         3,267,997         1,732,003   

August - December 2010

     —           —           3,267,997         1,732,003   

 

(a) On January 7, 2008, our board of directors approved a share repurchase program authorizing management at its discretion to purchase, in the open market or in privately negotiated transactions, up to 5 million shares of our outstanding Common Stock. The authorization has no time limit.

Annual Meeting

Our annual meeting of shareholders will be held on May 24, 2011, beginning at 9:00 a.m. EDT at the Jepson Alumni Center of the University of Richmond, 49 Crenshaw Way, Richmond, Virginia. We expect to mail formal notice of the annual meeting, proxies and proxy statements to shareholders on or about April 13, 2011.

 

10


Table of Contents

Comparative Tredegar Common Stock Performance

The following graph compares cumulative total shareholder returns for Tredegar, the S&P SmallCap 600 Stock Index (an index comprised of companies with market capitalizations similar to Tredegar) and the Russell 2000 Index for the five years ended December 31, 2010. Tredegar is part of both the S&P SmallCap 600 Index and Russell 2000 Index.

LOGO

* $100 invested on 12/31/05 in stock or index, including reinvestment of dividends. Fiscal year ending December 31.

Copyright© 2011 S&P, a division of The McGraw-Hill Companies Inc. All rights reserved.

 

11


Table of Contents

Inquiries

Inquiries concerning stock transfers, dividends, dividend reinvestment, consolidating accounts, changes of address, or lost or stolen stock certificates should be directed to Computershare Investor Services, the transfer agent and registrar for our common stock:

Computershare Investor Services

250 Royall Street

Canton, MA 02021

Phone: 800-622-6757

E-mail: web.queries@computershare.com

All other inquiries should be directed to:

Tredegar Corporation

Investor Relations Department

1100 Boulders Parkway

Richmond, Virginia 23225

Phone: 800-411-7441

E-mail: invest@tredegar.com

Website: www.tredegar.com

Quarterly Information

We do not generate or distribute quarterly reports to shareholders. Information on quarterly results can be obtained from our website. In addition, we file quarterly, annual and other information electronically with the SEC, which can be accessed on its website at www.sec.gov.

 

Legal Counsel

 

Independent Registered Public Accounting Firm

   

Hunton & Williams LLP

Richmond, Virginia

 

PricewaterhouseCoopers LLP

Richmond, Virginia

 

 

Item 6. SELECTED FINANCIAL DATA

The tables that follow on pages 13-18 present certain selected financial and segment information for the five years ended December 31, 2010.

 

12


Table of Contents

FIVE-YEAR SUMMARY

 

Tredegar Corporation and Subsidiaries

 

Years Ended December 31

   2010     2009     2008     2007     2006  
(In Thousands, Except Per-Share Data)                               

Results of Operations (a):

          

Sales

   $ 740,475      $ 648,613      $ 883,899      $ 922,583      $ 937,561   

Other income (expense), net

     (940 )(c     8,464 (d)      10,341 (e)      1,782 (f)      1,444 (g) 
                                        
     739,535        657,077        894,240        924,365        939,005   
                                        

Cost of goods sold

     596,330 (c)      516,933 (d)      739,721 (e)      761,509 (f)      779,376 (g) 

Freight

     17,812        16,085        20,782        19,808        22,602   

Selling, general & administrative expenses

     68,610        60,481        58,699        68,501        64,082   

Research and development expenses

     13,625        11,856        11,005        8,354        8,088   

Amortization of intangibles

     466        120        123        149        149   

Interest expense

     1,136        783        2,393        2,721        5,520   

Asset impairments and costs associated with exit and disposal activities

     773 (c)      2,950 (d)      12,390 (e)      4,027 (f)      4,080 (g) 

Goodwill impairment charge

     —          30,559 (b)      —          —          —     
                                        
     698,752        639,767        845,113        865,069        883,897   
                                        

Income from continuing operations before income taxes

     40,783        17,310        49,127        59,296        55,108   

Income taxes

     13,756 (c)      18,663 (d)      19,486 (e)      24,366        19,791 (g) 
                                        

Income (loss) from continuing operations (a)

     27,027        (1,353     29,641        34,930        35,317   
                                        

Discontinued operations (a):

          

Income (loss) from aluminum extrusions business in Canada

     —          —          (705     (19,681     2,884   
                                        

Net income (loss)

   $ 27,027      $ (1,353   $ 28,936      $ 15,249      $ 38,201   
                                        

Diluted earnings (loss) per share (a):

          

Continuing operations

   $ .83      $ (.04   $ .87      $ .90      $ .91   

Discontinued operations

     —          —          (.02     (.51     .07   
                                        

Net income (loss)

   $ .83      $ (.04   $ .85      $ .39      $ .98   
                                        

Refer to notes to financial tables on page 18.

 

13


Table of Contents

FIVE-YEAR SUMMARY

 

Tredegar Corporation and Subsidiaries

 

Years Ended December 31

   2010     2009     2008     2007     2006  
(In Thousands, Except Per-Share Data)                               

Share Data:

          

Equity per share

   $ 13.10      $ 12.66      $ 12.40      $ 14.13      $ 13.15   

Cash dividends declared per share

     .16        .16        .16        .16        .16   

Weighted average common shares outstanding during the period

     32,292        33,861        33,977        38,532        38,671   

Shares used to compute diluted earnings (loss) per share during the period

     32,572        33,861        34,194        38,688        38,931   

Shares outstanding at end of period

     31,883        33,888        33,910        34,765        39,286   

Closing market price per share:

          

High

   $ 20.19      $ 18.68      $ 20.59      $ 24.45      $ 23.32   

Low

     14.93        12.79        11.41        13.33        13.06   

End of year

     19.38        15.82        18.18        16.08        22.61   

Total return to shareholders (h)

     23.5 %      (12.1 )%      14.1     (28.2 )%      76.6

Financial Position:

          

Total assets

   $ 580,342      $ 596,279      $ 610,632      $ 784,478      $ 781,787   

Cash and cash equivalents

     73,191        90,663        45,975        48,217        40,898   

Debt

     450        1,163        22,702        82,056        62,520   

Shareholders’ equity (net book value)

     417,546        429,072        420,416        491,328        516,595   

Equity market capitalization (i)

     617,893        536,108        616,484        559,021        888,256   

Refer to notes to financial tables on page 18.

 

14


Table of Contents

SEGMENT TABLES

Tredegar Corporation and Subsidiaries

 

Net Sales (j)

                                  

Segment

   2010      2009      2008      2007      2006  
(In Thousands)                                   

Film Products

   $ 520,445       $ 455,007       $ 522,839       $ 530,972       $ 511,169   

Aluminum Extrusions

     199,639         177,521         340,278         371,803         403,790   

Other

     2,579         —           —           —           —     
                                            

Total net sales

     722,663         632,528         863,117         902,775         914,959   

Add back freight

     17,812         16,085         20,782         19,808         22,602   
                                            

Sales as shown in Consolidated Statements of Income

   $ 740,475       $ 648,613       $ 883,899       $ 922,583       $ 937,561   
                                            

Identifiable Assets

                                  

Segment

   2010      2009      2008      2007      2006  
(In Thousands)                                   

Film Products

   $ 363,312       $ 371,639       $ 399,895       $ 488,035       $ 498,961   

Aluminum Extrusions

     81,731         82,429         112,259         115,223         128,967   

AFBS (formerly Therics)

     583         1,147         1,629         2,866         2,420   

Other

     19,701         —           —           —           —     
                                            

Subtotal

     465,327         455,215         513,783         606,124         630,348   

General corporate

     41,824         50,401         50,874         74,927         30,113   

Cash and cash equivalents

     73,191         90,663         45,975         48,217         40,898   
                                            

Identifiable assets from continuing operations

     580,342         596,279         610,632         729,268         701,359   

Discontinued operations (a):

              

Aluminum extrusions business in Canada

     —           —           —           55,210         80,428   
                                            

Total

   $ 580,342       $ 596,279       $ 610,632       $ 784,478       $ 781,787   
                                            

Refer to notes to financial tables on page 18.

 

15


Table of Contents

SEGMENT TABLES

Tredegar Corporation and Subsidiaries

 

0000000 0000000 0000000 0000000 0000000

Operating Profit

                              

Segment

   2010     2009     2008     2007     2006  
(In Thousands)                               

Film Products:

          

Ongoing operations

   $ 71,184      $ 64,379      $ 53,914      $ 59,423      $ 57,645   

Plant shutdowns, asset impairments and restructurings, net of gains on sale of assets and related income from LIFO inventory liquidations

     (505 )(c)      (1,846 )(d)      (11,297 )(e)      (649 )(f)      221 (g) 
                                        

Aluminum Extrusions:

          

Ongoing operations

     (4,154     (6,494     10,132        16,516        18,302   

Plant shutdowns, asset impairments, restructurings and other

     493 (c)      (639 )(d)      (687 )(e)      (634 )(f)      (1,434 )(g) 

Goodwill impairment charge

     —          (30,559 )(b)      —          —          —     
                                        

AFBS (formerly Therics):

          

Loss on investment in Therics, LLC

     —          —          —          —          (25

Gain on sale of investments in Theken Spine and Therics, LLC

     —          1,968 (d)      1,499 (e)      —          —     

Plant shutdowns, asset impairments, restructurings and other

     —          —          —          (2,786 )(f)      (637 )(g) 

Other

          

Ongoing operations

     (4,173     —          —          —          —     

Plant shutdowns, asset impairments, restructurings and other

     (253 )(c)      —          —          —          —     
                                        

Total

     62,592        26,809        53,561        71,870        74,072   

Interest income

     709        806        1,006        1,212        1,240   

Interest expense

     1,136        783        2,393        2,721        5,520   

Gain on sale of corporate assets

     —          404        1,001        2,699        56   

Gain (loss) on investment accounted for under the fair value method

     (2,200 )(c)      5,100 (d)      5,600 (e)      —          —     

Loss from write-down of an investment

     —          —          —          2,095 (f)      —     

Stock option-based compensation costs

     2,064        1,692        782        978        970   

Corporate expenses, net

     17,118        13,334        8,866        10,691        13,770   
                                        

Income from continuing operations before income taxes

     40,783        17,310        49,127        59,296        55,108   

Income taxes

     13,756 (c)      18,663 (d)      19,486 (e)      24,366        19,791 (g) 
                                        

Income (loss) from continuing operations

     27,027        (1,353     29,641        34,930        35,317   

Income (loss) from discontinued operations (a)

     —          —          (705     (19,681     2,884   
                                        

Net income (loss)

   $ 27,027      $ (1,353   $ 28,936      $ 15,249      $ 38,201   
                                        

Refer to notes to financial tables on page 18.

 

16


Table of Contents

SEGMENT TABLES

Tredegar Corporation and Subsidiaries

 

Depreciation and Amortization

                                  

Segment

   2010      2009      2008      2007      2006  
(In Thousands)                                   

Film Products

   $ 33,765       $ 32,360       $ 34,588       $ 34,092       $ 31,847   

Aluminum Extrusions

     9,054         7,566         8,018         8,472         8,378   

Other

     695         —           —           —           —     
                                            

Subtotal

     43,514         39,926         42,606         42,564         40,225   

General corporate

     74         71         70         91         111   
                                            

Total continuing operations

     43,588         39,997         42,676         42,655         40,336   

Discontinued operations (a):

              

Aluminum extrusions business in Canada

     —           —           515         3,386         3,945   
                                            

Total

   $ 43,588       $ 39,997       $ 43,191       $ 46,041       $ 44,281   
                                            

Capital Expenditures and Investments

                                  

Segment

   2010      2009      2008      2007      2006  
(In Thousands)                                   

Film Products

   $ 15,664       $ 11,487       $ 11,135       $ 15,304       $ 33,168   

Aluminum Extrusions

     4,339         22,530         9,692         4,391         6,609   

Other

     179         —           —           —           —     
                                            

Subtotal

     20,182         34,017         20,827         19,695         39,777   

General corporate

     236         125         78         6         24   
                                            

Capital expenditures for continuing operations

     20,418         34,142         20,905         19,701         39,801   

Discontinued operations (a):

              

Aluminum extrusions business in Canada

     —           —           39         942         772   
                                            

Total capital expenditures

     20,418         34,142         20,944         20,643         40,573   

Investments

     —           —           5,391         23,513         542   
                                            

Total

   $ 20,418       $ 34,142       $ 26,335       $ 44,156       $ 41,115   
                                            

Refer to notes to financial tables on page 18.

 

17


Table of Contents

NOTES TO FINANCIAL TABLES

 

 

(a) On February 12, 2008, we sold our aluminum extrusions business in Canada. All historical results for this business have been reflected as discontinued operations. In 2008, discontinued operations include an after-tax loss of $412,000 on the sale in addition to operating results through the closing date. In 2007, discontinued operations also include $11.4 million in cash income tax benefits from the sale that were realized in 2008.
(b) A goodwill impairment charge of $30.6 million ($30.6 million after taxes) was recognized in Aluminum Extrusions upon completion of an impairment analysis performed as of March 31, 2009. The non-cash charge, computed under U.S. generally accepted accounting principles, resulted from the estimated adverse impact on the business unit’s fair value of possible future losses and the uncertainty of the amount and timing of an economic recovery.
(c) Plant shutdowns, asset impairments, restructurings and other for 2010 include gains of $893,000 associated with Aluminum Extrusions for timing differences between the recognition of realized losses on aluminum futures contracts and related revenues from the delayed fulfillment by customers of fixed-price forward purchase commitments (included in “Cost of goods sold” in the consolidated statements of income); asset impairment charges of $608,000 related to Films Products ($355,000) and the Other segment ($253,000); a charge of $400,000 related to expected future environmental costs at the aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income); charges of $165,000 for severance and other employee-related costs in connection with restructurings in Film Products; a gain of $120,000 on the sale of previously impaired equipment (included in “Other income (loss), net” in the consolidated statements of income) at the film products manufacturing facility in Pottsville, Pennsylvania; and losses of $105,000 on the disposal of equipment (included in “Other income (expense), net” in the consolidated statements of income) from a previously shutdown film products manufacturing facility in LaGrange, Georgia. The loss from the write-down of an investment accounted for under the fair value method of $2.2 million in 2010 is included in “Other income (expense), net” in the consolidated statement of income. Income taxes in 2010 include the recognition of an additional valuation allowance of $215,000 related to the expected limitations on the utilization of assumed capital losses on certain investments.
(d) Plant shutdowns, asset impairments, restructurings and other for 2009 include a charge of $2.1 million for severance and other employee related costs in connection with restructurings for Film Products ($1.3 million), Aluminum Extrusions ($433,000) and corporate headquarters ($396,000, included in “Corporate expenses, net” in the operating profit by segment table); an asset impairment charge of $1.0 million in Films Products; losses of $952,000 associated with Aluminum Extrusions for timing differences between the recognition of realized losses on aluminum futures contracts and related revenues from the delayed fulfillment by customers of fixed-price forward purchase commitments (included in “Cost of goods sold” in the consolidated statements of income); a gain of $640,000 related to the sale of land at our aluminum extrusions facility in Newnan, Georgia (included in “Other income (expense), net” in the consolidated statements of income); a gain of $275,000 on the sale of equipment (included in “Other income (expense), net” in the consolidated statements of income) from a previously shutdown film products manufacturing facility in LaGrange, Georgia; a gain of $175,000 on the sale of a previously shutdown aluminum extrusions manufacturing facility in El Campo, Texas (included in “Other income (expense), net” in the consolidated statements of income); a gain of $149,000 related to the reversal to income of certain inventory impairment accruals in Film Products; and a net charge of $69,000 (included in “Costs of goods sold” in the consolidated statement of income) related to adjustments of future environmental costs expected to be incurred by Aluminum Extrusions. The gain from the write-up of an investment accounted for under the fair value method of $5.1 million in 2009 is included in “Other income (expense), net” in the consolidated statement of income. The gain on sale of investments in Theken Spine and Therics, LLC, which is also included in “Other income (expense), net” in the consolidated statement of income, includes the receipt of a contractual earn-out payment of $1.8 million and a post-closing contractual adjustment of $150,000. AFBS Inc. (formerly Therics, Inc.) received these investments in 2005, when substantially all of the assets of AFBS, Inc., a wholly owned subsidiary of Tredegar, were sold or assigned to a newly created limited liability company, Therics, LLC, controlled and managed by an individual not affiliated with Tredegar. Income taxes in 2009 include the recognition of an additional valuation allowance of $2.1 million related to the expected limitations on the utilization of assumed capital losses on certain investments.
(e) Plant shutdowns, asset impairments, restructurings and other for 2008 include an asset impairment charge of $9.7 million for Film Products; a charge of $2.7 million for severance and other employee related costs in connection with restructurings for Film Products ($2.2 million) and Aluminum Extrusions ($510,000); a gain of $583,000 from the sale of land rights and related improvements at the film products facility in Shanghai, China (included in “Other income (expense), net” in the consolidated statement of income); and a $177,000 charge related to expected future environmental costs at the aluminum extrusions facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income). The gain of $1.5 million from the sale of our investments in Theken Spine and Therics, LLC is included in “Other income (expense), net” in the consolidated statements of income. The gain from the write-up of an investment accounted for under the fair value method of $5.6 million in 2008 is included in “Other income (expense), net” in the consolidated statements of income. Income taxes in 2008 includes the reversal of a valuation allowance recognized in the third quarter of 2007 of $1.1 million that originally related to expected limitations on the utilization of assumed capital losses on certain investments.
(f) Plant shutdowns, asset impairments, restructurings and other for 2007 include a charge of $2.8 million related to the estimated loss on the sub-lease of a portion of the AFBS (formerly Therics) facility in Princeton, New Jersey; charges of $594,000 for asset impairments in Film Products; a charge of $592,000 for severance and other employee-related costs in Aluminum Extrusions; a charge of $55,000 related to the shutdown of the films manufacturing facility in LaGrange, Georgia; and a charge of $42,000 associated with the expected future environmental costs at the aluminum extrusions facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income). The loss from the write-down of an investment in 2007 of $2.1 million is included in “Other income (expense), net” in the consolidated statements of income.
(g) Plant shutdowns, asset impairments, restructurings and other for 2006 include a net gain of $1.5 million associated with the shutdown of the films manufacturing facility in LaGrange, Georgia, including a gain of $2.9 million for related LIFO inventory liquidations (included in “Cost of goods sold” in the consolidated statements of income) and a gain of $261,000 on the sale of related property and equipment (included in “Other income (expense), net” in the consolidated statements of income), partially offset by severance and other costs of $1.6 million and asset impairment charges of $130,000; charges of $1.0 million for asset impairments in Film Products; a charge of $920,000 related to expected future environmental costs at the aluminum extrusions facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income); charges of $727,000 for severance and other employee-related costs in connection with restructurings in Film Products ($213,000) and Aluminum Extrusions ($514,000); and charges of $637,000 related to the estimated loss on the sub-lease of a portion of the AFBS facility in Princeton, New Jersey. Income taxes in 2006 include a reversal of a valuation allowance of $577,000 for deferred tax assets associated with capital loss carry-forwards recorded with the write-down of the investment in Novalux in 2005. Outside appraisal of the value of corporate assets, primarily real estate, performed in December 2006, indicated that realization of related deferred tax assets is more likely than not.
(h) Total return to shareholders is defined as the change in stock price during the year plus dividends per share, divided by the stock price at the beginning of the year.
(i) Equity market capitalization is the closing market price per share for the period multiplied by the shares outstanding at the end of the period.
(j) Net sales represent gross sales less freight. Net sales is the measure used by the chief operating decision maker of each segment for purposes of assessing performance.

 

18


Table of Contents
Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-looking and Cautionary Statements

Some of the information contained in this Form 10-K may constitute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When we use the words “believe,” “estimate,” “anticipate,” “expect,” “project,” “likely,” “may” and similar expressions, we do so to identify forward-looking statements. Such statements are based on our then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that our actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. For risks and important factors that could cause actual results to differ from expectations refer to “Risk Factors” in Part I, Item 1A of this Form 10-K. Readers are urged to review and consider carefully the disclosures Tredegar makes in the reports Tredegar files with or furnishes to the SEC. Tredegar does not undertake to update any forward-looking statement to reflect any change in management’s expectations or any change in conditions, assumptions or circumstances on which such statements are based.

Executive Summary

General

Tredegar is primarily a manufacturer of plastic films and aluminum extrusions. Descriptions of all of our businesses are provided on pages 1-7.

Income from continuing operations was $27.0 million (83 cents per diluted share) in 2010, compared with losses from continuing operations of $1.4 million (4 cents per diluted share) in 2009. Losses associated with plant shutdowns, assets impairments and restructurings and gains and losses on the sale of assets, gains or losses on investments accounted for under the fair value method and other items are described in results of continuing operations beginning on page 25. The business segment review begins on page 36.

Film Products

A summary of operating results for Film Products is provided below:

 

(In thousands, except percentages)    Year Ended
December 31
     Favorable/
(Unfavorable)
% Change
 
     2010      2009     

Sales volume (pounds)

     221,210         206,670         7.0

Net sales

   $ 520,445       $ 455,007         14.4

Operating profit from ongoing operations

   $ 71,184       $ 64,379         10.6

Net sales increased in 2010 compared to the prior year due to higher volume in all major markets and an increase in average selling prices from the pass-through of higher resin prices. Operating profit from ongoing operations increased in 2010 compared to 2009 due to the higher sales volumes referenced above, partially offset by the unfavorable lag in the pass-through of higher resin costs, an increase in selling, general and administrative expenses that were planned to support growth initiatives and unfavorable changes in the U.S. dollar value of currencies for operations outside the U.S.

Film Products has index-based pass-through raw material cost agreements for the majority of its business. However, under certain agreements, changes in resin prices are not passed through for an average period of 90 days. The estimated impact of the lag in the pass-through of changes in average resin costs and year-end adjustments for inventories accounted for under the last-in first-out method (“LIFO”) was a negative $5.5 million in 2010 and a positive $1.7 million in 2009. The estimated unfavorable impact from U.S. dollar value currencies for operations outside the U.S. was $1.3 million in 2010 compared with 2009.

 

19


Table of Contents

Future operating profit levels within Film Products will depend upon our ability to design and market new application of our films, to maintain margins associated with new product introductions and growth initiatives and to effectively address competitive pricing pressures and the challenge of competition from substitute materials.

Capital expenditures in Film Products were $15.7 million in 2010 compared to $11.5 million in 2009, and are projected to be approximately $27 million in 2011. Depreciation expense was $33.6 million in 2010 compared to $32.2 million in 2009, and is projected to be approximately $35 million in 2011.

Aluminum Extrusions

A summary of operating results for Aluminum Extrusions is provided below:

 

(In thousands, except percentages)    Year Ended
December 31
    Favorable/
(Unfavorable)
% Change
 
     2010     2009    

Sales volume (pounds)

     94,890        91,486        3.7

Net sales

   $ 199,639      $ 177,521        12.5

Operating loss from ongoing operations

   $ (4,154   $ (6,494     36.0

The increase in net sales was due to higher volumes and an increase in average selling prices driven by higher average aluminum costs. Sales volume increased 3.7% in 2010 compared to 2009 despite extremely challenging conditions in nonresidential construction. Shipments in nonresidential construction, which comprised 68% of total volume in 2010, were relatively flat in 2010 compared with 2009. The favorable change in operating losses from ongoing operations in 2010 reflects higher volumes in multiple sectors, tightly managed overhead expenses, and the favorable impact in 2010 versus 2009 of $2.9 million for adjustments related to inventories accounted for under LIFO, partially offset by a less favorable sales mix. Aluminum Extrusions continues to concentrate its efforts on controlling costs and effectively managing working capital, as the timing of a meaningful recovery in the U.S. nonresidential construction market remains uncertain.

Upon completing an impairment analysis as of March 31, 2009, a goodwill impairment charge of $30.6 million ($30.6 million after tax) was recognized in Aluminum Extrusions in the prior year. This impairment charge represents the entire amount of goodwill associated with the Aluminum Extrusions reporting unit. For additional detail on this goodwill impairment charge, see Note 1 of the notes to the financial statements beginning on page 49.

Capital expenditures in Aluminum Extrusions were $4.3 million in 2010, an $18.2 million decrease from $22.5 million in 2009, and are projected to be approximately $5 million in 2011. The project to expand capacity at our Carthage, Tennessee manufacturing facility, which was completed in 2009 and increased our capabilities in the nonresidential construction sector, accounted for $19.0 million of capital expenditures in 2009. Depreciation expense was $9.1 million in 2010, compared to $7.6 million in 2009, and is projected to be $9 million in 2011.

Other

In February 2010, we reported an additional segment, Other, comprised of the start-up operations of Bright View and Falling Springs. We acquired the assets of Bright View, a late-stage development company, on February 3, 2010. Bright View is a developer and producer of high-value microstructure-based optical films for the LED (light emitting diode) and fluorescent lighting markets. Falling Springs develops, owns and operates multiple mitigation banks. Through the establishment of perpetual easements to restore, enhance and preserve wetlands, streams or other protected environmental resources, these mitigation banks create saleable credits that are used by the purchaser of credits to offset the negative environmental impacts from private and public development projects.

Net sales for this segment can fluctuate from quarter-to-quarter as Bright View is a late-stage development company and Falling Springs’ revenue can vary based upon the timing of development projects within its markets. Operating losses from ongoing operations were $4.2 million in 2010. Although these companies are in their relative infancy and currently are incurring operating losses, we are encouraged by their progress in developing new products and sustainable business models.

 

20


Table of Contents

Corporate Expenses, Interest and Income Taxes

Pension expense was $662,000 in 2010, an unfavorable change of $3.8 million from net pension income recognized in 2009. Most of the change is reflected in “Corporate expenses, net” in the segment operating profit table presented on page 16. We contributed approximately $167,000 to our pension plans in 2010, and minimum required contributions to our pension plans in 2011 are expected to be comparable. Pension expense in 2011 is estimated at $2.3 million. Corporate expenses, net in 2010 increased in comparison to 2009 primarily due to the unfavorable impact of pension expense noted above and adjustments for certain performance-based compensation programs.

In June 2010, we entered into a new four-year, $300 million unsecured revolving credit facility, which replaced our previous revolving credit facility that was due to expire on December 15, 2010. Interest expense, which includes the amortization of debt issue costs, increased by $353,000 in 2010.

The effective tax rate used to compute income taxes was 33.7% in 2010 compared with 107.8% in 2009. The change in the effective tax rate for 2010 versus 2009 was due to numerous factors as shown in the effective income tax rate reconciliation provided in Note 14 on page 71.

In 2010, we repurchased 2.1 million shares of our stock under a standing authorization from our board of directors for $35.1 million, compared to 105,497 shares for $1.5 million in 2009 and 1.1 million shares for $16.4 million in 2008. Our net cash balance (cash and cash equivalents of $73.2 million in excess of total debt of $450,000) at December 31, 2010 was $72.7 million, compared to net cash balance (cash and cash equivalents of $90.7 million in excess of total debt of $1.2 million) at December 31, 2009 of $89.5 million. Net cash is not intended to represent debt or cash as defined by generally accepted accounting principles, but is utilized by management in evaluating financial leverage and equity valuation and we believe that investors also may find net debt or cash helpful for the same purposes. Consolidated net capitalization and other credit measures are provided in the financial condition section beginning on page 28.

Critical Accounting Policies

In the ordinary course of business, we make a number of estimates and assumptions relating to the reporting of results of operations and financial position in the preparation of financial statements in conformity with generally accepted accounting principles. Actual results could differ significantly from those estimates under different assumptions and conditions. We believe the following discussion addresses our critical accounting policies. These policies require management to exercise judgments that are often difficult, subjective and complex due to the necessity of estimating the effect of matters that are inherently uncertain.

Impairment and Useful Lives of Long-lived Identifiable Assets and Goodwill

We regularly assess our long-lived identifiable assets for impairment when events or circumstances indicate that their carrying value may not be recoverable from future cash flows. Any necessary impairment charges are recorded when we do not believe the carrying value of the long-lived asset will be recoverable. We also reassess the useful lives of our long-lived assets based on changes in our business and technologies.

We assess goodwill for impairment when events or circumstances indicate that the carrying value may not be recoverable, or, at a minimum, on an annual basis (December 1st of each year). Our reporting units include, but are not limited to, Film Products and Aluminum Extrusions, each of which may have separately identifiable operating net assets (operating assets including goodwill and intangible assets net of operating liabilities). As of December 31, 2010, Film Products was the only reporting unit that carried a goodwill balance.

In assessing the recoverability of long-lived identifiable assets and goodwill, we estimate fair value using discounted cash flow analysis and comparative enterprise value-to-EBITDA (earnings before interest, taxes, depreciation and amortization) multiples. These calculations require us to make assumptions regarding estimated future cash flows, discount rates and other factors to determine if an impairment exists. If these estimates or their related assumptions change in the future, we may be required to record additional impairment charges.

 

21


Table of Contents

Based on the severity of the economic downturn and its impact on sales volumes of our aluminum extrusions business (a 36.8% decline in sales volume in the first quarter of 2009 compared with the first quarter of 2008), the resulting loss in the first quarter of 2009, possible future losses and the uncertainty in the amount and timing of an economic recovery, we determined that impairment indicators existed in the first quarter of 2009. Upon completing the impairment analysis as of March 31, 2009, a goodwill impairment charge of $30.6 million, which represents the entire amount of goodwill associated with Aluminum Extrusions, was recorded.

Based upon assessments performed as to the recoverability of long-lived identifiable assets, we have recorded asset impairment losses for continuing operations of $608,000 in 2010, $1.0 million in 2009 and $8.6 million in 2008.

Investment Accounted for Under the Fair Value Method

During the third quarter of 2007, we invested $6.5 million in a privately held specialty pharmaceutical company. In the fourth quarter of 2008, we invested an additional $1.0 million as part of a new round of equity financing completed by the investee. This investment is accounted for under the fair value method. We elected the fair value option over the equity method of accounting since our investment objectives are similar to those of venture capitalists, which typically do not have controlling financial interests (venture capital funds generally use the fair value method to account for their investment portfolios). At December 31, 2010, our ownership interest was approximately 21% on a fully diluted basis.

U.S. generally accepted accounting principles requires disclosure of the level within the fair value hierarchy in which fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). On the dates of our investments (August 31, 2007 and December 15, 2008), we believe that the amount we paid for our ownership interest and liquidation preferences was based on Level 2 inputs, including investments by other investors. Subsequent to the last round of financing, and until the next round of financing, we believe fair value estimates drop to Level 3 inputs since there is no secondary market for our ownership interest. In addition, the investee currently has no product sales. Accordingly, after the latest financing and until the next round of financing or any other significant financial transaction, fair value estimates will primarily be based on assumptions relating to meeting product development and commercialization milestones, cash flow projections (projections of development and commercialization milestone payments, sales, costs, expenses, capital expenditures and working capital investment) and discounting of these factors for the high degree of risk.

In connection with the new round of equity financing in the fourth quarter of 2008, we recognized an unrealized gain of $5.6 million for the write-up of this investment based upon the implied valuation of our ownership interest. In the fourth quarter of 2009, we recognized an additional unrealized gain of $5.1 million for the appreciation of our ownership interest upon the investee entering into an exclusive licensing agreement that included an upfront payment, additional potential milestone payments and tiered royalties on sales of any products commercialized under the license. In the fourth quarter of 2010, we recognized an unrealized loss of $2.2 million after the investee, which had its new drug application to the Food & Drug Administration (“FDA”) accepted for review during the quarter, reassessed its projected timeframe for obtaining final marketing approval from the FDA. At December 31, 2010 and 2009, the fair value of our investment (the carrying value included in “Other assets and deferred charges” in our consolidated balance sheet) was $16.0 million and $18.2 million, respectively. The fair market valuation of our interest in the specialty pharmaceutical company is sensitive to changes in the weighted average cost of capital used to discount cash flow projections for the high degree of risk associated with meeting development and commercialization milestones as anticipated. At December 31, 2010, the effect of a 500 basis point change in the weighted average cost of capital assumption would have increased or decreased the fair value of our interest in the specialty pharmaceutical company by approximately $1-2 million. Any future changes in the estimated fair value of our ownership interest will likely be attributed to a new round of financing, a merger or initial public offering or adjustments to the timing or magnitude of cash flows associated with development and commercialization milestones. Adjustments to the estimated fair value of our investment will be made in the period upon which such changes can be quantified.

 

22


Table of Contents

Pension Benefits

We have noncontributory defined benefit (pension) plans in our continuing operations that have resulted in varying amounts of net pension income or expense, as developed from actuarial valuations. Inherent in these valuations are key assumptions including discount rates, expected return on plan assets and rate of future compensation increases. We are required to consider current market conditions, including changes in interest rates and plan asset investment returns, in determining these assumptions. Actuarial assumptions may differ materially from actual results due to changing market and economic conditions, higher or lower withdrawal rates or longer or shorter life spans of participants. These differences may result in a significant impact to the amount of net pension income or expense recorded in future periods.

The discount rate is used to determine the present value of future payments. The discount rate is the single rate that, when applied to expected benefit payments, provides a present value equal to the present value of expected benefit payments determined by using the AA-rated bond yield curve. In general, our liability increases as the discount rate decreases and vice versa. Our weighted average discount rate for continuing operations was 5.45% at the end of 2010, 5.70% at the end of 2009 and 6.5% at the end of 2008, with changes between periods due to changes in market interest rates. Based on plan changes announced in 2006, pay for active participants of the plan was frozen as of December 31, 2007. A lower expected return on plan assets increases the amount of expense and vice versa. Decreases in the level of actual plan assets will also serve to increase the amount of pension expense. The value of our plan assets relating to continuing operations, which is primarily affected by the change in fair value of plan assets and current year payments to participants, increased 4.7% and 17.7%, in 2010 and 2009, respectively, partially recovering from an $89.6 million decline in 2008. The 31.5% asset value decline in 2008 was primarily due to the drop in global stock prices. Between 2003 and 2007, the value of our plan assets relating to continuing operations increased due to improved general market conditions after declining from 2000 to 2002. Our expected long-term return on plan assets relating to continuing operations, which is estimated by asset class and generally based on inflation-adjusted historical returns, volatilities, risk premiums and managed asset premiums, was 8.25% in 2010 and 2009 and 8.5% from 2004 to 2008. We anticipate that our expected long-term return on plan assets will be 8.25% for 2011. See page 68 for more information on expected long-term return on plan assets and asset mix.

See the executive summary beginning on page 19 for further discussion regarding the financial impact of our pension plans.

Income Taxes

On a quarterly basis, we review our judgments regarding uncertain tax positions and the likelihood that the benefits of a deferred tax asset will be realized. As circumstances change, we reflect in earnings any adjustments to unrecognized benefits for uncertain tax positions and valuation allowances for deferred tax assets.

For financial reporting purposes, we had unrecognized tax benefits on uncertain tax positions of $1.1 million, $1.0 million and $2.6 million as of December 31, 2010, 2009 and 2008, respectively. Included in the 2010, 2009 and 2008 amounts were $234,000, $348,000 and $1.8 million, respectively, for tax positions for which ultimate deductibility is highly certain but for which the timing of deductibility is uncertain. Because of the impact of deferred income tax accounting, other than interest, penalties and deductions not related to timing, a longer deductibility period would not affect the total income tax expense or the annual effective tax rate shown for financial reporting purposes, but would accelerate payments to the taxing authority. Tax payments resulting from the successful challenge by the taxing authority for accelerated deductions taken by us would possibly result in the payment of interest and penalties. Accordingly, we also accrue for possible interest and penalties on uncertain tax positions. The balance of accrued interest and penalties on deductions taken relating to uncertain tax positions was approximately $125,000, $537,000, and $1.3 million at December 31, 2010, 2009 and 2008, respectively ($79,000, $342,000 and $827,000, respectively, net of corresponding federal and state income tax benefits). Accruals for possible interest and penalties on uncertain tax positions are reflected in income tax expense for financial reporting purposes.

 

23


Table of Contents

In 2009, we settled several disputed issues raised by the IRS during its examination of our U.S. income tax returns for 2001-2003, the most significant of which regards the recognition of our captive insurance subsidiary as an insurance company for U.S. income tax purposes. The settlement with the IRS for the disputed issues cost us approximately $1.0 million, which is lower than the previous estimate of $1.3 million and was applied against the balance of unrecognized tax benefits.

Tredegar and its subsidiaries file income tax returns in the U.S., various states, and jurisdictions outside the U.S. Generally, except for refund claims and amended returns, Tredegar is no longer subject to U.S. federal income tax examinations by tax authorities for years before 2006. With few exceptions, Tredegar and its subsidiaries are no longer subject to state or non-U.S. income tax examinations by tax authorities for years before 2007.

As of December 31, 2010 and 2009, we had valuation allowances relating to deferred tax assets of $12.0 million and $11.7 million, respectively. For more information on deferred income tax assets and liabilities, see Note 14 of the notes to financial statements.

Recently Issued Accounting Standards

The Financial Accounting Standards Board (“FASB”) Emerging Issues Task Force issued a consensus updating accounting standards for revenue recognition for multiple-deliverable arrangements in October 2009. The stated objective of the accounting standards update was to address the accounting for multiple-deliverable arrangements to enable vendors to account for products or services (deliverables) separately rather than as a combined unit. The revision of current FASB guidance provides amended methodologies for separating consideration in multiple-deliverable arrangements and expands disclosure requirements. The accounting standards update will be effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010, with early adoption permitted. We do not expect these FASB rules to have a material impact on our financial statements and disclosures.

The FASB issued guidance in January 2010 that requires new disclosures for fair value measurements and provides clarification for existing disclosure requirements. More specifically, this update will require (a) an entity to disclose separately the amounts of significant transfers in and out of Levels 1 and 2 fair value measurements and to describe the reasons for such transfers; and (b) information about purchases, sales, issuances and settlements to be presented separately (i.e. present the activity on a gross basis rather than net) in the reconciliation for fair value measurements using significant unobservable inputs (Level 3 inputs). This update also clarifies existing disclosure requirements for the level of disaggregation used for classes of assets and liabilities measured at fair value and requires disclosures about the valuation techniques and inputs used to measure fair value for both recurring and nonrecurring fair value measurements using Level 2 and Level 3 inputs. The new disclosures and clarifications of existing disclosures were effective for interim and annual reporting periods beginning after December 15, 2009, except for disclosures about the purchase, sale, issuance and settlement activity of Level 3 fair value measurements. Those disclosures are effective for fiscal years beginning after December 15, 2010, and for the interim periods in that year. The adoption of these new disclosures and clarifications of existing disclosures have not and are not expected to materially expand our current financial statement footnote disclosures.

In March 2010, the Patient Protection and Affordable Care Act (the “PPACA”) was signed into law, as was the Health Care and Education Reconciliation Act of 2010, which amends certain aspects of the PPACA. Included in the provisions of these laws are changes to the taxation related to the federal subsidy available to companies that provide retiree health benefit plans that include a benefit that is at least actuarially equivalent to the benefits of Medicare Part D. Our retiree medical plan does not include prescription drug coverage for Medicare-eligible retirees, so we are not impacted by changes to the taxation of this federal subsidy. We will continue to assess the other potential long-term impacts, if any, that any amendments or clarifications of this legislation may have on future results of operations, cash flows or financial position related to our health care benefits and postretirement health care obligations, as events warrant.

 

24


Table of Contents

Results of Continuing Operations

2010 versus 2009

Revenues. Sales in 2010 increased by 14.2% compared with 2009 due to higher sales in both Film Products and Aluminum Extrusions. Net sales (sales less freight) increased 14.4% in Film Products due to higher volumes in all major markets and an increase in average selling prices related to the pass-through of higher resin prices to customers. Net sales increased 12.5% in Aluminum Extrusions as a result of higher volumes (an increase of 3.7%) and an increase in average selling prices driven by higher average aluminum prices. For more information on net sales and volume, see the executive summary beginning on page 19.

Operating Costs and Expenses. Consolidated gross profit (sales minus cost of goods sold and freight) as a percentage of sales was 17.1% in 2010 and 17.8% in 2009. The gross profit margin decreased in Film Products primarily due to the unfavorable effect of the lag in the pass-through of higher average resin costs and the unfavorable changes in the U.S. dollar value of currencies for operations outside of the U.S. Excluding adjustments related to inventories accounted for under LIFO, gross profit margins in Aluminum Extrusions decreased primarily as a result of a less favorable sales mix.

As a percentage of sales, selling, general and administrative and R&D expenses were 11.1% in 2010, which was relatively flat in comparison to 11.2% in 2009. Selling, general and administrative expenses and R&D expenses increased 13.7% primarily due to higher product development costs and expenditures for planned strategic initiatives in Film Products and expenditures related to our development and start-up enterprises in the Other segment, partially offset by tightly managed overhead expenses in Aluminum Extrusions.

Losses associated with plant shutdowns, asset impairments, restructurings and other charges in 2010 totaled $265,000 ($297,000 after taxes) and included:

 

 

A fourth quarter benefit of $413,000 ($257,000 after taxes), a third quarter benefit of $14,000 ($9,000 after taxes), a second quarter benefit of $23,000 ($14,000 after taxes), and a first quarter benefit of $443,000 ($275,000 after taxes) for timing differences between the recognition of realized losses on aluminum futures contracts and related revenues from the delayed fulfillment by customers of fixed-price forward purchase commitments (included in “Cost of goods sold” in the consolidated statements of income, see Note 6 starting on page 59 for additional detail);

 

 

Fourth quarter charges of $253,000 ($155,000 after taxes) for asset impairments in the Other segment and a second quarter charge of $355,000 ($355,000 after taxes) for asset impairments in Film Products;

 

 

A fourth quarter charge of $400,000 ($249,000 after taxes) related to expected future environmental costs at our aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income);

 

 

A third quarter charge of $109,000 ($69,000 after taxes) and a first quarter charge of $56,000 ($35,000 after taxes) for severance and other employee-related costs in connection with restructurings in Film Products;

 

 

A second quarter gain of $120,000 ($73,000 after taxes) related to the sale of previously impaired equipment (included in “Other income (expense), net” in the consolidated statements of income) at our film products manufacturing facility in Pottsville, Pennsylvania; and

 

 

A second quarter loss of $44,000 ($26,000 after taxes) and a first quarter loss of $61,000 ($36,000 after taxes) on the disposal of equipment (included in “Other income (expense), net” in the consolidated statements of income) from a previously shutdown films manufacturing facility in LaGrange, Georgia.

Results in 2010 include an unrealized loss from the write-down of an investment accounted for under the fair value method of $2.2 million ($1.4 million after taxes; see further discussion on page 22). For more information on costs and expenses, see the executive summary beginning on page 19.

Interest Income and Expense. Interest income, which is included in “Other income (expense), net” in the consolidated statements of income, was $709,000 in 2010, compared to $806,000 in 2009. Our policy permits investment of excess cash in marketable securities that have the highest credit ratings and maturities of less than one year with the primary objectives being safety of principal and liquidity.

 

25


Table of Contents

Interest expense, which includes the amortization of debt issue costs, was $1.1 million in 2010, compared to $783,000 for 2009. Average debt outstanding and interest rates were as follows:

 

0000 0000

(In Millions)

   2010     2009  

Floating-rate debt with interest charged on a rollover basis at one-month LIBOR plus a credit spread:

    

Average outstanding debt balance

   $ —        $ 5.0   

Average interest rate

     n/a        1.2

Fixed-rate and other debt:

    

Average outstanding debt balance

   $ 0.9      $ 1.5   

Average interest rate

     4.0     3.5
                

Total debt:

    

Average outstanding debt balance

   $     0.9      $ 6.5   

Average interest rate

     4.0     1.8
                

Income Taxes. The effective tax rate used to compute income taxes from continuing operations was 33.7% in 2010 compared with 107.8% in 2009. The differences between the U.S. federal statutory rate and the effective tax rate for continuing operations are shown in the effective income tax rate reconciliation provided in Note 14 on page 71.

2009 versus 2008

Revenues. Sales in 2009 decreased by 26.6% compared with 2008 due to sales declines in both Film Products and Aluminum Extrusions. Net sales (sales less freight) decreased 13.0% in Film Products due to the impact of lower selling prices from the pass-through of reduced resin prices, volume declines in personal care materials and packaging films and the unfavorable effect of foreign currency rates. Net sales decreased 47.8% in Aluminum Extrusions due to lower sales volumes and a decrease in average selling prices driven by lower aluminum prices. Volume in Aluminum Extrusions was 91.5 million pounds in 2009, down 32.8% from 136.2 million pounds in 2008.

Operating Costs and Expenses. Consolidated gross profit (sales minus cost of goods sold and freight) as a percentage of sales was 17.8% in 2009 and 14.0% in 2008. The gross profit margin increased in Film Products primarily due to cost reduction efforts, productivity gains, a change in product mix mostly driven by sales of higher-value surface protection materials and the lag in the pass-through of substantially higher average resin costs in 2008. Gross profit margins in Aluminum Extrusions decreased as a result of volume declines noted above.

As a percentage of sales, selling, general and administrative and R&D expenses were 11.2% in 2009, an increase from 7.9% in 2008. The increase in selling, general and administrative and R&D expenses as a percentage of sales was primarily due to the decline in sales noted above and adjustments made to accruals for certain performance-based compensation programs.

Losses associated with plant shutdowns, asset impairments, restructurings and other charges in 2009 totaled $2.9 million ($2.3 million after taxes) and included:

 

 

A fourth quarter charge of $181,000 ($121,000 after taxes) and a first quarter charge of $1.1 million ($806,000 after taxes) for severance and other employee-related costs in connection with restructurings in Film Products;

 

 

A fourth quarter charge of $1.0 million ($1.0 million after taxes) for asset impairments in Film Products;

 

 

A fourth quarter benefit of $547,000 ($340,000 after taxes), a third quarter charge of $111,000 ($69,000 after taxes), a second quarter charge of $779,000 ($484,000 after taxes), and a first quarter charge of $609,000 ($378,000 after taxes) for timing differences between the recognition of realized losses on aluminum futures contracts and related revenues from the delayed fulfillment by customers of fixed-price forward purchase commitments (included in “Cost of goods sold” in the consolidated statements of income, see Note 6 starting on page 59 for additional detail);

 

26


Table of Contents
 

A fourth quarter gain of $640,000 ($398,000 after taxes) related to the sale of land at our aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Other income (expense), net” in the consolidated statements of income);

 

 

A fourth quarter charge of $64,000 ($40,000 after taxes) and a first quarter charge of $369,000 ($232,000 after taxes) for severance and other employee-related costs in connection with restructurings in Aluminum Extrusions;

 

 

A fourth quarter charge of $218,000 ($139,000 after taxes) and a first quarter charge of $178,000 ($113,000 after taxes) for severance and other employee-related costs in connection with restructurings at corporate headquarters (included in “Corporate expenses, net” in the segment operating profit table in Note 3 on page 57);

 

 

A first quarter gain of $275,000 ($162,000 after taxes) on the sale of equipment (included in “Other income (expense), net” in the consolidated statements of income) from a previously shutdown films manufacturing facility in LaGrange, Georgia;

 

 

A second quarter gain of $175,000 ($110,000 after taxes) on the sale of previously shutdown aluminum extrusions manufacturing facility in El Campo, Texas (included in “Other income (expense), net” in the consolidated statements of income);

 

 

A second quarter gain of $149,000 ($91,000 after taxes) related to the reversal to income of certain inventory impairment accruals in Film Products; and

 

 

A fourth quarter charge of $345,000 ($214,000 after taxes) and a second quarter benefit of $276,000 ($172,000 after taxes) related to adjustments of future environmental costs expected to be incurred by Aluminum Extrusions (included in “Cost of goods sold” in the consolidated statements of income).

The severance in Film Products includes reduction in workforce in 2009 (approximately 50 employees) that saved approximately $2.0 million on an annual basis.

We recognized gains of $1.8 million ($1.2 million after taxes) from the receipt of a contractual earn-out payment and $150,000 ($96,000 after taxes) from a post-closing contractual adjustment from the sale in 2008 of our investments in Theken Spine and Therics, LLC. These gains are included in “Other income (expense), net” in the consolidated statements of income. AFBS Inc. (formerly Therics, Inc.) received these investments in 2005, when substantially all of the assets of AFBS, Inc., a wholly owned subsidiary of Tredegar, were sold or assigned to a newly created limited liability company, Therics, LLC, controlled and managed by an individual not affiliated with Tredegar.

Results in 2009 include unrealized gains from the write-up of an investment accounted for under the fair value method of $5.1 million ($3.2 million after taxes; see further discussion on page 22). Gains on the sale of corporate assets in 2009 include realized gains of $404,000 ($257,000 after taxes) from the sale of corporate real estate. The pretax amounts for each of these items are included in “Other income (expense), net” in the consolidated statements of income and separately shown in the segment operating profit table on page 16.

For more information on costs and expenses, see the executive summary beginning on page 19.

Interest Income and Expense. Interest income, which is included in “Other income (expense), net” in the consolidated statements of income, was $806,000 in 2009, compared to $1.0 million in 2008.

 

27


Table of Contents

Interest expense, which includes the amortization of debt issue costs, was $783,000 in 2009, a 67.3% decrease in comparison to $2.4 million for 2008 due to lower average debt levels and lower average interest rates during 2009. Average debt outstanding and interest rates were as follows:

 

0000 0000

(In Millions)

   2009     2008  

Floating-rate debt with interest charged on a rollover basis at one-month LIBOR plus a credit spread:

    

Average outstanding debt balance

   $ 5.0      $ 47.7   

Average interest rate

     1.2     3.8

Fixed-rate and other debt:

    

Average outstanding debt balance

   $ 1.5      $ 1.8   

Average interest rate

     3.5     4.1
                

Total debt:

    

Average outstanding debt balance

   $ 6.5      $ 49.5   

Average interest rate

     1.8     3.8
                

Income Taxes. The effective tax rate used to compute income taxes from continuing operations was 107.8% in 2009 compared with 39.7% in 2008. The differences between the U.S. federal statutory rate and the effective tax rate for continuing operations are shown in the effective income tax rate reconciliation provided in Note 14 on page 71.

Financial Condition

Assets and Liabilities

Changes in assets and liabilities from continuing operations from December 31, 2009 to December 31, 2010 are summarized below:

 

 

Accounts receivable increased $10.1 million (13.6%).

 

   

Accounts receivable in Film Products increased by $3.7 million due mainly to higher sales.

 

   

Accounts receivable in Aluminum Extrusions increased by $4.6 million primarily due to higher sales prices and an increase in sales in the fourth quarter of 2010.

 

   

Accounts and other receivables in corporate and other segment businesses increased $1.8 million due to timing of cash receipts.

 

 

Inventories increased $7.5 million (21.2%).

 

   

Inventories in Film Products increased by approximately $8.7 million. The increase can be primarily attributed to efforts to meet a surge in customer demand during the second and third quarters of 2010.

 

   

Inventories in Aluminum Extrusions decreased by approximately $1.3 million. Lower inventories at Aluminum Extrusions can be primarily attributed to efforts to effectively manage working capital balances in light of the uncertainty of the timing and the extent of the recovery in the nonresidential building and construction sector.

 

 

Net property, plant and equipment decreased $24.0 million (10.4%) due primarily to depreciation of $43.1 million, a change in the value of the U.S. dollar relative to foreign currencies (a decrease of approximately $3.3 million) and asset impairments and property disposals of $1.1 million, partially offset by capital expenditures of $20.4 million and equipment of $3.1 million acquired as part of the Bright View asset acquisition.

 

 

Goodwill and other intangibles increased by $1.6 million (1.5%) primarily due to the acquisition of the assets of Bright View, partially offset by changes in the value of the U.S. dollar relative to foreign currencies (decrease of approximately $646,000). Identifiable intangible assets purchased as part of the acquisition were $2.4 million. There was no goodwill recorded from the acquisition of the assets of Bright View.

 

 

Other assets increased by $2.6 million (5.6%) primarily due to additional investments in mitigation banking properties and an increase in deferred debt issuance costs related to our new revolving credit facility, partially offset by cash received from the initial withdrawal proceeds from Harbinger and the write-down of our investment accounted for under the fair value method (see Note 2 on page 54 for additional detail).

 

 

Accounts payable increased by $4.4 million (8.3%).

 

   

Accounts payable in Film Products increased by $5.8 million, or 20.9%, primarily due to higher sales volume, higher raw material costs and the timing of payments.

 

28


Table of Contents
   

Accounts payable in Aluminum Extrusions decreased by $2.4 million, or 9.1%, primarily due to the timing of aluminum purchases.

 

   

Accounts payable increased in corporate and the Other segment businesses by $1.0 million due to the normal volatility associated with the timing of payments.

 

 

Accrued expenses decreased by $1.7 million (4.9%) from December 31, 2009 primarily due to lower restructuring accruals in the current year (see Note 7 on page 62 for additional detail).

 

 

Other noncurrent liabilities increased by $737,000 (4.0%) due primarily to the change in the funded status of our defined benefit plans. As of December 31, 2010, the funded status of our defined benefit pension plan was a net liability of $8.3 million compared with $6.0 million as of December 31, 2009, while the liability associated with our other post-employment benefits plan was $7.4 million compared to $8.7 million as of December 31, 2009.

 

 

Net deferred income tax liabilities in excess of assets decreased by $8.3 million primarily due to numerous changes between years in the balance of the components shown in the December 31, 2010 and 2009 schedule of deferred income tax assets and liabilities provided in Note 14 on page 72. Income taxes recoverable increased by $2.6 million primarily due to timing of tax payments.

Net capitalization and indebtedness as defined under our revolving credit agreement as of December 31, 2010 were as follows:

Net Capitalization and Indebtedness as of December 31, 2010

(In Thousands)

 

Net capitalization:

  

Cash and cash equivalents

   $ 73,191   

Debt:

  

$300 million revolving credit agreement maturing June 21, 2014

     —     

Other debt

     450   
        

Total debt

     450   
        

Cash and cash equivalents net of debt

     (72,741

Shareholders’ equity

     417,546   
        

Net capitalization

   $ 344,805   
        

Indebtedness as defined in revolving credit agreement:

  

Total debt

   $ 450   

Face value of letters of credit

     6,621   

Liabilities relating to derivative financial instruments, net of cash deposits

     223   

Other

     106   
        

Indebtedness

   $ 7,400   
        

 

29


Table of Contents

Under the revolving credit agreement, borrowings are permitted up to $300 million, and approximately $263 million was available to borrow at December 31, 2010 based on the most restrictive covenants (no amounts borrowed at December 31, 2010). The credit spread and commitment fees charged on the unused amount under the revolving credit agreement at various indebtedness-to-adjusted EBITDA levels are as follows:

Pricing Under Revolving Credit Agreement (Basis Points)

 

Indebtedness-to-Adjusted EBITDA Ratio

   Credit Spread
Over LIBOR
     Commitment
Fee
 

> 2.0x but <= 3.0x

     250         40   

> 1.0x but <=2.0x

     225         35   

<= 1.0x

     200         30   

At December 31, 2010, the interest rate on debt borrowed under the revolving credit agreement would have been priced at one-month LIBOR plus the applicable credit spread of 200 basis points.

The computations of adjusted EBITDA, adjusted EBIT, the leverage ratio and interest coverage ratio as defined in the credit agreement are presented below along with the related most restrictive covenants. Adjusted EBITDA and adjusted EBIT as defined in the credit agreement are not intended to represent net income or cash flow from operations as defined by GAAP and should not be considered as either an alternative to net income or to cash flow.

 

30


Table of Contents

Computations of Adjusted EBITDA, Adjusted EBIT, Leverage Ratio and

Interest Coverage Ratio as Defined in Revolving Credit Agreement Along with Related Most

Restrictive Covenants

As of and for the Twelve Months Ended December 31, 2010 (In Thousands)

 

Computations of adjusted EBITDA and adjusted EBIT as defined in revolving credit agreement for the twelve months ended December 31, 2010:

  

Net income

   $ 27,027   

Plus:

  

After-tax losses related to discontinued operations

     —     

Total income tax expense for continuing operations

     13,756   

Interest expense

     1,136   

Depreciation and amortization expense for continuing operations

     43,588   

All non-cash losses and expenses, plus cash losses and expenses not to exceed $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings (cash-related of $565)

     1,278   

Charges related to stock option grants and awards accounted for under the fair value-based method

     2,064   

Losses related to the application of the equity method of accounting

     —     

Losses related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting

     2,200   

Minus:

  

After-tax income related to discontinued operations

     —     

Total income tax benefits for continuing operations

     —     

Interest income

     (709

All non-cash gains and income, plus cash gains and income in excess of $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings

     —     

Income related to changes in estimates for stock option grants and awards accounted for under the fair value-based method

     —     

Income related to the application of the equity method of accounting

     (242

Income related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting

     —     

Plus cash dividends declared on investments accounted for under the equity method of accounting

     267   

Plus or minus, as applicable, pro forma EBITDA adjustments associated with acquisitions and asset dispositions

     —     
        

Adjusted EBITDA as defined in revolving credit agreement

     90,365   

Less: Depreciation and amortization expense for continuing operations (including pro forma for acquisitions and asset dispositions)

     (43,588
        

Adjusted EBIT as defined in revolving credit agreement

   $ 46,777   
        

Shareholders’ equity at December 31, 2010 as defined in revolving credit agreement

   $ 417,546   

Computations of leverage and interest coverage ratios as defined in revolving credit agreement at December 31, 2010:

  

Leverage ratio (indebtedness-to-adjusted EBITDA)

     .08x   

Interest coverage ratio (adjusted EBIT-to-interest expense)

     41.18x   

Most restrictive covenants as defined in revolving credit agreement:

  

Maximum permitted aggregate amount of dividends that can be paid by Tredegar during the term of the revolving credit agreement ($100,000 plus 50% of net income generated beginning January 1, 2010)

   $ 113,514   

Minimum adjusted shareholders’ equity permitted ($300,000 plus 50% of net income generated, to the extent positive, beginning January 1, 2010)

   $ 313,514   

Maximum leverage ratio permitted:

  

Ongoing

     3.00x   

Pro forma for acquisitions

     2.50x   

Minimum interest coverage ratio permitted

     2.50x   

 

31


Table of Contents

While we had no outstanding borrowings on our $300 million credit facility as of December 31, 2010, noncompliance with any of the debt covenants may have a material adverse effect on financial condition or liquidity in the event such noncompliance cannot be cured or should we be unable to obtain a waiver from the lenders. Renegotiation of the covenant(s) through an amendment to the credit agreement may effectively cure the noncompliance, but may have an effect on financial condition or liquidity depending upon how the covenant is renegotiated.

We are obligated to make future payments under various contracts as set forth below:

 

     Payments Due by Period  

(In Millions)

   2011      2012      2013      2014      2015      Remainder      Total  

Debt

   $ .2       $ .1       $ .1       $ —         $ —         $ —         $ .4   

Operating leases:

                    

AFBS (formerly Therics)

     .4         —           —           —           —           —           .4   

Other

     1.3         1.7         1.6         1.7         1.1         3.2         10.6   

Estimated contributions required (1) :

                    

Defined benefit plans

     .2         1.9         .2         .2         .2         1.5         4.2   

Other postretirement benefits

     .4         .5         .5         .5         .5         5.0         7.4   

Capital expenditure commitments (2)

     3.4         —           —           —           —           —           3.4   

Estimated obligations relating to uncertain tax positions (3)

     —           —           —           —           —           1.2         1.2   

Other (4)

     .5         —           —           —           .3         —           .8   
                                                              

Total

   $ 6.4       $ 4.2       $ 2.4       $     2.4       $     2.1       $ 10.9       $ 28.4   
                                                              

 

(1) Estimated minimum required contributions for defined benefit plans and benefit payments for other postretirement plans are based on actuarial estimates using current assumptions for discount rates, long-term rate of return on plan assets, rate of compensation increases and health care cost trends. The expected defined benefit plan contribution estimates for 2011 through 2020 were determined under provisions of the Pension Protection Act of 2006 using the preliminary assumptions chosen by Tredegar for the 2010 plan year. Tredegar has determined that it is not practicable to present defined benefit contributions and other postretirement benefit payments beyond 2020. See Note 11 on page 65.
(2) Represents contractual obligations for plant construction and purchases of real property and equipment. See Note 13 on page 70.
(3) Amounts for which reasonable estimates about the timing of payments cannot be made are included in the remainder column.
(4) Includes contractual severance and derivative settlement payments and the expected contingent earnout from our purchase of the assets of Bright View.

We believe that existing borrowing availability, our current cash balances and our cash flow from operations will be sufficient to satisfy our working capital, capital expenditure and dividend requirements for the foreseeable future.

From time to time, we enter into transactions with third parties in connection with the sale of assets or businesses in which we agree to indemnify the buyers or third parties involved in the sale for certain liabilities or risks related to the assets or business. Also, in the ordinary course of our business, we may enter into agreements with third parties for the sale of goods or services that may contain indemnification provisions. In the event that an indemnification claim is asserted, liability for indemnification would be subject to an assessment of the underlying facts and circumstances under the terms of the applicable agreement. Further, any indemnification payments may be limited or barred by a monetary cap, a time limitation, or a deductible or basket. For these reasons, we are unable to estimate the maximum potential amount of the potential future liability under the indemnity provisions of these agreements. We do, however, accrue for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable and the amount is reasonably estimable. We disclose contingent liabilities if the probability of loss is reasonably possible and material.

Shareholders’ Equity

At December 31, 2010, we had 31,883,173 shares of common stock outstanding and a total market capitalization of $617.9 million, compared with 33,887,550 shares of common stock outstanding and a total market capitalization of $536.1 million at December 31, 2009.

 

32


Table of Contents

We purchased 2.1 million shares in 2010, 105,497 shares in 2009 and 1.1 million shares in 2008 on the open market at an average price of $16.54, $14.44 and $14.88 per share, respectively. See the issuer purchases of equity securities section of Item 5 on page 10 regarding purchases of our common stock and our standing authorization permitting additional purchases as of December 31, 2010.

Cash Flows

The discussion in this section supplements the information presented in the consolidated statements of cash flows on page 47. Cash flows for discontinued operations have not been separately disclosed in the consolidated statements of cash flows.

Cash provided by operating activities was $46.4 million in 2010 compared with $103.2 million in 2009. The decrease is due primarily to normal volatility of working capital components (see the assets and liabilities section beginning on page 28 for discussion of changes in working capital).

Cash used in investing activities was $22.2 million in 2010 compared with $31.7 million in 2009. Cash used in investing activities in 2010 includes capital expenditures and the purchase of the assets of Bright View, partially offset by the initial withdrawal proceeds from Harbinger.

Net cash flow used in financing activities was $42.1 million in 2010, which is primarily due to the repurchase of 2.1 million shares of Tredegar common stock for $35.1 million, the payment of regular quarterly dividends of $5.1 million (4 cents per share per quarter) and the payment of debt issuance costs of $2.1 million related to our new revolving credit facility.

Cash provided by operating activities was $103.2 million in 2009 compared with $75.4 million in 2008. The increase is due primarily to normal volatility of working capital components (see the assets and liabilities section beginning on page 28 for discussion of changes in working capital).

Cash used in investing activities was $31.7 million in 2009 compared with cash provided by investing activities of $3.5 million in 2008. The change between periods was primarily due to proceeds received in 2008 from the sale of our aluminum extrusions business in Canada of $23.4 million and a $16.6 million increase in capital expenditures. Capital expenditures in 2009 primarily included the expansion of capacity at our aluminum extrusion facility Carthage, Tennessee as well as the normal replacement of machinery and equipment.

Net cash flow used in financing activities was $28.2 million in 2009 and was related to net repayments on our former revolving credit facility with excess cash flow of $21.5 million, the payment of regular quarterly dividends of $5.4 million (4 cents per share per quarter) and repurchase of 105,497 shares of Tredegar common stock for $1.5 million.

Quantitative and Qualitative Disclosures about Market Risk

Tredegar has exposure to the volatility of interest rates, polyethylene and polypropylene resin prices, aluminum ingot and scrap prices, energy prices, foreign currencies and emerging markets. See the assets and liabilities section beginning on page 28 regarding credit agreement and interest rate exposures related to borrowings under the credit agreement.

Changes in resin prices, and the timing of those changes, could have a significant impact on profit margins in Film Products. Profit margins in Aluminum Extrusions are sensitive to fluctuations in aluminum ingot and scrap prices as well as natural gas prices (natural gas is the principal energy source used to operate our casting furnaces). There is no assurance of our ability to pass through higher raw material and energy costs to our customers.

 

33


Table of Contents

See the executive summary beginning on page 19 and the business segment review beginning on page 36 for discussion regarding the impact of the lag in the pass-through of resin price changes. The volatility of average quarterly prices of low density polyethylene resin in the U.S. (a primary raw material for Film Products) is shown in the chart below.

LOGO

Source: Quarterly averages computed by Tredegar using monthly data provided by Chemical Data Inc. (“CDI”). In January 2005, CDI reflected a 4 cents per pound non-market adjustment based on their estimate of the growth of discounts over the 2000 to 2003 period. The 4th quarter 2004 average rate of 67 cents per pound is shown on a pro forma basis as if the non-market adjustment was made in October 2004. In January 2010, CDI reflected a 15 cents per pound non-market adjustment based on their estimate of the growth of discounts over the 2005 to 2009 period. The 4th quarter 2009 average rate of 61 cents per pound is shown on a pro forma basis as if the non-market adjustment was made in October 2009.

Resin prices in Europe, Asia and South America have exhibited similar trends. The price of resin is driven by several factors including supply and demand and the price of oil, ethylene and natural gas. To address fluctuating resin prices, Film Products has index-based pass-through raw material cost agreements for the majority of its business. However, under certain agreements, changes in resin prices are not passed through for an average period of 90 days (see the executive summary on page 19 and the business segment review on page 36 for more information).

In the normal course of business, we enter into fixed-price forward sales contracts with certain customers for the sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge our exposure to aluminum price volatility (see the chart below) under these fixed-price arrangements, which generally have a duration of not more than 12 months, we enter into a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the scheduled deliveries. See Note 6 on page 59 for more information. The volatility of quarterly average aluminum prices is shown in the chart below.

LOGO

Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.

 

34


Table of Contents

In Aluminum Extrusions, we hedge from time-to-time a portion of our exposure to natural gas price volatility by entering into fixed-price forward purchase contracts with our natural gas suppliers. We estimate that, in an unhedged situation, every $1 per mmBtu per month change in the market price of natural gas has a $70,000 impact on the continuing monthly operating profit for our U.S. operations in Aluminum Extrusions. In September 2005, we announced an energy surcharge for our aluminum extrusions business in the U.S. to be applied when the previous quarter’s NYMEX natural gas average settlement price is in excess of $8.85 per mmBtu. The volatility of quarterly average natural gas prices is shown in the chart below.

LOGO

Source: Quarterly averages computed by Tredegar using monthly NYMEX settlement prices.

We sell to customers in foreign markets through our foreign operations and through exports from U.S. plants. The percentage of sales and total assets for ongoing operations related to foreign markets for 2010, 2009 and 2008 are as follows:

Tredegar Corporation - Continuing Ongoing Operations

Percentage of Net Sales and Total Assets Related to Foreign Markets

 

     2010      2009      2008  
     % of Total
Net Sales *
     % Total      % of Total
Net Sales *
     % Total      % of Total
Net Sales *
     % Total  
     Exports
From
U.S.
     Foreign
Operations
     Assets -
Foreign
Operations *
     Exports
From
U.S.
     Foreign
Operations
     Assets -
Foreign
Operations *
     Exports
From
U.S.
     Foreign
Operations
     Assets -
Foreign
Operations *
 

Canada

     7         —           —           6         —           —           5         —           —     

Europe

     1         16         15         1         19         14         1         18         15   

Latin America

     —           3         2         —           3         2         —           3         2   

Asia

     10         5         7         7         6         6         3         7         7   
                                                                                

Total % exposure to foreign markets

     18         24         24         14         28         22         9         28         24   
                                                                                

 

* The percentages for foreign markets are relative to Tredegar’s total net sales and total assets from ongoing operations (consolidated net sales and total assets from continuing operations excluding cash and cash equivalents and AFBS (formerly Therics)).

We attempt to match the pricing and cost of our products in the same currency and generally view the volatility of foreign currencies (see trends for the Euro and Chinese Yuan in the chart below) and emerging markets, and the corresponding impact on earnings and cash flow, as part of the overall risk of operating in a global environment. Exports from the U.S. are generally denominated in U.S. Dollars. Our foreign currency exposure on income from continuing foreign operations relates to the Euro, the Chinese Yuan, the Hungarian Forint, the Brazilian Real, and the Indian Rupee.

 

35


Table of Contents

In Film Products, where we are typically able to match the currency of our sales and costs, we estimate that the change in value of foreign currencies relative to the U.S. Dollar had a negative impact on operating profit of approximately $1.3 million in 2010 compared with 2009, $1.9 million in 2009 compared with 2008 and a positive impact of $3.6 million in 2008 compared with 2007.

Trends for the Euro and Chinese Yuan are shown in the chart below:

LOGO

Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.

Business Segment Review

Net sales (sales less freight) and operating profit from ongoing operations are the measures of sales and operating profit used by the chief operating decision maker for purposes of assessing performance.

Film Products

Net Sales. See the executive summary beginning on page 19 for the discussion of net sales (sales less freight) in Film Products in 2010 compared with 2009.

In Film Products, net sales were $455.0 million in 2009, down 13.0% versus $522.8 million in 2008. Volume decreased to 206.7 million pounds in 2009 from 221.2 million pounds in 2008. Net sales in 2009 declined compared to 2008 due to the impact on selling prices from the pass-through of lower resin costs, volume declines in personal care materials and packaging films and the unfavorable effect of changes in the U.S. dollar value of currencies for operations outside the U.S.

Operating Profit. See the executive summary beginning on page 19 for the discussion of operating profit in Film Products in 2010 compared with 2009.

Operating profit from ongoing operations was $64.4 million in 2009, an increase of 19.4% compared with $53.9 million in 2008. Operating profit from ongoing operations increased in 2009 compared to 2008 as cost reduction efforts, productivity gains, the positive impact of the change in product mix driven mostly by an increase in sales of high-value surface protection materials and the lag in the pass-through of reduced resin costs were partially offset by lower overall sales volumes and the unfavorable effects of foreign currency rates. The estimated impact of the lag in the pass-through of changes in average resin costs and year-end adjustments for inventories accounted for under LIFO was a positive $1.7 million in 2009 and a negative $600,000 in 2008. The estimated unfavorable impact from U.S. dollar value currencies for operations outside the U.S. was $1.9 million in 2009 compared with 2008.

Identifiable Assets. Identifiable assets in Film Products decreased to $363.3 million at December 31, 2010, from $371.6 million at December 31, 2009, due primarily to depreciation of $33.6 million, partially offset by capital expenditures of $15.7 million and higher accounts receivable ($3.7 million) and inventory ($8.7 million) balances. See the assets and liabilities section beginning on page 28 for further discussion on changes in assets and liabilities.

 

36


Table of Contents

Identifiable assets in Film Products decreased to $371.6 million at December 31, 2009, from $399.9 million at December 31, 2008, due primarily to the depreciation of $32.2 million, partially offset by capital expenditures of $11.5 million, and a lower accounts receivable balance ($4.2 million). See the assets and liabilities section beginning on page 28 for further discussion on changes in assets and liabilities.

Depreciation, Amortization and Capital Expenditures. Depreciation and amortization for Film Products was $33.8 million in 2010, $32.4 million in 2009 and $34.6 million in 2008. The increase in depreciation in 2010 compared with 2009 is primarily related to capital expenditures in 2009 and 2010. The decrease in 2009 compared with 2008 is primarily due to the write-down of certain assets in prior years and lower than normal capital expenditures in the preceding years. We expect depreciation and amortization expense for Film Products will be approximately $35 million in 2011.

Capital expenditures increased to $15.7 million in 2010 from $11.5 million in 2009 compared with $11.1 million in 2008. Capital expenditures in 2010 include the construction of our new manufacturing facility in India as well as capital spending to support growth initiatives. Capital expenditures in 2009 and 2008 primarily included the normal replacement of machinery and equipment. Capital expenditures in 2011 are expected to be approximately $27 million.

Aluminum Extrusions (Continuing Operations)

Net Sales and Operating Profit. See the executive summary beginning on page 19 for the discussion of net sales (sales less freight) and operating profit from ongoing U.S. operations of Aluminum Extrusions in 2010 compared with 2009.

Net sales from continuing operations in Aluminum Extrusions were $177.5 million in 2009, down 47.8% from $340.3 million in 2008. Operating losses from ongoing U.S. operations were $6.5 million, a negative change of $16.6 million from operating profits of $10.1 million in 2008. Volume from continuing operations was 91.5 million pounds in 2009, down 32.8% from 136.2 million pounds in 2008.

The decrease in net sales for 2009 compared to 2008 was mainly due to lower sales volume and a decrease in average selling prices driven by lower average aluminum costs. Weak market conditions led to decreased shipments in most markets. Shipments in nonresidential construction, which comprised 71% of total volume in 2009, declined by approximately 34% in 2009 compared with 2008. Operating losses from ongoing U.S. operations in 2009 were primarily driven by lower sales volume.

Identifiable Assets. Identifiable assets in Aluminum Extrusions were $81.7 million at December 31, 2010, $82.4 million at December 31, 2009 and $112.3 million at December 31, 2008. The decrease between December 31, 2010 and 2009 can be attributed to lower property, plant and equipment balances from higher depreciation expense due to the recently completed capacity expansion project at our Carthage, Tennessee manufacturing facility and a reduction in inventory balances in an effort to manage working capital in light of an uncertain economic environment, partially offset by an increase in accounts receivable balances as a result of higher volume in the latter half of 2010. The decline of $29.9 million at the end of 2009 compared with 2008 is mainly due to the goodwill impairment charge of $30.6 million in 2009 and lower accounts receivable balances of $13.2 million, partially offset by higher property, plant and equipment balances from capital expenditures of $22.5 million, net of depreciation expense of $7.6 million.

Depreciation, Amortization and Capital Expenditures. Depreciation and amortization for Aluminum Extrusions was $9.1 million in 2010, $7.6 million in 2009 and $8.0 million in 2008. The increase between 2010 compared to 2009 is primarily attributed to increased depreciation from the recent capacity expansion project at our Carthage, Tennessee manufacturing facility. We expect depreciation and amortization expense for Aluminum Extrusions to be approximately $9 million in 2011.

Capital expenditures totaled $4.3 million in 2010, $22.5 million in 2009 and $9.7 million in 2008. Capital expenditures of $19.0 million in 2009 and $5.7 million in 2008 reflect spending on the capacity expansion project at our Carthage, Tennessee manufacturing facility. Capital expenditures are expected to be approximately $5 million in 2011.

 

37


Table of Contents

Other

Net Sales and Operating Profit. See the executive summary beginning on page 19 for the discussion of net sales (sales less freight) and operating profit for the continuing operations of the businesses in the Other segment in 2010 compared with 2009.

Identifiable Assets. Identifiable assets in the Other segment were $19.7 million at December 31, 2010. Other assets primarily consist of investments in mitigation banking properties by Fallings Springs and intellectual property and machinery and equipment utilized by Bright View.

Depreciation, Amortization and Capital Expenditures. Depreciation and amortization expense for the Other segment was $695,000 in 2010, and capital expenditures for the Other segment were $179,000 in 2010. Capital expenditures are not expected to be material in 2011.

 

Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

See discussion of quantitative and qualitative disclosures about market risk beginning on page 33 in Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

See the index on page 43 for references to the report of the independent registered public accounting firm, the consolidated financial statements and selected quarterly financial data.

 

Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

 

Item 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we carried out an evaluation, with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

38


Table of Contents

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) under the Exchange Act. The Company’s internal control over financial reporting is designed to provide reasonable assurance to the Company’s management and board of directors regarding the reliability of financial reporting and the preparation and fair presentation of published financial statements in accordance with U.S. generally accepted accounting principles and includes policies and procedures that:

 

 

Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

 

 

Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorization of our management and directors; and

 

 

Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the consolidated financial statements.

Internal control over financial reporting includes the controls themselves, monitoring (including internal auditing practices) and actions taken to correct deficiencies as identified.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on their evaluation under the framework in Internal Control — Integrated Framework, our management concluded that our internal control over financial reporting was effective as of December 31, 2010.

The effectiveness of our internal control over financial reporting as of December 31, 2010 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which is included on pages 43-44.

Changes in Internal Control Over Financial Reporting

There has been no change in our internal control over financial reporting during the quarter ended December 31, 2010, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

Item 9B. OTHER INFORMATION

None.

 

39


Table of Contents

PART III

 

Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The information concerning directors and persons nominated to become directors of Tredegar to be included in our Proxy Statement under the headings “Election of Directors” and “Tredegar’s Board of Directors” is incorporated herein by reference.

The information concerning corporate governance to be included in the Proxy Statement under the heading “Board Meetings, Meetings of Non-Management Directors and the Board Committees” and “Corporate Governance” is incorporated herein by reference.

The information to be included in the Proxy Statement under the heading “Section 16(a) Beneficial Ownership Reporting Requirements” is incorporated herein by reference.

Set forth below are the names, ages and titles of our executive officers:

 

Name

  

Age

    

Title

Nancy M. Taylor

   51      President and Chief Executive Officer

Duncan A. Crowdis

   58      President, The William L. Bonnell Company and Corporate Vice President

A. Brent King

   42      Vice President, General Counsel and Corporate Secretary

Monica Moretti

   41      President, Tredegar Film Products Corporation and Corporate Vice President

Kevin A. O’Leary

   52      Vice President, Chief Financial Officer and Treasurer

Larry J. Scott

   60      Vice President, Audit

Nancy M. Taylor. Ms. Taylor was elected President and Chief Executive Officer effective February 1, 2010. Prior to February 1, 2010, Ms. Taylor was President of Tredegar Films Products Corporation and Executive Vice President. She was elected Executive Vice President effective January 1, 2009. She was elected President of Tredegar Film Products Corporation effective April 5, 2005. She was elected Senior Vice President effective November 1, 2004. Ms. Taylor served as Senior Vice President, Strategy and Special Projects from November 1, 2004 until April 5, 2005.

Duncan A. Crowdis. Mr. Crowdis was elected Vice President effective January 1, 2009. Mr. Crowdis was elected President of The William L. Bonnell Company, Inc. on June 13, 2005, and continues to serve in such capacity. Mr. Crowdis served as Plant Manager of The William L. Bonnell Company, Inc. from March 2005 until June 2005. He previously served as Chief Process Officer of The William L. Bonnell Company, Inc. from December 2002 until March 2005.

A. Brent King. Mr. King was elected Vice President, General Counsel and Corporate Secretary on October 20, 2008, the date that he joined Tredegar. From October 2005 until October 2008, he served as General Counsel at Hilb Rogal & Hobbs. Mr. King was Vice President and Assistant Secretary for Hilb Rogal & Hobbs from October 2001 to October 2008. He served as Associate General Counsel for Hilb Rogal & Hobbs from October 2001 to October 2005.

Kevin A. O’Leary. Mr. O’Leary was elected Vice President, Chief Financial Officer and Treasurer effective December 11, 2009. He was appointed Vice President, Finance, of Tredegar Film Products Corporation, effective January 1, 2009 until December 11, 2009 and served as Director, Finance, of Tredegar Film Products Corporation from October 2008 until January 2009. Mr. O’Leary previously served as Vice President, Finance – Mergers and

 

40


Table of Contents

Acquisitions of the Avery Dennison Retail Information Services Group (“Avery Dennison RIS”), a division of Avery Dennison Corporation from March 2007 through August 2008. He served as General Manager of the Printer Systems division of Avery Dennison RIS from February 2006 through February 2007 and as Director, Finance, of Avery Dennison RIS from August 2004 through January 2006.

Monica Moretti. Ms. Moretti was elected Vice President on May 18, 2010. She was elected President of Tredegar Film Products Corporation and its subsidiaries effective February 1, 2010. She served as Vice President and General Manager, Consumer Care, of Tredegar Film Products Corporation from May 2008 until January 31, 2010 and as General Manager, Hygienics, of Tredegar Film Products Corporation from March 2008 until May 2008. Ms. Moretti served as Chief Marketing Officer and Vice President, Marketing and Technology, of H.B. Fuller Company from February 2007 until March 2008. She served as Group Vice President, Marketing and Technology, of H.B. Fuller Company from December 2005 until February 2007 and as Global Business Unit Manager, Assembly, of H.B. Fuller Company from December 2004 until December 2005.

Larry J. Scott. Mr. Scott was elected Vice President, Audit, on May 24, 2000.

We have adopted a Code of Conduct that applies to all of our directors, officers and employees (including our chief executive officer, chief financial officer and principal accounting officer) and have posted the Code of Conduct on our website. We intend to satisfy the disclosure requirement under Item 10 of Form 8-K relating to amendments to or waivers from any provision of our Code of Conduct applicable to the chief executive officer, chief financial officer and principal accounting officer by posting this information on our website. Our Internet address is www.tredegar.com. The information on or that can be accessed through our website is not, and shall not be deemed to be, a part of this report or incorporated into other filings we make with the SEC.

 

Item 11. EXECUTIVE COMPENSATION

The information to be included in the Proxy Statement under the headings “Compensation of Directors,” “Board Meetings of Non-Management Directors and Board Committees - Executive Compensation Committee Interlocks and Insider Participation,” “Compensation Discussion and Analysis,” “Executive Compensation Committee Report” and “Compensation of Executive Officers” is incorporated herein by reference.

 

41


Table of Contents
Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The information to be included in the Proxy Statement under the heading “Stock Ownership” is incorporated herein by reference. The following table summarizes information with respect to equity compensation plans under which securities are authorized for issuance as of December 31, 2010.

 

Column (a)    Column (b)      Column (c)      Column (d)  

Plan Category

   Number of Securities
to be Issued Upon
Exercise of
Outstanding  Options,
Warrants and Rights
     Weighted Average
Exercise Price of
Outstanding Options,
Warrants and Rights
    

 

Number of Securities
Remaining Available for
Future Issuance Under
Equity Compensation Plans,
Excluding Securities
Reflected in  Column

 

Equity compensation plans approved by security holders

     *1,262,050       $ 16.64         3,151,868   
                          

Equity compensation plans not approved by security holders

     —           —           —     
                          

Total

     1,262,050       $ 16.64         3,151,868   
                          

 

* Includes performance stock units that give the holder the right to receive shares of Tredegar common stock upon the satisfaction of certain performance criteria.

 

Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information to be included in the Proxy Statement under the headings “Certain Relationships and Related Transactions”, “Tredegar’s Board of Directors” and “Board Meetings, Meetings of Non-Management Directors and Board Committees” is incorporated herein by reference.

 

Item 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

The following is incorporated herein by reference:

 

 

Information on accounting fees and services to be included in the Proxy Statement under the heading “Audit Fees;” and

 

 

Information on the Audit Committee’s procedures for pre-approving certain audit and non-audit services to be included in the Proxy Statement under the heading “Board Meetings, Meetings of Non-Management Directors and Board Committees - Audit Committee Matters.”

 

42


Table of Contents

PART IV

 

Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

  (a) List of documents filed as a part of the report:

 

  (1) Financial statements:

Tredegar Corporation

Index to Financial Statements and Supplementary Data

 

     Page

Report of Independent Registered Public Accounting Firm

   44

Financial Statements:

  

Consolidated Statements of Income for the Years Ended December 31, 2010, 2009 and 2008

   45

Consolidated Balance Sheets as of December 31, 2010 and 2009

   46

Consolidated Statements of Cash Flows for the Years Ended December 31, 2010, 2009 and 2008

   47

Consolidated Statements of Shareholders’ Equity for the Years Ended December  31, 2010, 2009 and 2008

   48

Notes to Financial Statements

   49

 

  (2) Financial statement schedules:

None.

 

  (3) Exhibits:

See Exhibit Index on pages 81-82.

 

43


Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Shareholders of

Tredegar Corporation:

In our opinion, the consolidated financial statements listed in the index appearing under Item 15(a)(1) present fairly, in all material respects, the financial position of Tredegar Corporation and its subsidiaries (the “Company”) at December 31, 2010 and 2009, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2010 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2010, based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company’s management is responsible for these financial statements, for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on these financial statements and on the Company’s internal control over financial reporting based on our integrated audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ PricewaterhouseCoopers LLP

Richmond, Virginia

March 4, 2011

 

44


Table of Contents

CONSOLIDATED STATEMENTS OF INCOME

 

Tredegar Corporation and Subsidiaries

 

Years Ended December 31

   2010     2009     2008  
(In Thousands, Except Per-Share Data)                   

Revenues and other:

      

Sales

   $ 740,475      $ 648,613      $ 883,899   

Other income (expense), net

     (940     8,464        10,341   
                        
     739,535        657,077        894,240   
                        

Costs and expenses:

      

Cost of goods sold

     596,330        516,933        739,721   

Freight

     17,812        16,085        20,782   

Selling, general and administrative

     68,610        60,481        58,699   

Research and development

     13,625        11,856        11,005   

Amortization of intangibles

     466        120        123   

Interest expense

     1,136        783        2,393   

Asset impairments and costs associated with exit and disposal activities

     773        2,950        12,390   

Goodwill impairment charge

     —          30,559        —     
                        

Total

     698,752        639,767        845,113   
                        

Income from continuing operations before income taxes

     40,783        17,310        49,127   

Income taxes

     13,756        18,663        19,486   
                        

Income (loss) from continuing operations

     27,027        (1,353     29,641   

Income (loss) from discontinued operations

     —          —          (705
                        

Net income (loss)

   $ 27,027      $ (1,353   $ 28,936   
                        

Earnings (loss) per share:

      

Basic:

      

Continuing operations

   $ .84      $ (.04   $ .87   

Discontinued operations

     —          —          (.02
                        

Net income (loss)

   $ .84      $ (.04   $ .85   
                        

Diluted:

      

Continuing operations

   $ .83      $ (.04   $ .87   

Discontinued operations

     —          —          (.02
                        

Net income (loss)

   $ .83      $ (.04   $ .85   
                        

See accompanying notes to financial statements.

 

45


Table of Contents

CONSOLIDATED BALANCE SHEETS

 

Tredegar Corporation and Subsidiaries

 

December 31

   2010     2009  
(In Thousands, Except Share Data)             

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 73,191      $ 90,663   

Accounts and notes receivable, net of allowance for doubtful accounts and sales returns of $5,286 in 2010 and $5,299 in 2009

     84,076        74,014   

Income taxes recoverable

     6,643        4,016   

Inventories

     43,058        35,522   

Deferred income taxes

     6,924        5,750   

Prepaid expenses and other

     5,369        5,335   
                

Total current assets

     219,261        215,300   
                

Property, plant and equipment, at cost:

    

Land and land improvements

     7,034        6,496   

Buildings

     86,145        87,297   

Machinery and equipment

     576,111        580,493   
                

Total property, plant and equipment

     669,290        674,286   

Less accumulated depreciation

     462,453        443,410   
                

Net property, plant and equipment

     206,837        230,876   

Other assets and deferred charges

     48,127        45,561   

Goodwill and other intangibles (other intangibles of $2,478 in 2010 and $252 in 2009)

     106,117        104,542   
                

Total assets

   $ 580,342      $ 596,279   
                

Liabilities and Shareholders’ Equity

    

Current liabilities:

    

Accounts payable

   $ 58,209      $ 53,770   

Accrued expenses

     33,229        34,930   

Current portion of long-term debt

     222        451   
                

Total current liabilities

     91,660        89,151   

Long-term debt

     228        712   

Deferred income taxes

     51,879        59,052   

Other noncurrent liabilities

     19,029        18,292   
                

Total liabilities

     162,796        167,207   
                

Commitments and contingencies (Notes 13 and 16)

    

Shareholders’ equity:

    

Common stock (no par value):

    

Authorized 150,000,000 shares;

    

Issued and outstanding - 31,883,173 shares in 2010 and 33,887,550 in 2009 (including restricted stock)

     10,724        41,137   

Common stock held in trust for savings restoration plan (60,986 shares in 2010 and 60,424 in 2009)

     (1,332     (1,322

Accumulated other comprehensive income (loss):

    

Foreign currency translation adjustment

     23,572        26,250   

Gain (loss) on derivative financial instruments

     280        758   

Pension and other postretirement benefit adjustments

     (59,871     (60,028

Retained earnings

     444,173        422,277   
                

Total shareholders’ equity

     417,546        429,072   
                

Total liabilities and shareholders’ equity

   $ 580,342      $ 596,279   
                

See accompanying notes to financial statements.

 

46


Table of Contents

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

Tredegar Corporation and Subsidiaries

 

Years Ended December 31

   2010     2009     2008  
(In Thousands)                   

Cash flows from operating activities:

      

Net income (loss)

   $ 27,027      $ (1,353   $ 28,936   

Adjustments for noncash items:

      

Depreciation

     43,122        39,877        43,068   

Amortization of intangibles

     466        120        123   

Goodwill impairment charge

     —          30,559        —     

Deferred income taxes

     (6,392     6,771        22,183   

Accrued pension and postretirement benefits

     1,125        (2,654     (4,426

(Gain) loss on an investment accounted for under the fair value method

     2,200        (5,100     (5,600

Gain on sale of assets

     (15     (3,462     (3,083

Loss on asset impairments and divestitures

     608        1,005        10,136   

Changes in assets and liabilities, net of effects of acquisitions and divestitures:

      

Accounts and notes receivable

     (10,981     18,449        (678

Inventories

     (7,717     2,200        13,374   

Income taxes recoverable

     (2,627     8,533        (12,092

Prepaid expenses and other

     (969     1,209        (1,873

Accounts payable and accrued expenses

     2,942        7,023        (18,900

Other, net

     (2,380     38        4,238   
                        

Net cash provided by operating activities

     46,409        103,215        75,406   
                        

Cash flows from investing activities:

      

Capital expenditures (including settlement of related accounts payable of $1,709 in 2009 and net of accounts payable of $1,709 in 2008)

     (20,418     (35,851     (19,235

Acquisition

     (5,500     —          —     

Proceeds from the sale of assets and property disposals

     3,768        4,146        4,691   

Investments

     —          —          (5,391

Proceeds from the sale of the aluminum extrusions business in Canada (net of cash included in sale and transaction costs)

     —          —          23,407   
                        

Net cash provided by (used in) investing activities

     (22,150     (31,705     3,472   
                        

Cash flows from financing activities:

      

Repurchases of Tredegar common stock (including settlement of $3,368 in 2008)

     (35,141     (1,523     (19,792

Dividends paid

     (5,141     (5,426     (5,447

Debt principal payments and financing costs

     (2,815     (21,539     (84,489

Borrowings

     —          —          25,000   

Proceeds from exercise of stock options

     980        244        4,069   
                        

Net cash used in financing activities

     (42,117     (28,244     (80,659
                        

Effect of exchange rate changes on cash

     386        1,422        (461
                        

Increase (decrease) in cash and cash equivalents

     (17,472     44,688        (2,242

Cash and cash equivalents at beginning of period

     90,663        45,975        48,217   
                        

Cash and cash equivalents at end of period

   $ 73,191      $ 90,663      $ 45,975   
                        

Supplemental cash flow information:

      

Interest payments (net of amount capitalized)

   $ 911      $ 786      $ 2,465   

Income tax payments (refunds), net

     23,539        3,019        8,794   

See accompanying notes to financial statements.

 

47


Table of Contents

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

 

Tredegar Corporation and Subsidiaries

 

    

 

 

Common Stock

    Retained
Earnings
    Trust for
Savings
Restoration
Plan
    Foreign
Currency
Translation
    Gain
(Loss) on
Derivative
Financial
Instruments
    Pension &
Other
Post-
retirement
Benefit
Adjust.
    Total
Share-
holders’
Equity
 
     Shares     Amount              

(In Thousands, Except Share and Per-Share
Data)

                                                

Balance December 31, 2007

     34,765,450      $ 51,444      $ 405,548      $ (1,303   $ 40,610      $ (1,204   $ (3,767   $ 491,328   
                                                                

Comprehensive income (loss):

                

Net income

     —          —          28,936        —          —          —          —          28,936   

Other comprehensive income (loss):

                

Foreign currency translation adjustment (net of tax of $1,607)

     —          —          —          —          (2,875     —          —          (2,875

Reclassification of foreign currency translation gain realized on the sale of the aluminum extrusions business in Canada (net of tax of $7,696)

     —          —          —          —          (14,292     —          —          (14,292

Derivative financial instruments adjustment (net of tax of $3,325)

     —          —          —          —          —          (5,488     —          (5,488

Net gains or losses and prior service costs (net of tax of $39,678)

     —          —          —          —          —          —          (66,292     (66,292

Amortization of prior service costs and net gains or losses (net of tax of $228)

     —          —          —          —          —          —          400        400   

Reclassification of net actuarial losses and prior service costs realized on the sale of the aluminum extrusions business in Canada (net of tax of $1,799)

     —          —          —          —          —          —          4,871        4,871   
                      

Comprehensive loss

                   (54,740

Cash dividends declared ($.16 per share)

     —          —          (5,447     —          —          —          —          (5,447

Stock-based compensation expense

     (6,000     1,379        —          —          —          —          —          1,379   

Issued upon exercise of stock options (including related income tax benefits of $76) & other

     254,582        4,320        —          —          —          —          —          4,320   

Repurchases of Tredegar common stock

     (1,104,100     (16,424     —          —          —          —          —          (16,424

Tredegar common stock purchased by trust for savings restoration plan

     —          —          10        (10     —          —          —          —     
                                                                

Balance December 31, 2008

     33,909,932        40,719        429,047        (1,313     23,443        (6,692     (64,788     420,416   
                                                                

Comprehensive income (loss):

                

Net loss

     —          —          (1,353     —          —          —          —          (1,353

Other comprehensive income (loss):

                

Foreign currency translation adjustment (net of tax of $1,563)

     —          —          —          —          2,807        —          —          2,807   

Derivative financial instruments adjustment (net of tax of $4,538)

     —          —          —          —          —          7,450        —          7,450   

Net gains or losses and prior service costs (net of tax of $2,310)

     —          —          —          —          —          —          4,061        4,061   

Amortization of prior service costs and net gains or losses (net of tax of $398)

     —          —          —          —          —          —          699        699   
                      

Comprehensive income

                   13,664   

Cash dividends declared ($.16 per share)

     —          —          (5,426     —          —          —          —          (5,426

Stock-based compensation expense

     9,387        2,538        —          —          —          —          —          2,538   

Issued upon exercise of stock options (including related income tax benefits of $64) & other

     73,728        (597     —          —          —          —          —          (597

Repurchases of Tredegar common stock

     (105,497     (1,523     —          —          —          —          —          (1,523

Tredegar common stock purchased by trust for savings restoration plan

     —          —          9        (9     —          —          —          —     
                                                                

Balance December 31, 2009

     33,887,550        41,137        422,277        (1,322     26,250        758        (60,028     429,072   
                                                                

Comprehensive income (loss):

                

Net income

     —          —          27,027        —          —          —          —          27,027   

Other comprehensive income (loss):

                

Foreign currency translation adjustment (net of tax of $1,443)

     —          —          —          —          (2,678     —          —          (2,678

Derivative financial instruments adjustment (net of tax of $287)

     —          —          —          —          —          (478     —          (478

Net gains or losses and prior service costs (net of tax of $2,135)

     —          —          —          —          —          —          (2,838     (2,838

Amortization of prior service costs and net gains or losses (net of tax of $1,732)

     —          —          —          —          —          —          2,995        2,995   
                      

Comprehensive income

                   24,028   

Cash dividends declared ($.16 per share)

     —          —          (5,141     —          —          —          —          (5,141

Stock-based compensation expense

     8,017        3,952        —          —          —          —          —          3,952   

Issued upon exercise of stock options (including related income tax of $204) & other

     112,506        776        —          —          —          —          —          776   

Repurchases of Tredegar common stock

     (2,124,900     (35,141     —          —          —          —          —          (35,141

Tredegar common stock purchased by trust for savings restoration plan

     —          —          10        (10     —          —          —          —     
                                                                

Balance December 31, 2010

     31,883,173      $ 10,724      $ 444,173      $ (1,332   $ 23,572      $ 280      $ (59,871   $ 417,546   
                                                                

See accompanying notes to financial statements.

 

48


Table of Contents

NOTES TO FINANCIAL STATEMENTS

Tredegar Corporation and Subsidiaries

 

1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization and Nature of Operations. Tredegar Corporation and subsidiaries (collectively “Tredegar,” “we,” “us” or “our”) are primarily engaged in the manufacture of plastic films and aluminum extrusions. See Note 15 regarding restructurings and Note 17 regarding discontinued operations.

Basis of Presentation. The consolidated financial statements include the accounts and operations of Tredegar and all of its majority-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. On February 12, 2008, we sold our aluminum extrusions business in Canada. All historical results for this business have been reflected as discontinued operations in these financial statements. Certain amounts for the prior years have been reclassified to conform to the current year’s presentation.

The preparation of financial statements in conformity with United States (“U.S.”) generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.

Foreign Currency Translation. The financial statements of subsidiaries located outside the U.S., where the local currency is the functional currency, are translated into U.S. Dollars using exchange rates in effect at the period end for assets and liabilities and average exchange rates during each reporting period for results of operations. Adjustments resulting from the translation of these financial statements are reflected as a separate component of shareholders’ equity. We have no subsidiaries located outside the U.S. where the U.S. Dollar is the functional currency.

Transaction and remeasurement gains or losses included in income were not material in 2010, 2009 and 2008. These amounts do not include the effects between reporting periods that exchange rate changes have on income of our locations outside the U.S, that result from translation into U.S. Dollars.

Cash and Cash Equivalents. Cash and cash equivalents consist of cash on hand in excess of daily operating requirements and highly liquid investments with original maturities of three months or less. At December 31, 2010 and 2009, Tredegar had cash and cash equivalents of $73.2 million and $90.7 million, respectively, including funds held in locations outside the U.S. of $35.7 million and $34.2 million, respectively.

Our policy permits investment of excess cash in marketable securities that have the highest credit ratings and maturities of less than one year. The primary objectives of the policy are safety of principal and liquidity.

Accounts and Notes Receivable. Accounts receivable are stated at the amount invoiced to customers less allowances for doubtful accounts and sales returns. Accounts receivable are non-interest bearing and arise from the sale of product to customers under typical industry trade terms. Notes receivable are not significant. Past due amounts are determined based on established terms and charged-off when deemed uncollectible. The allowance for doubtful accounts is determined based on our assessment of probable losses taking into account past due amounts, customer credit profile, historical experience and current economic conditions. Other receivables include value-added taxes related to certain foreign subsidiaries and other miscellaneous receivables due within one year.

Inventories. Inventories are stated at the lower of cost or market, with cost determined on the last-in, first-out (“LIFO”) basis, the weighted average cost or the first-in, first-out basis. Cost elements included in work-in-process and finished goods inventories are raw materials, direct labor and manufacturing overhead.

Property, Plant and Equipment. Accounts include costs of assets constructed or purchased, related delivery and installation costs and interest incurred on significant capital projects during their construction periods. Expenditures for renewals and betterments also are capitalized, but expenditures for repairs and maintenance are expensed as incurred. The cost and accumulated depreciation applicable to assets retired or sold are removed from the respective accounts, and gains or losses thereon are included in income.

 

49


Table of Contents

Capital expenditures for property, plant and equipment include capitalized interest of $37,000 in 2010, $116,000 in 2009 and $228,000 in 2008.

Depreciation is computed primarily by the straight-line method based on the estimated useful lives of the assets, which range from 10 to 25 years for buildings and land improvements and 2 to 11 years for machinery and equipment. The average depreciation period for machinery and equipment is approximately 10 years in Film Products and for the continuing operations of Aluminum Extrusions.

Investments in Private Entities with Less Than or Equal to 50% Voting Ownership Interest. We account for our investments in private entities where our voting ownership is less than or equal to 50% based on the facts and circumstances surrounding the investment. We are required to account for investments under the consolidation method in situations where we are the primary beneficiary of a variable interest entity. The primary beneficiary is the party that has a controlling financial interest in a variable interest entity. We are deemed to have a controlling financial interest if we have (i) the power to direct activities of the variable interest entity that most significantly impact its economic performance and (ii) the obligation to absorb losses or the right to receive benefits from the variable interest entity that could potentially be significant to its operations.

If we are not deemed the primary beneficiary in an investment in a private entity then we select either: (i) the fair value method or (ii) either (a) the cost method if we do not have significant influence over operating and financial policies of the investee or (b) the equity method if we do have significant influence.

U.S. generally accepted accounting principles requires disclosure of the level within the fair value hierarchy in which fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).

Goodwill and Other Intangibles. The excess of the purchase price over the fair value of identifiable net assets of acquired companies is allocated to goodwill. We assess goodwill for impairment when events or circumstances indicate that the carrying value may not be recoverable, or, at a minimum, on an annual basis (December 1st of each year). Our reporting units include, but are not limited to, Film Products and Aluminum Extrusions, each of which may have separately identifiable operating net assets (operating assets including goodwill and intangible assets net of operating liabilities). As of December 31, 2010, Film Products was the only reporting unit that carried a goodwill balance.

We estimate the fair value of our reporting units using discounted cash flow analysis and comparative enterprise value-to-EBITDA multiples. Based on the severity of the economic downturn and its impact on the sales volumes of our aluminum extrusions business (a 36.8% decline in sales volume in the first quarter of 2009 compared with the first quarter of 2008), the resulting operating loss in the first quarter of 2009, possible future losses and the uncertainty in the amount and timing of an economic recovery, we determined that impairment indicators existed in the first quarter of 2009. Upon completing the impairment analysis as of March 31, 2009, a goodwill impairment charge of $30.6 million ($30.6 million after tax) was recognized in Aluminum Extrusions. This impairment charge represented the entire amount of goodwill associated with the Aluminum Extrusions reporting unit, and it represents the only goodwill impairment recorded by Tredegar. The goodwill of Film Products continues to be tested for impairment at the annual testing date, with the estimated fair value of Film Products exceeding the carrying value of its net assets by a wide margin.

 

50


Table of Contents

The components of goodwill and other intangibles at December 31, 2010 and 2009, and related amortization periods for continuing operations are as follows:

 

(In Thousands)

   2010      2009     

Amortization Periods

Carrying value of goodwill:

        

Film Products

   $ 103,639       $ 104,290       Not amortized

Carrying value of other intangibles:

        

Film Products (cost basis of $1,172 in 2010 and 2009)

     137         252       Not more than 17 yrs.

Other (cost basis of $2,687 in 2010)

     2,341         —         Not more than 15 yrs.
                    

Total carrying value of other intangibles

     2,478         252      
                    

Total carrying value of goodwill and other intangibles

   $ 106,117       $ 104,542      
                    

On February 3, 2010, we purchased the assets of Bright View Technologies Corporation (“Bright View”). The primary identifiable intangible assets purchased in the transaction were patented and unpatented technology, which are being amortized over a weighted average period of 12 years.

A reconciliation of the beginning and ending balances of goodwill and other intangibles for each of the three years in the period ended December 31, 2010 is as follows:

 

(In Thousands)

   2010     2009     2008  

Goodwill and other intangibles:

      

Net carrying value, beginning of year

   $ 104,542      $ 135,075      $ 135,907   

Acquisition

     2,394        —          —     

Amortization

     (466     (120     (123

Goodwill impairment charge

     —          (30,559     —     

Increase (decrease) due to foreign currency translation and other

     (353     146        (709
                        

Total carrying value of goodwill and other intangibles

   $ 106,117      $ 104,542      $ 135,075   
                        

Impairment of Long-Lived Assets. We review long-lived assets for possible impairment when events indicate that an impairment may exist. For assets to be held and used in operations, if events indicate that an asset may be impaired, we estimate the future unlevered pre-tax cash flows expected to result from the use of the asset and its eventual disposition. Assets are grouped for this purpose at the lowest level for which there are identifiable and independent cash flows. If the sum of these undiscounted pre-tax cash flows is less than the carrying amount of the asset, an impairment loss is recognized. Measurement of the impairment loss is based on the estimated fair value of the asset, generally determined on a discounted after-tax cash flow basis.

Assets to be disposed of are reported at the lower of their carrying amount or estimated fair value less cost to sell, with an impairment loss recognized for any write-down required.

Pension Costs and Postretirement Benefit Costs Other than Pensions. Pension costs and postretirement benefit costs other than pensions are accrued over the period employees provide service to Tredegar. Liabilities and expenses for pension plans and other postretirement benefits are determined using actuarial methodologies and incorporate significant assumptions, including the rate used to discount the future estimated liability, the long-term rate of return on plan assets, and several assumptions relating to the employee workforce, and we recognize the funded status of our pension and other postretirement plans in the accompanying consolidated balance sheets. Our policy is to fund our pension plans at amounts not less than the minimum requirements of the Employee Retirement Income Security Act of 1974 and to fund postretirement benefits other than pensions when claims are incurred.

Postemployment Benefits. We periodically provide certain postemployment benefits purely on a discretionary basis. Related costs for these programs are accrued when it is probable that benefits will be paid and amounts can be reasonably estimated. All other postemployment benefits are either accrued under current benefit plans or are not material to our financial position or results of operations.

Revenue Recognition. Revenue from the sale of products, which is shown net of estimated sales returns and allowances, is recognized when title has passed to the customer, the price of the product is fixed and determinable, and collectability is reasonably assured. Amounts billed to customers related to freight have been classified as sales in the

 

51


Table of Contents

accompanying consolidated statements of income. The cost of freight has been classified as a separate line in the accompanying consolidated statements of income. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction between Tredegar and its customers (such as value-added taxes) are accounted for on a net basis and therefore excluded from revenues.

Research & Development (“R&D”) Costs. R&D costs are expensed as incurred and include primarily salaries, wages, employee benefits, equipment depreciation, facility costs and the cost of materials consumed relating to R&D efforts. R&D costs include a reasonable allocation of indirect costs.

Income Taxes. Income taxes are recognized during the period in which transactions enter into the determination of income for financial reporting purposes, with deferred income taxes being provided at enacted statutory tax rates on the differences between the financial reporting and tax bases of assets and liabilities (see Note 14). We accrue U.S. federal income taxes on unremitted earnings of our foreign subsidiaries. The benefit of an uncertain tax position is included in the accompanying financial statements when we determine that it is more likely than not that the position will be sustained, based on the technical merits of the position, if the taxing authority examines the position and the dispute is litigated. This determination is made on the basis of all the facts, circumstances and information available as of the reporting date.

Earnings Per Share. Basic earnings per share is computed using the weighted average number of shares of common stock outstanding. Diluted earnings per share is computed using the weighted average common and potentially dilutive common equivalent shares outstanding, determined as follows:

 

     2010      2009      2008  

Weighted average shares outstanding used to compute basic earnings per share

     32,291,556         33,861,171         33,976,833   

Incremental shares attributable to stock options and restricted stock

     280,565         —           216,887   
                          

Shares used to compute diluted earnings per share

     32,572,121         33,861,171         34,193,720   
                          

Incremental shares attributable to stock options and restricted stock are computed using the average market price during the related period. During 2010, 2009 and 2008, the average out-of-the-money options to purchase shares that were excluded from the calculation of incremental shares attributable to stock options and restricted stock was 324,558, 545,450 and 507,982, respectively.

Stock-Based Employee Compensation Plans. Compensation expense is recorded on all share-based awards based upon its calculated fair value. The fair value of stock option awards was estimated as of the grant date using the Black-Scholes options-pricing model. The assumptions used in this model for valuing Tredegar stock options granted in 2010, 2009 and 2008 are as follows:

 

     2010     2009     2008  

Dividend yield

     0.9     0.9     1.0

Weighted average volatility percentage

     46.6     39.9     39.0

Weighted average risk-free interest rate

     2.7     2.1     3.0

Holding period (years):

      

Officers

     6.0        6.0        6.0   

Management

     5.0        5.0        5.0   

Weighted average excercise price at date of grant (also weighted average market price at date of grant):

      

Officers

   $ 17.18      $ 18.12      $ 15.64   

Management

     17.13        17.81        15.81   

 

52


Table of Contents

The dividend yield is the dividend yield on our common stock at the date of grant, which we believe is a reasonable estimate of the expected yield during the holding period. We calculate expected volatility based on the historical volatility of our common stock using a sequential period of historical data equal to the expected holding period of the option. We have no reason to believe that future volatility for this period is likely to differ from the past. The assumed risk-free interest rate is based on observed interest rates (zero coupon U.S. Treasury debt securities) appropriate for the expected holding period. The expected holding period and forfeiture assumptions are based on historical experience. Estimated forfeiture assumptions are reviewed through the vesting period. Adjustments are made if actual forfeitures differ from previous estimates. The cumulative effect of a change in estimated forfeitures is recognized in the period of the change.

Tredegar stock options granted during 2010, 2009 and 2008, and related estimated fair value at the date of grant, are as follows:

 

     2010      2009      2008  

Stock options granted (number of shares):

        

Officers

     190,000         99,600         220,000   

Management

     126,000         183,800         181,000   
                          

Total

     316,000         283,400         401,000   
                          

Estimated weighted average fair value of options per share at date of grant:

        

Officers

   $ 7.47       $ 7.53       $ 6.01   

Management

     7.00         6.93         5.48   
                          

Total estimated fair value of stock options granted (in thousands)

   $ 2,301       $ 2,023       $ 2,314   

Additional disclosure of Tredegar stock options is included in Note 10.

Financial Instruments. We use derivative financial instruments for the purpose of hedging aluminum price volatility and currency exchange rate exposures that exist as part of ongoing business operations. Our derivative financial instruments are designated as and qualify as cash flow hedges and are recognized in the accompanying balance sheet at fair value. A change in the fair value of the derivative that is highly effective as and that is designated and qualifies as a cash flow hedge is recorded in other comprehensive income. Gains and losses reported in other comprehensive income are reclassified to earnings in the periods in which earnings are affected by the variability of cash flows of the hedged transaction. Such gains and losses are reported on the same line as the underlying hedged item, and the cash flows related to financial instruments are classified in the consolidated statements of cash flows in a manner consistent with those of the transactions being hedged. Any hedge ineffectiveness (which represents the amount by which the changes in the fair value of the derivative exceed the variability in the cash flows of the forecasted transaction) is recorded in current period earnings. The amount of gains and losses recognized for hedge ineffectiveness was immaterial in 2010, 2009 and 2008.

Our policy requires that we formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking various hedge transactions. We also formally assess (both at the hedge’s inception and on an ongoing basis) whether the derivatives that are used in hedging transactions have been highly effective in offsetting changes in the fair value or cash flows of hedged items and whether those derivatives may be expected to remain highly effective in future periods. When it is determined that a derivative is not (or has ceased to be) highly effective as a hedge, we discontinue hedge accounting prospectively.

As a policy, we do not engage in speculative or leveraged transactions, nor do we hold or issue financial instruments for trading purposes. Additional disclosure of our utilization of derivative hedging instruments is included in Note 6.

Comprehensive Income or Loss. Comprehensive income or loss, which is included in the consolidated statement of shareholders’ equity, is defined as net income or loss and other comprehensive income or loss. Other comprehensive income or loss includes changes in foreign currency translation adjustments, unrealized gains and losses on derivative

 

53


Table of Contents

financial instruments, prior service costs and net gains or losses from pension and other postretirement benefit plans arising during the period and amortization of these prior service costs and net gains or losses adjustments, all recorded net of deferred income taxes directly in shareholders’ equity.

Recently Issued Accounting Standards. The Financial Accounting Standards Board (“FASB”) Emerging Issues Task Force issued a consensus updating accounting standards for revenue recognition for multiple-deliverable arrangements in October 2009. The stated objective of the accounting standards update was to address the accounting for multiple-deliverable arrangements to enable vendors to account for products or services (deliverables) separately rather than as a combined unit. The revision of current FASB guidance provides amended methodologies for separating consideration in multiple-deliverable arrangements and expands disclosure requirements. The accounting standards update will be effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010, with early adoption permitted. We do not expect these FASB rules to have a material impact on our financial statements and disclosures.

The FASB issued guidance in January 2010 that requires new disclosures for fair value measurements and provides clarification for existing disclosure requirements. More specifically, this update will require (a) an entity to disclose separately the amounts of significant transfers in and out of Levels 1 and 2 fair value measurements and to describe the reasons for such transfers; and (b) information about purchases, sales, issuances and settlements to be presented separately (i.e. present the activity on a gross basis rather than net) in the reconciliation for fair value measurements using significant unobservable inputs (Level 3 inputs). This update also clarifies existing disclosure requirements for the level of disaggregation used for classes of assets and liabilities measured at fair value and requires disclosures about the valuation techniques and inputs used to measure fair value for both recurring and nonrecurring fair value measurements using Level 2 and Level 3 inputs. The new disclosures and clarifications of existing disclosures were effective for interim and annual reporting periods beginning after December 15, 2009, except for disclosures about the purchase, sale, issuance and settlement activity of Level 3 fair value measurements. Those disclosures are effective for fiscal years beginning after December 15, 2010, and for the interim periods in that year. The adoption of these new disclosures and clarifications of existing disclosures have not and are not expected to materially expand our current financial statement footnote disclosures.

In March 2010, the Patient Protection and Affordable Care Act (the “PPACA”) was signed into law, as was the Health Care and Education Reconciliation Act of 2010, which amends certain aspects of the PPACA. Included in the provisions of these laws are changes to the taxation related to the federal subsidy available to companies that provide retiree health benefit plans that include a benefit that is at least actuarially equivalent to the benefits of Medicare Part D. Our retiree medical plan does not include prescription drug coverage for Medicare-eligible retirees, so we are not impacted by changes to the taxation of this federal subsidy. We will continue to assess the other potential long-term impacts, if any, that any related amendments or clarification of this legislation may have on future results of operations, cash flows or financial position related to our health care benefits and postretirement health care obligations, as events warrant.

 

2 INVESTMENTS

 

During the third quarter of 2007, we invested $6.5 million in a privately held specialty pharmaceutical company. In the fourth quarter of 2008, we invested an additional $1.0 million as part of a new round of equity financing completed by the investee. The company is developing and commercializing state of the art drug delivery systems designed to improve patient compliance and outcomes, and our ownership interest on a fully diluted basis is approximately 21%. The investment is accounted for under the fair value method. We elected the fair value option over the equity method of accounting since our investment objectives are similar to those of venture capitalists, which typically do not have controlling financial interests. In 2008, we recognized an unrealized gain of $5.6 million ($3.6 million after taxes) based on the valuation of our ownership interest implied from a new round of equity financing completed for the investee in the fourth quarter of 2008. We recognized an additional unrealized gain of $5.1 million ($3.2 million after taxes) in the fourth quarter of 2009 for the estimated appreciation of our ownership interest upon the investee entering into an exclusive licensing agreement that included an upfront payment, additional potential milestone payments and tiered royalties on sales of any products commercialized under the license. In the fourth

 

54


Table of Contents

quarter of 2010, we recognized an unrealized loss of $2.2 million ($1.4 million after taxes) for the estimated changes in the fair value of our investment after the investee, which had its new drug application to the Food & Drug Administration (“FDA”) accepted for review during the quarter, reassessed its projected timeframe for obtaining final marketing approval from the FDA. Unrealized gains (losses) associated with this investment are included in “Other income (expense), net” in the consolidated statements of income and separately stated in the segment operating profit table in Note 3.

At December 31, 2010 and 2009, the estimated fair value of our investment (included in “Other assets and deferred charges” in the consolidated balance sheets) was $16.0 million and $18.2 million, respectively. On the date of our most recent investment (December 15, 2008), we believe that the amount we would be paid for our ownership interest and liquidation preferences was based on Level 2 inputs, including investments by other investors. Subsequent to December 15, 2008, and until the next round of financing, we believe fair value estimates drop to Level 3 inputs since there is no secondary market for our ownership interest. In addition, the specialty pharmaceutical company currently has no product sales. Accordingly, after the latest financing and until the next round of financing or any other significant financial transaction, value estimates will primarily be based on assumptions relating to meeting product development and commercialization milestones, cash flow projections (projections of development and commercialization milestone payments, sales, costs, expenses, capital expenditures and working capital investment) and discounting of these factors for the high degree of risk. As a result, any future changes in the estimated fair value of our ownership interest will likely be attributed to a new round of financing, a merger or initial public offering or adjustments to the timing or magnitude of cash flows associated with development and commercialization milestones. If the company does not meet its development and commercialization milestones and there are indications that the amount or timing of its projected cash flows or related risks are unfavorable versus our most recent valuation, or a new round of financing or other significant financial transaction indicates a lower enterprise value, then our estimate of the fair value of our ownership interest in the company is likely to decline. Adjustments to the estimated fair value of our investment will be made in the period upon which such changes can be quantified.

Had we not elected to account for our investment under the fair value method, we would have been required to use the equity method of accounting. On December 31, 2008, the privately held specialty pharmaceutical company was converted from a limited liability company taxed as a pass-through entity (partnership) to a corporation. Substantially all shareholder rights from the limited liability company carried over in the conversion. Our allocation of losses for tax purposes as a pass-through entity in 2008 was approximately $4.8 million.

The condensed balance sheets for the specialty pharmaceutical company at December 31, 2010 and 2009 and related condensed statements of income for the last three years ended December 31, 2010, that were reported to us by the investee, are provided below:

 

     December 31,           December 31,  

(In Thousands)

   2010      2009           2010     2009  

Assets:

        

Liabilities & Equity:

    
        

Current portion of deferred revenues

   $ 8,839      $ 18,360   
        

Other current liabilities

     1,488        1,029   

Cash & cash equivalents

   $ 18,819       $ 22,835      

Non-current liabilities

     599        5,440   

Other current assets

     5,304         2,526      

Equity:

    

Other tangible assets

     796         1,046      

Redeemable preferred stock

     19,041        18,044   

Identifiable intangibles assets

     1,650         1,743      

Other

     (3,398     (14,723
                                     

Total assets

   $ 26,569       $ 28,150      

Total liabilities & equity

   $ 26,569      $ 28,150   
                                     

 

     2010     2009     2008  

Revenues & Expenses:

      

Revenues

   $ 29,099      $ 2,062      $ —     

Expenses and other, net

     (10,426     (6,732     (7,321

Income tax (expense) benefit

     (6,584     2,309        —     
                        

Net income (loss)

   $ 12,089      $ (2,361   $ (7,321
                        

On April 2, 2007, we invested $10.0 million in Harbinger Capital Partners Special Situations Fund, L.P. (“Harbinger”), a private investment fund that is subject to limitations on withdrawal. There is no secondary market for

 

55


Table of Contents

interests in the fund. Our investment in Harbinger, which represents less than 2% of its total partnership capital, is accounted for under the cost method. The December 31, 2010 and 2009 carrying value in the consolidated balance sheets (included in “Other assets and deferred charges”) was equal to our cost basis of $6.4 million and $10.0 million, respectively. The carrying value at December 31, 2010 reflected the receipt of the first installments of withdrawal proceeds, which started in August 2010. The timing and amount of future withdrawal proceeds were not known as of December 31, 2010. There were no gains or losses associated with our investment in Harbinger in 2010. Gains on our investment in Harbinger will be recognized when the amounts expected to be collected from our withdrawal from the investment are known, which will likely be when cash in excess of our remaining carrying value is received. Losses will be recognized if management believes it is probable that future withdrawal proceeds will not exceed the remaining carrying value.

At December 31, 2010 and 2009, our reported capital account value in Harbinger was $9.6 million and $14.5 million, respectively.

 

3 BUSINESS SEGMENTS

 

In February 2010, we added a fourth segment, Other, comprised of the start-up operations of Bright View and Falling Springs, LLC (“Falling Springs”). Bright View is a developer and producer of high-value microstructure-based optical films for the LED (light emitting diode) and fluorescent lighting markets. Falling Springs develops, owns and operates multiple mitigation banks. Through the establishment of perpetual easements to restore, enhance and preserve wetland, stream or other protected environmental resources, these mitigation banks create saleable credits that are used by the purchaser of credits to offset the negative environmental impacts from private and public development projects.

Information by business segment and geographic area for the last three years is provided below. For periods prior to 2010, net sales and income (loss) from ongoing operations for Falling Springs (which were immaterial) have been included in “Corporate expense, net” and identifiable assets for this business (which were immaterial) have been included in “General corporate” in order to reflect the strategic view and structure of operations during this time period. There are no accounting transactions between segments and no allocations to segments. Net sales (sales less freight) and operating profit from ongoing operations are the measures of sales and operating profit used by the chief operating decision maker for purposes of assessing performance. Film Products’ net sales to The Procter & Gamble Company (“P&G”) totaled $273.1 million in 2010, $253.5 million in 2009 and $282.7 million in 2008. These amounts include plastic film sold to others that convert the film into materials used with products manufactured by P&G.

 

56


Table of Contents
     Net Sales  

(In Thousands)

   2010     2009     2008  

Film Products

   $ 520,445      $ 455,007      $ 522,839   

Aluminum Extrusions

     199,639        177,521        340,278   

Other

     2,579        —          —     
                        

Total net sales

     722,663        632,528        863,117   

Add back freight

     17,812        16,085        20,782   
                        

Sales as shown in consolidated statements of income

   $ 740,475      $ 648,613      $ 883,899   
                        
     Operating Profit  

(In Thousands)

   2010     2009     2008  

Film Products:

      

Ongoing operations

   $ 71,184      $ 64,379      $ 53,914   

Plant shutdowns, asset impairments, restructurings and other (a)

     (505     (1,846     (11,297

Aluminum Extrusions:

      

Ongoing operations

     (4,154     (6,494     10,132   

Plant shutdowns, asset impairments, restructurings and other (a)

     493        (639     (687

Goodwill impairment charge (a)

     —          (30,559     —     

AFBS (formerly Therics):

      

Gain on sale of investments in Theken Spine and Therics, LLC

     —          1,968        1,499   

Other:

      

Ongoing operations

     (4,173     —          —     

Plant shutdowns, asset impairments, restructurings and other (a)

     (253     —          —     
                        

Total

     62,592        26,809        53,561   

Interest income

     709        806        1,006   

Interest expense

     1,136        783        2,393   

Gain on sale of corporate assets (a)

     —          404        1,001   

Gain (loss) on investment accounted for under the fair value method (a)

     (2,200     5,100        5,600   

Stock option-based compensation expense

     2,064        1,692        782   

Corporate expenses, net (a)

     17,118        13,334        8,866   
                        

Income from continuing operations before income taxes

     40,783        17,310        49,127   

Income taxes (a)

     13,756        18,663        19,486   
                        

Income (loss) from continuing operations

     27,027        (1,353     29,641   

Income (loss) from discontinued operations (a)

     —          —          (705
                        

Net income (loss)

   $ 27,027      $ (1,353   $ 28,936   
                        

 

(a) See Notes 1, 2 and 15 for more information on losses associated with plant shutdowns, asset impairments and restructurings, unusual items, gains or losses from sale of assets, gains or losses on an investment accounted for under the fair value method and other items.
(b) We recognize in the balance sheets the funded status of each of our defined benefit pension and other postretirement plans. The funded status of our defined benefit pension plan was a net liability of $8.3 million, $6.0 million and $17.1 million in “Other noncurrent liabilities” as of December 31, 2010, 2009 and 2008. See Note 11 for more information on our pension and other postretirement plans.
(c) The difference between total consolidated sales as reported in the consolidated statements of income and segment and geographic net sales reported in this note is freight of $17.8 million in 2010, $16.1 million in 2009 and $20.8 million in 2008.
(d) Information on exports and foreign operations are provided on the next page. Cash and cash equivalents includes funds held in locations outside the U.S. of $35.7 million, $34.2 million and $37.3 million at December 31, 2010, 2009 and 2008, respectively. Export sales relate almost entirely to Film Products. Operations outside the U.S. in The Netherlands, Hungary, China, Italy, Brazil and India also relate to Film Products. Sales from our locations in The Netherlands, Hungary and Italy are primarily to customers located in Europe. Sales from our locations in China (Guangzhou and Shanghai) are primarily to customers located in China, but also include other customers in Asia. Sales activity at the new film products manufacturing facility in India will begin in 2011.

 

57


Table of Contents
     Identifiable Assets  

(In Thousands)

   2010      2009      2008  

Film Products

   $ 363,312       $ 371,639       $ 399,895   

Aluminum Extrusions

     81,731         82,429         112,259   

AFBS (formerly Therics)

     583         1,147         1,629   

Other

     19,701         —           —     
                          

Subtotal

     465,327         455,215         513,783   

General corporate (b)

     41,824         50,401         50,874   

Cash and cash equivalents (d)

     73,191         90,663         45,975   
                          

Total

   $ 580,342       $ 596,279       $ 610,632   
                          

 

     Depreciation and Amortization      Capital Expenditures  

(In Thousands)

   2010      2009      2008      2010      2009      2008  

Film Products

   $ 33,765       $ 32,360       $ 34,588       $ 15,664       $ 11,487       $ 11,135   

Aluminum Extrusions

     9,054         7,566         8,018         4,339         22,530         9,692   

Other

     695         —           —           179         —           —     
                                                     

Subtotal

     43,514         39,926         42,606         20,182         34,017         20,827   

General corporate

     74         71         70         236         125         78   
                                                     

Continuing operations

     43,588         39,997         42,676         20,418         34,142         20,905   

Discontinued aluminum extrusions business in Canada (a)

     —           —           515         —           —           39   
                                                     

Total

   $ 43,588       $ 39,997       $ 43,191       $ 20,418       $ 34,142       $ 20,944   
                                                     

 

     Net Sales by Geographic Area (d)  

(In Thousands)

   2010      2009      2008  

United States

   $ 416,892       $ 363,570       $ 531,235   

Exports from the United States to:

        

Canada

     50,534         39,300         46,790   

Latin America

     2,684         2,238         1,614   

Europe

     8,572         7,261         12,532   

Asia

     68,818         43,948         26,156   

Operations outside the United States:

        

The Netherlands

     81,945         88,563         109,392   

Hungary

     23,645         20,300         34,889   

China

     35,999         36,438         62,957   

Italy

     9,272         10,497         11,057   

Brazil

     24,302         20,413         26,495   
                          

Total (c)

   $ 722,663       $ 632,528       $ 863,117   
                          

 

     Identifiable Assets
by Geographic Area (d)
    

Property, Plant & Equipment,

Net by Geographic Area (d)

 

(In Thousands)

   2010      2009      2008      2010      2009      2008  

United States (b)

   $ 341,970       $ 326,120       $ 373,073       $ 135,840       $ 152,189       $ 150,354   

Operations outside the United States:

                 

The Netherlands

     47,574         56,761         61,204         31,979         40,832         44,559   

Hungary

     13,535         12,265         15,195         7,515         7,978         7,731   

China

     31,587         34,176         40,092         21,385         23,605         27,809   

Italy

     13,639         15,492         15,187         2,137         2,546         2,792   

Brazil

     11,660         10,401         9,032         3,107         3,212         3,088   

India

     5,362         —           —           4,241         —           —     

General corporate (b)

     41,824         50,401         50,874         633         514         537   

Cash and cash equivalents (d)

     73,191         90,663         45,975         n/a         n/a         n/a   
                                                     

Total

   $ 580,342       $ 596,279       $ 610,632       $ 206,837       $ 230,876       $ 236,870   
                                                     

See footnotes on prior page and a reconciliation of net sales to sales as shown in the consolidated statements of income.

 

58


Table of Contents
4 ACCOUNTS AND NOTES RECEIVABLE

 

Accounts and notes receivable consist of the following:

 

(In Thousands)

   2010      2009  

Trade, less allowance for doubtful accounts and sales returns of $5,286 in 2010 and $5,299 in 2009

   $ 78,768       $ 69,789   

Other

     5,308         4,225   
                 

Total

   $ 84,076       $ 74,014   
                 

A reconciliation of the beginning and ending balances of the allowance for doubtful accounts and sales returns for the last three years in the period ended December 31, 2010 is as follows:

 

(In Thousands)

   2010     2009     2008  

Balance, beginning of year

   $ 5,299      $ 3,949      $ 5,198   

Charges to expense

     1,779        4,034        2,527   

Recoveries

     (1,633     (1,522     (1,494

Write-offs

     (25     (1,411     (2,171

Foreign exchange and other

     (134     249        (111
                        

Balance, end of year

   $ 5,286      $ 5,299      $ 3,949   
                        

 

5 INVENTORIES

 

Inventories consist of the following:

 

(In Thousands)

   2010      2009  

Finished goods

   $ 7,373       $ 6,080   

Work-in-process

     3,669         2,740   

Raw materials

     15,327         12,249   

Stores, supplies and other

     16,689         14,453   
                 

Total

   $ 43,058       $ 35,522   
                 

Inventories stated on the LIFO basis amounted to $18.4 million at December 31, 2010 and $13.4 million at December 31, 2009, which are below replacement costs by approximately $20.6 million at December 31, 2010 and $21.5 million at December 31, 2009. During 2010 and 2009, certain inventories accounted for on a LIFO basis declined, which resulted in cost of goods sold being stated at below current replacement costs, by approximately $2.6 million in 2010 ($935,000 in Film Products and $1.7 million in Aluminum Extrusions) and $1.1 million in 2009 in Film Products.

 

6 FINANCIAL INSTRUMENTS

 

We use derivative financial instruments for the purpose of hedging margin exposure from fixed-price forward sales contracts in Aluminum Extrusions and currency exchange rate exposures that exist as part of ongoing business operations (primarily in Film Products). Our derivative financial instruments are designated as and qualify as cash flow hedges and are recognized in the consolidated balance sheet at fair value. The fair value of derivative instruments recorded on the consolidated balance sheets are based upon Level 2 inputs. If individual derivative instruments with the same counterparty can be settled on a net basis, we record the corresponding derivative fair values as a net asset or net liability.

In the normal course of business, we enter into fixed-price forward sales contracts with certain customers for the future sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge our margin exposure created from the fixing of future sales prices relative to volatile raw material (aluminum) costs, we enter into

 

59


Table of Contents

a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the scheduled purchases for the firm sales commitments. The fixed-price firm sales commitments and related hedging instruments generally have durations of not more than 12 months, and the notional amount of aluminum futures contracts that hedged future purchases of aluminum to meet fixed-price forward sales contract obligations was $5.8 million (5.7 million pounds of aluminum) at December 31, 2010 and $6.9 million (7.8 million pounds of aluminum) at December 31, 2009.

The table below summarizes the location and gross amounts of aluminum futures contract fair values in the consolidated balance sheets as of December 31, 2010 and 2009:

 

     December 31, 2010      December 31, 2009  

(In Thousands)

   Balance Sheet
Account
     Fair
Value
     Balance Sheet
Account
     Fair
Value
 

Derivatives Designated as Hedging Instruments

           

Asset derivatives:

           

Aluminum futures contracts

    

 

Prepaid expenses

and other

  

  

   $     490        

 

Prepaid expenses

and other

  

  

   $   1,184   

Liability derivatives:

           

Aluminum futures contracts

    

 

Prepaid expenses

and other

  

  

   $ 36        

 

Prepaid expenses

and other

  

  

   $ —     
                                   

Derivatives Not Designated as Hedging Instruments

           

Asset derivatives:

           

Aluminum futures contracts

    

 

Prepaid expenses

and other

  

  

   $ —          

 

Prepaid expenses

and other

  

  

   $ 614   

Liability derivatives:

           

Aluminum futures contracts

    

 

Prepaid expenses

and other

  

  

   $ —          

 

Prepaid expenses

and other

  

  

   $ 614   
                                   

In the event that a counterparty to an aluminum fixed-price forward sales contract chooses not to take delivery of its aluminum extrusions, the customer is contractually obligated to compensate us for any losses on the related aluminum futures and/or forward purchase contracts through the date of cancellation. The offsetting asset and liability positions for derivatives not designated as hedging instruments included in the table above are associated with the unwinding of aluminum futures contracts that relate to such cancellations.

Gains associated with the aluminum extrusions business of $893,000 ($555,000 after taxes) were recognized in 2010 for timing differences between the recognition of realized losses on aluminum futures contracts and related revenues from delayed fulfillment by customers of fixed-price forward purchase commitments. Such timing differences are included in “Plant shutdowns, assets impairments, restructurings and other” in the net sales and operating profit by segment table in Note 3. Losses of $952,000 ($592,000 after tax) were recognized in 2009 for timing differences between the recognition of realized losses on aluminum futures contracts and related revenues from delayed fulfillment by customers of fixed-price forward purchase commitments. Timing differences prior to 2009 were not significant.

We had future fixed Euro-denominated contractual payments for equipment being purchased as part of our capacity expansion at the Carthage, Tennessee aluminum extrusion manufacturing facility. We used a fixed rate Euro forward contract with various settlement dates to hedge exchange rate exposure on these obligations. The notional amount of this foreign currency forward was $1.6 million at December 31, 2009. There were no foreign currency forward contracts outstanding at December 31, 2010.

 

60


Table of Contents

The table below summarizes the location and gross amounts of foreign currency forward contract fair values in the consolidated balance sheets as of December 31, 2009 (none at December 31, 2010):

 

     December 31, 2009  

(In Thousands)

   Balance Sheet
Account
     Fair
Value
 

Derivatives Designated as Hedging Instruments

     

Asset derivatives:

     

Foreign currency forward contracts

    

 

Prepaid expenses

and other

  

  

   $ 35   
                 

Derivatives Not Designated as Hedging Instruments

     

Liability derivatives:

     

Foreign currency forward contracts

     Accrued expenses       $ 41   
                 

We receive Euro-based royalty payments relating to our operations in Europe. From time to time we use zero-cost collar currency options to hedge a portion of our exposure to changes in cash flows due to variability in U.S. Dollar and Euro exchange rates. There were no outstanding notional amounts on these collars at December 31, 2010 and 2009 as there were no derivatives outstanding at December 31, 2010 and 2009 related to the hedging of royalty payments with currency options.

Our derivative contracts involve elements of credit and market risk, including the risk of dealing with counterparties and their ability to meet the terms of the contracts. The counterparties to our forward purchase commitments are major aluminum brokers and suppliers, and the counterparties to our aluminum futures contracts are major financial institutions. Fixed-price forward sales contracts are only made available to our best and most credit-worthy customers. The counterparties to our foreign currency futures and zero-cost collar contracts are major financial institutions.

The pretax effect on net income (loss) and other comprehensive income (loss) of derivative instruments classified as cash flow hedges and described in the previous paragraphs for years ended December 31, 2010, 2009, and 2008 is summarized in the tables below:

 

0000000000 0000000000 0000000000 0000000000 0000000000 0000000000
(In Thousands)    Cash Flow Derivative Hedges  
     Aluminum Futures Contracts     Foreign Currency Forwards and Options  

Years Ended December 31,

   2010     2009     2008     2010     2009     2008  

Amount of pre-tax gain (loss) recognized in other comprehensive income

   $ (102   $ 1,762      $ (9,771   $ (284   $ (336   $ 56   
                                                

Location of gain (loss) reclassified from accumulated other comprehensive income into net income (effective portion)

    

 

Cost of

sales

  

  

   
 
Cost of
sales
  
  
 

 

 

Cost of

sales

  

  

   

 

 

Selling,

general and

admin. exp.

  

  

  

   

 

 

Selling,

general and

admin. exp.

  

  

  

 

Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income to net income (effective portion)

   $ 641      $ (10,248   $ (760   $ (271   $ (315   $ —     
                                                

Gains and losses on the ineffective portion of derivative instruments or derivative instruments that were not designated as hedging instruments were not significant in 2010, 2009 and 2008. For the years ended December 31, 2010 and 2009 (none in 2008), unrealized net losses from hedges that were discontinued were not significant. As of December 31, 2010, we expect $280,000 of unrealized after-tax gains on derivative instruments reported in accumulated other comprehensive income to be reclassified to earnings within the next twelve months.

 

61


Table of Contents
7 ACCRUED EXPENSES

 

Accrued expenses consist of the following:

 

(In Thousands)

   2010      2009  

Payrolls, related taxes and medical and other benefits

   $ 6,642       $ 5,332   

Incentive compensation

     6,436         6,528   

Vacation

     5,995         5,665   

Workers’ compensation and disabilities

     2,468         2,360   

Plant shutdowns and divestitures

     1,900         3,981   

Futures contracts, net of cash deposits

     223         255   

Other

     9,565         10,809   
                 

Total

   $ 33,229       $ 34,930   
                 

A reconciliation of the beginning and ending balances of accrued expenses associated with asset impairments and costs associated with exit and disposal activities for each of the three years in the period ended December 31, 2010 is as follows:

 

(In Thousands)

   Severance     Long-Lived
Asset
Impairments
    Accelerated
Depreciation (a)
    Other (b)     Total  

Balance at December 31, 2007

   $ 363      $ —        $ —        $ 5,838      $ 6,201   

2008:

          

Charges

     2,662        6,994        1,649        —          11,305   

Cash spent

     (2,594     —          —          (1,347     (3,941

Charged against assets

     —          (6,994     (1,649     —          (8,643
                                        

Balance at December 31, 2008

     431        —          —          4,491        4,922   

2009:

          

Charges

     2,094        1,005        —          —          3,099   

Cash spent

     (1,702     —          —          (1,333     (3,035

Charged against assets

     —          (1,005     —          —          (1,005
                                        

Balance at December 31, 2009

     823        —          —          3,158        3,981   

2010:

          

Charges

     165        608        —          —          773   

Cash spent

     (751     —          —          (1,565     (2,316

Charged against assets

     —          (608     —          —          (608
                                        

Balance at December 31, 2010

   $ 237      $ —        $ —        $ 1,593      $ 1,830   
                                        

 

(a) Represents depreciation accelerated due to plant shutdowns based on a remaining useful life of less than one year.
(b) Other includes primarily accrued losses on a sub-lease at a facility in Princeton, New Jersey.

See Note 15 for more information on plant shutdowns, asset impairments and restructurings of continuing operations.

 

8 DEBT AND CREDIT AGREEMENTS

 

On June 21, 2010, we entered into a $300 million four-year, unsecured revolving credit facility (the “Credit Agreement”), with an option to increase that amount by an additional $75 million. The Credit Agreement replaces our previous five-year, unsecured revolving credit facility that was due to expire on December 15, 2010. There were no outstanding borrowings under the previous revolving credit facility when it was replaced.

 

62


Table of Contents

Borrowings under the Credit Agreement bear an interest rate of LIBOR plus a credit spread and commitment fees charged on the unused amount under the Credit Agreement at various indebtedness-to-adjusted-EBITDA levels as follows:

 

Pricing Under Revolving Credit Agreement (Basis Points)

 

Indebtedness-to-Adjusted EBITDA Ratio

   Credit Spread
Over LIBOR
     Commitment
Fee
 

> 2.0x but <= 3.0x

     250         40   

> 1.0x but <= 2.0x

     225         35   

<= 1.0x

     200         30   

At December 31, 2010, the interest cost on debt, if amounts had been borrowed, was priced at one-month LIBOR plus the applicable credit spread of 200 basis points.

The most restrictive covenants in the Credit Agreement include:

 

   

Maximum aggregate dividends over the term of the Credit Agreement of $100 million plus, beginning with the fiscal quarter ending March 31, 2010, 50% of net income;

 

   

Minimum shareholders’ equity at any point during the term of the Credit Agreement of at least $300 million increased on a cumulative basis at the end of each fiscal quarter, beginning with the fiscal quarter ending March 31, 2010, by an amount equal to 50% of net income (to the extent positive);

 

   

Maximum indebtedness-to-adjusted EBITDA of 3.0x; and

 

   

Minimum adjusted EBIT-to-interest expense of 2.5x.

At December 31, 2010, based upon the most restrictive covenants within the Credit Agreement, available credit under the Credit Agreement was approximately $263 million. Total debt due and outstanding at December 31, 2010 is summarized below:

 

000 000 000

Debt Due and Outstanding at December 31, 2010

(In Thousands)

 

Year Due

   Credit
Agreement
     Other      Total Debt
Due
 

2011

   $ —         $       222       $ 222   

2012

     —           114         114   

2013

     —           114         114   

2014

     —           —           —     

2015

     —           —           —     
                          

Total

   $ —         $ 450       $ 450   
                          

We believe we were in compliance with all of our debt covenants as of December 31, 2010. Noncompliance with any of the debt covenants may have a material adverse effect on financial condition or liquidity in the event such noncompliance cannot be cured or should we be unable to obtain a waiver from the lenders. Renegotiation of the covenant through an amendment to the Credit Agreement may effectively cure the noncompliance, but may have an effect on financial condition or liquidity depending upon how the covenant is renegotiated.

 

9 SHAREHOLDER RIGHTS AGREEMENT

 

Pursuant to an Amended and Restated Rights Agreement, dated as of June 30, 2009, between Tredegar and National City Bank, N.A., as Rights Agent (essentially renewing and extending our Rights Agreement, dated as of June 30, 1999), as amended, one right is attendant to each share of our common stock (“Right”). All Rights outstanding under the previous Rights Plan remain outstanding under the Amended and Restated Rights Agreement.

 

63


Table of Contents

Each Right entitles the registered holder to purchase from Tredegar one one-hundredth of a share of Participating Cumulative Preferred Stock, Series A (the “Preferred Stock”), at an exercise price of $150 (the “Purchase Price”). The Rights will become exercisable, if not earlier redeemed, only if a person or group acquires 10% or more of the outstanding shares of our common stock (thereby becoming an “Acquiring Person”) or announces a tender offer that would result in ownership by a person or group of 10% or more of our common stock. Any action by a person or group whose beneficial ownership was reported on Amendment No. 4 to the Schedule 13D filed with respect to Tredegar on March 20, 1997, cannot cause such person or group to become an Acquiring Person and thereby cause the Rights to become exercisable.

Each holder of a Right, upon the occurrence of certain events, will become entitled to receive, upon exercise and payment of the Purchase Price, Preferred Stock (or in certain circumstances, cash, property or other securities of Tredegar or a potential acquirer) having a value equal to twice the amount of the Purchase Price.

The Rights are scheduled to expire on June 30, 2019.

 

10 STOCK OPTION AND STOCK AWARD PLANS

 

We have one stock option plan under which stock options may be granted to purchase a specified number of shares of common stock at a price no lower than the fair market value on the date of grant and for a term not to exceed 10 years. In addition, we have one other stock option plan under which there are options that remain outstanding, but no future grants can be made. Employee options ordinarily vest two years from the date of grant. The option plans also permit the grant of stock appreciation rights (“SARs”), stock, restricted stock, stock unit awards and incentive awards. Restricted stock grants ordinarily vest three years from the date of grant. No SARs have been granted since 1992 and none are currently outstanding.

A summary of our stock options outstanding at December 31, 2010, 2009 and 2008, and changes during those years, is presented below:

 

           Option Exercise Price/Share  
     Number of
Options
           Range           Weighted
Average
 

Outstanding at December 31, 2007

     702,983      $ 13.95       to    $ 29.94       $ 17.25   

Granted

     401,000        14.06       to      19.25         15.72   

Forfeited and Expired

     (161,515     13.95       to      29.94         20.07   

Exercised

     (248,118     13.95       to      18.90         16.66   
                                       

Outstanding at December 31, 2008

     694,350        13.95       to      19.52         15.92   

Granted

     283,400        14.72       to      18.12         17.92   

Forfeited and Expired

     (171,875     13.95       to      19.52         17.59   

Exercised

     (9,700     13.95       to      15.11         14.37   
                                       

Outstanding at December 31, 2009

     796,175        13.95       to      19.52         16.29   

Granted

     316,000        16.66       to      17.54         17.15   

Forfeited and Expired

     (29,325     13.95       to      18.12         16.37   

Exercised

     (65,575     13.95       to      15.80         15.04   
                                       

Outstanding at December 31, 2010

     1,017,275      $ 13.95       to    $ 19.52       $ 16.64   
                                       

 

64


Table of Contents

The following table summarizes additional information about stock options outstanding and exercisable and non-vested restricted stock outstanding at December 31, 2010:

 

      Options Outstanding at
December 31, 2010
     Options Exercisable at
December 31, 2010
 
      Shares      Weighted Average      Aggregate
Intrinsic
Value (In
Thousands)
     Shares      Weighted
Average
Exercise
Price
     Aggregate
Intrinsic
Value (In
Thousands)
 

Range of Exercise Prices

      Remaining
Contractual
Life
(Years)
     Exercise
Price
             

$ —      to      $13.95

     24,075         0.2       $ 13.95       $ 131         24,075       $ 13.95       $ 131   

13.96    to      20.00

     993,200         5.1         16.70         2,662         419,300         15.59         1,587   
                                                              

Total

     1,017,275         5.0       $ 16.64       $ 2,793         443,375       $ 15.51       $ 1,718   
                                                              

 

     Non-vested Restricted Stock     Maximum Non-vested Restricted Stock Units
Issuable Upon Satisfaction of Certain
Performance Criteria
 
     Number
of Shares
    Wgtd. Ave.
Grant Date
Fair Value/Sh.
     Grant Date
Fair Value
(In Thousands)
    Number
of Shares
    Wgtd. Ave.
Grant Date
Fair Value/Sh.
     Grant Date
Fair Value
(In Thousands)
 

Outstanding at December 31, 2007

     59,500      $ 13.97       $ 831        176,875      $ 20.09       $ 3,554   

Granted

     12,690        16.01         203        146,600        15.80         2,316   

Vested

     (8,190     17.08         (140     —          —           —     

Forfeited

     (10,500     14.06         (148     (115,694     20.40         (2,360
                                                  

Outstanding at December 31, 2008

     53,500        13.94         746        207,781        16.89         3,510   

Granted

     50,637        17.52         887        76,175        17.93         1,366   

Vested

     (58,387     14.10         (823     (66,731     20.02         (1,336

Forfeited

     —          —           —          (145,050     15.63         (2,267
                                                  

Outstanding at December 31, 2009

     45,750        17.70         810        72,175        17.64         1,273   

Granted

     56,717        17.23         977        82,750        16.83         1,393   

Vested

     (8,284     17.84         (148     —          —           —     

Forfeited

     (333     18.12         (6     (4,000     17.10         (68
                                                  

Outstanding at December 31, 2010

     93,850      $ 17.40       $ 1,633        150,925      $ 17.21       $ 2,598   
                                                  

The total intrinsic value of stock options exercised was $221,000 in 2010, $14,000 in 2009 and $653,000 in 2008. The grant-date fair value of stock option-based awards vested was $1.9 million in 2010 and $1.8 million in 2008 (none in 2009). As of December 31, 2010, there was unrecognized compensation cost of $1.4 million related to stock option-based awards and $1.5 million related to non-vested restricted stock and other stock-based awards. This cost is expected to be recognized over the remaining weighted average period of 0.7 years for stock option-based awards and 1.1 years for non-vested restricted stock and other stock-based awards.

Stock options exercisable totaled 443,375 shares at December 31, 2010 and 199,775 shares at December 31, 2009. Stock options available for grant totaled 3,151,868 shares at December 31, 2010.

 

11 RETIREMENT PLANS AND OTHER POSTRETIREMENT BENEFITS

 

We have noncontributory defined benefit (pension) plans covering most employees. The plans for salaried and hourly employees currently in effect are based on a formula using the participant’s years of service and compensation or using the participant’s years of service and a dollar amount.

In addition to providing pension benefits, we provide postretirement life insurance and health care benefits for certain groups of employees. Tredegar and retirees share in the cost of postretirement health care benefits, with employees hired on or before January 1, 1993, receiving a fixed subsidy to cover a portion of their health care premiums. On December 8, 2003, the Medicare Prescription Drug Improvement and Modernization Act of 2003 (the “Act”) was signed into law. We eliminated prescription drug coverage for Medicare-eligible retirees as of January 1, 2006. Consequently, we are not eligible for any federal subsidies.

 

65


Table of Contents

Assumptions used for financial reporting purposes to compute net benefit income or cost and benefit obligations for continuing operations, and the components of net periodic benefit income or cost for continuing operations, are as follows:

 

                 Other Post-  
     Pension Benefits     Retirement Benefits  

(In Thousands)

   2010     2009     2010     2009  

Change in benefit obligation:

        

Benefit obligation, beginning of year

   $ 235,015      $ 211,685      $ 8,687      $ 8,124   

Service cost

     3,315        3,077        76        70   

Interest cost

     13,071        13,287        467        495   

Effect of actuarial (gains) losses related to the following:

        

Discount rate change

     8,587        18,758        307        656   

Retirement rate assumptions and mortality table adjustments

     1,175        462        25        (3

Retiree medical participation rate change

     —          —          (1,424     —     

Other

     (1,853     (1,436     (477     (373

Benefits paid

     (11,341     (10,818     (311     (282
                                

Benefit obligation, end of year

   $ 247,969      $ 235,015      $ 7,350      $ 8,687   
                                

Change in plan assets:

        

Plan assets at fair value, beginning of year

   $ 228,984      $ 194,538      $ —        $ —     

Actual return on plan assets

     21,896        45,135        —          —     

Employer contributions

     167        129        311        282   

Benefits paid

     (11,341     (10,818     (311     (282
                                

Plan assets at fair value, end of year

   $ 239,706      $ 228,984      $ —        $ —     
                                

Funded status of the plans

   $ (8,263   $ (6,031   $ (7,350   $ (8,687
                                

Amounts recognized in the consolidated balance sheets:

        

Prepaid benefit cost

   $ —        $ —        $ —        $ —     

Accrued benefit liability

     (8,263     (6,031     (7,350     (8,687
                                

Net amount recognized

   $ (8,263   $ (6,031   $ (7,350   $ (8,687
                                

 

66


Table of Contents

The following tables reconcile the changes in benefit obligations and plan assets in 2010 and 2009, and reconcile the funded status to prepaid or accrued cost at December 31, 2010 and 2009:

 

                       Other Post-  
     Pension Benefits     Retirement Benefits  

(In Thousands, Except Percentages)

   2010     2009     2008     2010     2009     2008  

Weighted-average assumptions used to determine benefit obligations:

            

Discount rate

     5.45     5.70     6.50     5.35     5.75     6.50

Rate of compensation increases

     n/a        n/a        n/a        4.00     4.00     4.00

Weighted-average assumptions used to determine net periodic benefit cost:

            

Discount rate

     5.70     6.50     6.25     5.75     6.50     6.25

Rate of compensation increases

     n/a        n/a        n/a        4.00     4.00     4.00

Expected long-term return on plan assets, during the year

     8.25     8.25     8.50     n/a        n/a        n/a   

Rate of increase in per-capita cost of covered health care benefits:

            

Indemnity plans, end of year

     n/a        n/a        n/a        6.00     6.00     6.00

Managed care plans, end of year

     n/a        n/a        n/a        6.00     6.00     6.00

Components of net periodic benefit income (cost):

            

Service cost

   $ (3,315   $ (3,077   $ (3,447   $ (76   $ (70   $ (71

Interest cost

     (13,071     (13,287     (12,909   $ (467   $ (495     (484

Expected return on plan assets

     20,530        20,680        21,965        —          —          —     

Amortization of prior service

            

costs and gains or losses

     (4,806     (1,224     (675     79        127        47   
                                                

Net periodic benefit income (cost)

   $ (662   $ 3,092      $ 4,934      $ (464   $ (438   $ (508
                                                

Net benefit income or cost is determined using assumptions at the beginning of each year. Funded status is determined using assumptions at the end of each year. Pension and other postretirement liabilities for continuing operations of $15.6 million and $14.7 million are included in “Other noncurrent liabilities” in the consolidated balance sheets at December 31, 2010 and 2009, respectively. The amount of our accumulated benefit obligation is the same as our projected benefit obligation.

At December 31, 2010, the effect of a 1% change in the health care cost trend rate assumptions would be immaterial.

Expected benefit payments for continuing operations over the next five years and in the aggregate for 2016-2020 are as follows:

 

(In Thousands)

   Pension
Benefits
     Other
Post-
Retirement
Benefits
 

2011

   $ 12,904       $ 441   

2012

     13,517         461   

2013

     14,126         483   

2014

     14,731         494   

2015

     15,365         506   

2016 - 2020

     84,604         2,602   

 

67


Table of Contents

Amounts recognized in 2010, 2009 and 2008 before related deferred income taxes in accumulated other comprehensive income consist of:

 

                       Other Post-  
     Pension     Retirement  

(In Thousands)

   2010     2009     2008     2010     2009     2008  

Prior service cost (benefit)

   $ (2,966   $ (4,035   $ (5,092   $ —        $ —        $ —     

Net actuarial (gain) loss

     102,037        101,368        110,319        (2,598     (1,107     (1,514

The amounts before related deferred income taxes in accumulated other comprehensive income that are expected to be recognized as components of net periodic benefit or cost during 2011 are as follows:

 

           Other Post-  

(In Thousands)

   Pension     Retirement  

Prior service cost (benefit)

   $ (1,078   $ —     

Net actuarial (gain) loss

     7,579        (267

The percentage composition of assets held by pension plans for continuing operations at December 31, 2010, 2009 and 2008, and the current expected long-term return on assets are as follows:

 

     % Composition of Plan Assets
at December 31,
    Expected
Long-term

Return %
 
     2010     2009     2008    

Pension plans related to continuing operations:

        

Low-risk fixed income securities

     1.9     3.5     10.3     3.9
                                

Large capitalization equity securities

     22.3        21.7        19.9        9.0   

Small-capitalization equity securities

     6.7        5.8        4.1        11.0   

International and emerging market equity securities

     21.6        21.4        18.6        10.8   
                                

Total equity securities

     50.6        48.9        42.6        10.0   
                                

Hedge and private equity funds

     42.7        42.9        43.8        8.7   

Other assets

     4.8        4.7        3.3        2.8   
                                

Total for continuing operations

     100.0     100.0     100.0     8.3
                                

Our targeted allocation percentage for pension plan assets is in the general range of the percentage composition that existed at December 31, 2010, with the exception of the targeted future range for low-risk fixed income securities being higher than actual allocations in 2009 and 2010. Expected long-term returns are estimated by asset class and generally are based on inflation-adjusted historical returns, volatilities, risk premiums and managed asset premiums. The portfolio of fixed income securities is structured with maturities that generally match estimated benefit payments over the next 1-2 years. Other assets are primarily comprised of cash and contracts with insurance companies. Our primary investment objective is to maximize total return with a strong emphasis on the preservation of capital. We believe that over the long term a diversified portfolio of equity securities, hedge funds and private equity funds has a better risk-return profile than fixed income securities. The average remaining duration of benefit payments for our pension plans is about 12 years. We expect our required contributions to approximate $174,000 in 2011.

 

68


Table of Contents

Estimates of the fair value of assets held by our pension plans are provided by third parties not affiliated with Tredegar. At December 31, 2010, the pension plan assets are categorized by level within the fair value measurement hierarchy as follows:

 

(In Thousands)           Quoted Prices in
Active Markets
for Identical
Assets
     Signficant
Other
Observable
Inputs
     Significant
Unobservable
Inputs
 

December 31, 2010

   Total      (Level 1)      (Level 2)      (Level 3)  

Large capitalization equity securities

   $ 53,543       $ 39,827       $ 13,716       $ —     

Small-capitalization equity securities

     16,170         16,170         —           —     

International and emerging market equity securities

     51,840         51,840         —           —     

Hedge and private equity funds

     102,309         —           94,267         8,042   

Low-risk fixed income securities

     4,469         1,613         2,856         —     

Other assets

     2,290         2,290         —           —     
                                   

Total plan assets at fair value

   $ 230,621       $ 111,740       $ 110,839       $ 8,042   

Contracts with insurance companies

     9,085            
                 

Total plan assets, December 31, 2010

   $ 239,706            
                 

December 31, 2009

                           

Large capitalization equity securities

   $ 49,655       $ 35,545       $ 14,110       $ —     

Small-capitalization equity securities

     13,272         13,272         —           —     

International and emerging market equity securities

     49,078         49,078         —           —     

Hedge and private equity funds

     98,204         —           86,567         11,637   

Low-risk fixed income securities

     8,069         4,047         4,022         —     

Other assets

     451         451         —           —     
                                   

Total plan assets at fair value

   $ 218,729       $ 102,393       $ 104,699       $ 11,637   

Contracts with insurance companies

     10,255            
                 

Total plan assets, December 31, 2009

   $ 228,984            
                 

For fair value measurements of plan assets using significant unobservable inputs (Level 3), a reconciliation of the balances from January 1, 2009 to December 31, 2010 are as follows:

 

(In Thousands)

   Hedge and private
equity funds
 

Balance at December 31, 2008

   $ 6,064   

Purchases, sales, and settlements

     (447

Actual return on plan assets still held at year end

     855   

Transfers in and/or out of Level 3

     5,165   
        

Balance at December 31, 2009

   $ 11,637   

Purchases, sales, and settlements

     (2,927

Actual return on plan assets still held at year end

     (668

Transfers in and/or out of Level 3

     —     
        

Balance at December 31, 2010

   $ 8,042   
        

We also have a non-qualified supplemental pension plan covering certain employees. Effective December 31, 2005, further participation in this plan was terminated and benefit accruals for existing participants were frozen. The

 

69


Table of Contents

plan was designed to restore all or a part of the pension benefits that would have been payable to designated participants from our principal pension plans if it were not for limitations imposed by income tax regulations. The projected benefit obligation relating to this unfunded plan was $2.5 million at December 31, 2010 and $2.9 million at December 31, 2009. Pension expense recognized for this plan was $178,000 in 2010, $202,000 in 2009 and $185,000 in 2008. This information has been included in the preceding pension benefit tables.

Approximately 113 employees at our films manufacturing facility in Kerkrade, The Netherlands are covered by a collective bargaining agreement that includes participation in a multi-employer pension plan. Pension expense recognized for participation in this plan, which is equal to required contributions, was $613,000 in 2010, $807,000 in 2009 and $1.0 million in 2008. This information has been excluded from the preceding pension benefit tables.

 

12 SAVINGS PLAN

 

We have a savings plan that allows eligible employees to voluntarily contribute a percentage of their compensation up to Internal Revenue Service (“IRS”) limitations. Effective January 1, 2007, and in conjunction with certain pension plan changes (see Note 11), the provisions of the savings plan provided the following benefits for salaried and certain hourly employees:

 

 

The company makes matching contributions to the savings plan of $1 for every $1 of employee contribution. The maximum matching contribution is 6% of base pay for 2007-2009 and 5% of base pay thereafter.

 

 

The savings plan includes immediate vesting for active employees of past matching contributions as well as future matching contributions when made (compared with the previous 5-year graded vesting) and automatic enrollment at 3% of base pay unless the employee opts out or elects a different percentage.

We also have a non-qualified plan that restores matching benefits for employees suspended from the savings plan due to certain limitations imposed by income tax regulations. Charges recognized for these plans were $2.6 million in 2010, $2.5 million in 2009 and $3.1 million in 2008. Our liability under the restoration plan was $1.3 million at December 31, 2010 (consisting of 67,313 phantom shares of common stock) and $1.3 million at December 31, 2009 (consisting of 79,088 phantom shares of common stock) valued at the closing market price on those dates.

The Tredegar Corporation Benefits Plan Trust (the “Trust”) purchased 7,200 shares of our common stock in 1998 for $192,000 and 46,671 shares of our common stock in 1997 for $1.0 million, as a partial hedge against the phantom shares held in the restoration plan. There have been no shares purchased since 1997 except for re-invested dividends. The cost of the shares held by the Trust is shown as a reduction to shareholders’ equity in the consolidated balance sheets.

 

13 RENTAL EXPENSE AND CONTRACTUAL COMMITMENTS

 

Rental expense for continuing operations was $2.9 million in 2010, $2.9 million in 2009 and $3.5 million in 2008. Rental commitments under all non-cancelable operating leases for continuing operations as of December 31, 2010, are as follows:

 

Year

   Amount
(In Thousands)
 

2011

   $ 1,681   

2012

     1,741   

2013

     1,617   

2014

     1,655   

2015

     1,131   

Remainder

     3,209   
        

Total

   $ 11,034   
        

AFBS, Inc. (formerly known as Therics, Inc), a wholly-owned subsidiary of Tredegar, has future rental commitments under noncancelable operating leases through 2011 (most of which contain sublease options) totaling approximately $400,000. These future rental commitments are included in the above table. Sublease rental commitments relating to excess space at AFBS total $27,000 (excluded from the above table).

 

70


Table of Contents

Contractual obligations for plant construction and purchases of real property and equipment amounted to $3.4 million at December 31, 2010.

 

14 INCOME TAXES

 

Income from continuing operations before income taxes and income taxes are as follows:

 

(In Thousands)

   2010     2009     2008  

Income from continuing operations before income taxes:

      

Domestic

   $ 30,723      $ 2,098      $ 31,838   

Foreign

     10,060        15,212        17,289   
                        

Total

   $ 40,783      $ 17,310      $ 49,127   
                        

Current income taxes:

      

Federal

   $ 14,431      $ 7,624      $ 1,494   

State

     1,414        (335     1,126   

Foreign

     4,308        4,399        6,038   
                        

Total

     20,153        11,688        8,658   
                        

Deferred income taxes:

      

Federal

     (6,225     6,088        9,672   

State

     (771     831        114   

Foreign

     599        56        1,042   
                        

Total

     (6,397     6,975        10,828   
                        

Total income taxes

   $ 13,756      $ 18,663      $ 19,486   
                        

Income from continuing operations before income taxes for domestic operations in 2009 varies from that for 2010 and 2008 primarily due to the 2009 goodwill impairment charge of $30.6 million in Aluminum Extrusions.

The significant differences between the U.S. federal statutory rate and the effective income tax rate for continuing operations are as follows:

 

     Percent of Income Before Income
Taxes for Continuing  Operations
 
     2010     2009     2008  

Income tax expense at federal statutory rate

     35.0        35.0        35.0   

Write-off of tax receivable from indemnification

     1.8        —          —     

Unremitted earnings from foreign operations

     1.3        8.1        6.7   

Valuation allowance for foreign operating loss carry-forwards

     1.3        (1.0     3.2   

State taxes, net of federal income tax benefit

     .9        2.2        1.6   

Reversal of income tax contingency accruals and tax settlements

     .6        (.9     (.3

Valuation allowance for capital loss carry-forwards

     .5        12.2        (2.2

Non-deductible expenses

     .3        —          .2   

Remitted earnings from foreign operations

     —          3.0        —     

Goodwill impairment charge

     —          61.8        —     

Research and development tax credit

     (.8     (2.1     (.4

Domestic Production Activities Deduction

     (1.1     —          —     

Foreign rate differences

     (1.8     (6.5     (4.2

Changes in estimates related to prior year tax provision

     (4.1     (.6     (.2

Other

     (.2     (3.4     .3   
                        

Effective income tax rate

     33.7        107.8        39.7   
                        

 

71


Table of Contents

Deferred tax liabilities and deferred tax assets at December 31, 2010 and 2009, are as follows:

 

(In Thousands)

   2010      2009  

Deferred tax liabilities:

     

Depreciation

   $ 26,238       $ 30,308   

Amortization of goodwill

     26,151         23,637   

Foreign currency translation gain adjustment

     10,068         14,023   

Derivative financial instruments

     174         461   

Other

     362         127   
                 

Total deferred tax liabilities

     62,993         68,556   
                 

Deferred tax assets:

     

Employee benefits

     10,428         9,222   

Asset write-offs, divestitures and environmental accruals

     4,512         4,098   

Excess capital losses and book/tax basis differences on investments

     4,405         3,230   

Tax benefit on state and foreign NOL and credit carryforwards

     4,112         4,720   

Pensions

     3,014         2,182   

Inventory

     1,973         1,279   

Allowance for doubtful accounts and sales returns

     1,298         1,343   

Timing adjustment for unrecognized tax benefits on uncertain tax positions, including portion relating to interest and penalties

     279         543   

Other

     —           317   
                 

Deferred tax assets before valuation allowance

     30,021         26,934   

Less: Valuation allowance

     11,983         11,680   
                 

Total deferred tax assets

     18,038         15,254   
                 

Net deferred tax liability

   $ 44,955       $ 53,302   
                 

Included in the balance sheet:

     

Noncurrent deferred tax liabilities in excess of assets

   $ 51,879       $ 59,052   

Current deferred tax assets in excess of liabilities

     6,924         5,750   
                 

Net deferred tax liability

   $ 44,955       $ 53,302   
                 

Except as noted below, we believe that it is more likely than not that future taxable income will exceed future tax deductible amounts thereby resulting in the realization of deferred tax assets. A valuation allowance of $3.0 million and $3.6 million at December 31, 2010 and 2009, respectively, is provided against the tax benefit on state and foreign net operating loss carryforwards for possible future tax benefits on domestic state and foreign operating losses generated by certain foreign and domestic subsidiaries that may not be recoverable in the carry-forward period. In addition, the valuation allowance for excess capital losses from investments and other related items was increased from $6.7 million at December 31, 2009 to $7.4 million at December 31, 2010 due to changes in the relative amounts of capital gains and losses generated during the year. The amount of the deferred tax asset considered realizable, however, could be adjusted in the near term if estimates of the fair value of certain investments during the carryforward period change. The valuation allowance for asset impairments in foreign jurisdictions where we believe it is more likely than not that the deferred tax asset will not be realized increased from $1.4 million in 2009 to $1.6 million in 2010.

 

72


Table of Contents

A reconciliation of our unrecognized uncertain tax positions since January 1, 2008, is shown below:

 

     Years Ended December 31,  

(In Thousands)

   2010     2009     2008  

Balance at beginning of period

   $ 996      $ 2,553      $ 3,268   

Increase (decrease) due to tax positions taken in:

      

Current period

     184        68        105   

Prior period

     493        208        (392

Increase (decrease) due to settlements with taxing authorities

     (375     (1,543     (31

Reductions due to lapse of statute of limitations

     (233     (290     (397
                        

Balance at end of period

   $ 1,065      $ 996      $ 2,553   
                        

Additional information related to our unrecognized uncertain tax positions since January 1, 2008 is summarized below:

 

     Years Ended December 31,  

(In Thousands)

   2010     2009     2008  

Gross unrecognized tax benefits on uncertain tax positions (reflected in current income tax and other noncurrent liability accounts in the balance sheet)

   $ 1,065      $ 996      $ 2,553   

Deferred income tax assets related to unrecognized tax benefits on uncertain tax positions for which ultimate deductibility is highly certain but for which the timing of the deduction is uncertain (reflected in deferred income tax accounts in the balance sheet)

     (234     (348     (1,828
                        

Net unrecognized tax benefits on uncertain tax positions, which would impact the effective tax rate if recognized

     831        648        725   

Interest and penalties accrued on deductions taken relating to uncertain tax positions (approximately $(400), $(800) and $100 reflected in income tax expense in the income statement in 2010, 2009 and 2008, respectively, with the balance shown in current income tax and other noncurrent liability accounts in the balance sheet)

     125        537        1,303   

Related deferred income tax assets recognized on interest and penalties

     (46     (195     (476
                        

Interest and penalties accrued on uncertain tax positions net of related deferred income tax benefits, which would impact the effective tax rate if recognized

     79        342        827   
                        

Total net unrecognized tax benefits on uncertain tax positions reflected in the balance sheet, which would impact the effective tax rate if recognized

   $ 910      $ 990      $ 1,552   
                        

We claimed an ordinary loss on the write-off of our investment in our aluminum extrusions operations in Canada, which was sold in February 2008, on our 2008 consolidated tax return (included in discontinued operations in the consolidated statement of income in 2007). The Internal Revenue Service (“IRS”) has recently challenged the ordinary nature of such deduction, asserting that the deduction should be re-characterized as capital in nature. We plan to vigorously defend our position related to this matter and believe that we will prevail but there can be no assurance of such a result. If the Company were not to prevail in final, non-appealable determinations, it is possible that the matter would result in additional tax payments of up to $12 million, plus any interest and penalties.

 

73


Table of Contents

In the second quarter of 2009, we settled several disputed issues raised by the IRS during its examination of our U.S. income tax returns for 2001-2003, the most significant of which regards the recognition of our captive insurance subsidiary as an insurance company for U.S. income tax purposes. The settlement with the IRS for the disputed issues cost us approximately $1.0 million, which is lower than the previous estimate of $1.3 million and was applied against the balance of unrecognized tax benefits.

Tredegar and its subsidiaries file income tax returns in the U.S., various states and jurisdictions outside the U.S. Generally, except for refund claims and amended returns, Tredegar is no longer subject to U.S. federal income tax examinations by tax authorities for years before 2006. With few exceptions, Tredegar and its subsidiaries are no longer subject to state or non-U.S. income tax examinations by tax authorities for years before 2007. We believe that it is reasonably possible that approximately $235,000 of the balance of unrecognized state tax positions may be recognized within the next twelve months as a result of a lapse of the statute of limitations.

 

15 LOSSES ASSOCIATED WITH PLANT SHUTDOWNS, ASSET IMPAIRMENTS AND RESTRUCTURINGS, UNUSUAL ITEMS, GAINS FROM SALE OF ASSETS AND OTHER ITEMS

 

Losses associated with plant shutdowns, asset impairments, restructurings and other charges for continuing operations in 2010 (as shown in the segment operating profit table in Note 3) totaled $265,000 ($297,000 after taxes), and unless otherwise noted below, are also included in “Asset impairments and costs associated with exit and disposal activities” in the consolidated statements of income. Results in 2010 included:

 

 

A fourth quarter benefit of $413,000 ($257,000 after taxes), a third quarter benefit of $14,000 ($9,000 after taxes), a second quarter benefit of $23,000 ($14,000 after taxes), and a first quarter benefit of $443,000 ($275,000 after taxes) for timing differences between the recognition of realized losses on aluminum futures contracts and related revenues from the delayed fulfillment by customers of fixed-price forward purchase commitments (included in “Cost of goods sold” in the consolidated statements of income, see Note 6 for additional detail);

 

 

Fourth quarter charges of $253,000 ($155,000 after taxes) for asset impairments in the Other segment and a second quarter charge of $355,000 ($355,000 after taxes) for an asset impairment in Film Products;

 

 

A fourth quarter charge of $400,000 ($249,000 after taxes) related to expected future environmental costs at our aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income);

 

 

A third quarter charge of $109,000 ($69,000 after taxes) and a first quarter charge of $56,000 ($35,000 after taxes) for severance and other employee-related costs in connection with restructurings in Film Products;

 

 

A second quarter gain of $120,000 ($73,000 after taxes) related to the sale of previously impaired equipment (included in “Other income (expense), net” in the consolidated statements of income) at our film products manufacturing facility in Pottsville, Pennsylvania; and

 

 

A second quarter loss of $44,000 ($26,000 after taxes) and a first quarter loss of $61,000 ($36,000 after taxes) on the disposal of equipment (included in “Other income (expense), net” in the consolidated statements of income) from a previously shutdown films manufacturing facility in LaGrange, Georgia.

Results in 2010 include an unrealized loss from the write-down of an investment accounted for under the fair value method of $2.2 million ($1.4 million after taxes). See Note 2 for additional information on this investment, which is accounted for under the fair value method. The impairment charges in Film Products and the Other segment were recognized to write down the machinery and equipment to the lower of their carrying value or estimated fair value. The estimated fair value of machinery and equipment that was evaluated for impairment was primarily based on our estimates of the proceeds that we would receive if and/or when assets are sold. Our estimates of the remaining fair value for the related machinery and equipment were based on both Level 2 and 3 inputs as defined under U.S generally accepted accounting principles.

Losses associated with plant shutdowns, asset impairments, restructurings and other charges for continuing operations in 2009 (as shown in the segment operating profit table in Note 3) totaled $2.9 million ($2.3 million after taxes), and unless otherwise noted below, are also included in “Asset impairments and costs associated with exit and disposal activities” in the consolidated statements of income. Results in 2009 included:

 

 

A fourth quarter charge of $181,000 ($121,000 after taxes) and a first quarter charge of $1.1 million ($806,000 after taxes) for severance and other employee-related costs in connection with restructurings in Film Products;

 

74


Table of Contents
 

A fourth quarter charge of $1.0 million ($1.0 million after taxes) for asset impairments in Film Products;

 

 

A fourth quarter benefit of $547,000 ($340,000 after taxes), a third quarter charge of $111,000 ($69,000 after taxes), a second quarter charge of $779,000 ($484,000 after taxes), and a first quarter charge of $609,000 ($378,000 after taxes) for timing differences between the recognition of realized losses on aluminum futures contracts and related revenues from the delayed fulfillment by customers of fixed-price forward purchase commitments (included in “Cost of goods sold” in the consolidated statements of income, see Note 6 for additional detail);

 

 

A fourth quarter gain of $640,000 ($398,000 after taxes) related to the sale of land at our aluminum extrusions manufacturing facility in Newnan, Georgia (included in “Other income (expense), net” in the consolidated statements of income);

 

 

A fourth quarter charge of $64,000 ($40,000 after taxes) and a first quarter charge of $369,000 ($232,000 after taxes) for severance and other employee-related costs in connection with restructurings in Aluminum Extrusions;

 

 

A fourth quarter charge of $218,000 ($139,000 after taxes) and a first quarter charge of $178,000 ($113,000 after taxes) for severance and other employee-related costs in connection with restructurings at corporate headquarters (included in “Corporate expenses, net” in the segment operating profit table in Note 3);

 

 

A first quarter gain of $275,000 ($162,000 after taxes) on the sale of equipment (included in “Other income (expense), net” in the consolidated statements of income) from a previously shutdown films manufacturing facility in LaGrange, Georgia;

 

 

A second quarter gain of $175,000 ($110,000 after taxes) on the sale of a previously shutdown aluminum extrusions manufacturing facility in El Campo, Texas (included in “Other income (expense), net” in the consolidated statements of income);

 

 

A second quarter gain of $149,000 ($91,000 after taxes) related to the reversal to income of certain inventory impairment accruals in Film Products; and

 

 

A fourth quarter charge of $345,000 ($214,000 after taxes) and a second quarter benefit of $276,000 ($172,000 after taxes) related to adjustments of future environmental costs expected to be incurred by Aluminum Extrusions (included in “Cost of goods sold” in the consolidated statements of income).

We recognized a gain of $1.8 million ($1.2 million after taxes) from the receipt of a contractual earn-out payment and a gain of $150,000 ($96,000 after taxes) from a post-closing contractual adjustment from the sale of our investments in Theken Spine and Therics, LLC. AFBS Inc. (formerly Therics, Inc.) received these investments in 2005, when substantially all of the assets of AFBS, Inc., a wholly owned subsidiary of Tredegar, were sold or assigned to a newly created limited liability company, Therics, LLC, controlled and managed by an individual not affiliated with Tredegar. Results in 2009 also include unrealized gains from the write-up of an investment accounted for under the fair value method of $5.1 million ($3.2 million after taxes). Gains on the sale of corporate assets in 2009 include realized gains of $404,000 ($257,000 after taxes) from the sale of corporate real estate. The pretax amount for each of these items is included in “Other income (expense), net” in the consolidated statements of income. Income taxes for 2009 include the recognition of a valuation allowance of $2.1 million related to expected limitations on the utilization of assumed capital losses on certain investments.

The severance in Film Products includes a reduction in workforce in the first and fourth quarters of 2009 (approximately 50 employees) that saved approximately $2.0 million on an annual basis. The impairment charge in Film Products was recognized to write down the machinery and equipment to the lower of their carrying value or estimated fair value. The estimated fair value of machinery and equipment that was evaluated for impairment was primarily based on our estimates of the proceeds that we would receive if and/or when assets are sold. Our estimates of the remaining fair value for the related machinery and equipment were based on both Level 2 and 3 inputs as defined under U.S generally accepted accounting principles.

Losses associated with plant shutdowns, asset impairments, restructurings and other charges for continuing operations in 2008 (as shown in the segment operating profit table in Note 3) totaled $12.0 million ($8.4 million after taxes), and unless otherwise noted below, are also included in “Asset impairments and costs associated with exit and disposal activities” in the consolidated statements of income. Results in 2008 included:

 

 

A fourth quarter charge of $7.2 million ($5.0 million after taxes), a second quarter charge of $854,000 ($717,000 after taxes) and a first quarter charge of $1.7 million ($1.2 million after taxes) for asset impairments in Film Products;

 

75


Table of Contents
 

A second quarter charge of $90,000 ($83,000 after taxes) and a first quarter charge of $2.1 million ($1.4 million after taxes) for severance and other employee-related costs in connection with restructurings in Film Products;

 

 

A second quarter charge of $275,000 ($169,000 after taxes) and a first quarter charge of $235,000 ($145,000 after taxes) for severance and other employee-related costs in connection with restructurings in Aluminum Extrusions;

 

 

A fourth quarter gain of $583,000 ($437,000 after taxes) related to the sale of land rights and related improvements at the Film Products facility in Shanghai, China (included in “Other income (expense), net” in the consolidated statements of income); and

 

 

A fourth quarter charge of $72,000 ($44,000 after taxes) and a second quarter charge of $105,000 ($65,000 after taxes) related to expected future environmental costs at the Aluminum Extrusions facility in Newnan, Georgia (included in “Cost of goods sold” in the consolidated statements of income).

A gain of $1.5 million ($965,000 after taxes) from the sale of our investments in Theken Spine and Therics, LLC is included in “Other income (expense), net” in the consolidated statements of income. Results in 2008 also include unrealized gains from the write-up of an investment in a privately held drug company of $5.6 million ($3.6 million after taxes). See Note 2 for additional information on this investment, which is accounted for under the fair value method. Gains on the sale of corporate assets in 2008 include realized gains of $509,000 ($310,000 after taxes) from the sale of equity securities and $492,000 ($316,000 after taxes) from the sale of corporate real estate. The pretax amounts for each of these items are included in “Other income (expense), net” in the consolidated statements of income. Income taxes for 2008 include the reversal of a valuation allowance recognized in the third quarter of 2007 of $1.1 million that originally related to expected limitations on the utilization of assumed capital losses on certain investments.

The severance in Film Products includes a reduction in workforce in the first quarter of 2008 (approximately 90 or 6% of Film Products’ total employees) that saved approximately $4 million on an annual basis. The impairment charges in Film Products were recognized to write down the machinery and equipment for certain product groups to the lower of their carrying value or estimated fair value. The estimated fair value of machinery and equipment that was evaluated for impairment was primarily based on our estimates of the proceeds that we would receive if and/or when assets are sold. Our estimates of the remaining fair value for the related machinery and equipment were based on both Level 2 and 3 inputs as defined under U.S generally accepted accounting principles.

 

16 CONTINGENCIES

 

We are involved in various stages of investigation and remediation relating to environmental matters at certain current and former plant locations. Where we have determined the nature and scope of any required environmental remediation activity, estimates of cleanup costs have been obtained and accrued. As we continue efforts to maintain compliance with applicable environmental laws and regulations, additional contingencies may be identified. If additional contingencies are identified, our practice is to determine the nature and scope of those contingencies, obtain and accrue estimates of the cost of remediation, and perform remediation. We do not believe that additional costs that could arise from those activities will have a material adverse effect on our financial position. However, those costs could have a material adverse effect on quarterly or annual operating results at that time.

We are involved in various other legal actions arising in the normal course of business. After taking into consideration information we deemed relevant, we believe that we have sufficiently accrued for probable losses and that the actions will not have a material adverse effect on our financial position. However, the resolution of the actions in a future period could have a material adverse effect on quarterly or annual operating results at that time.

From time to time, we enter into transactions with third parties in connection with the sale of assets or businesses in which we agree to indemnify the buyers or third parties involved in the sale for certain liabilities or risks related to the assets or business. Also, in the ordinary course of our business, we may enter into agreements with third parties for the sale of goods or services that may contain indemnification provisions. In the event that an indemnification claim is asserted, liability for indemnification would be subject to an assessment of the underlying facts and circumstances under the terms of the applicable agreement. Further, any indemnification payments may be limited or barred by a monetary cap, a time limitation, or a deductible or basket. For these reasons, we are unable to estimate the maximum potential amount of the potential future liability under the indemnity provisions of these agreements. We do, however, accrue for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable and the amount is reasonably estimable. We disclose contingent liabilities if the probability of loss is reasonably possible and material.

 

76


Table of Contents
17. DISCONTINUED OPERATIONS

 

On February 12, 2008, we sold our aluminum extrusions business in Canada for approximately $25.0 million to an affiliate of H.I.G. Capital. We realized cash income tax benefits in 2008 from the sale of approximately $12.0 million.

The sale of our aluminum extrusions business in Canada, which was suffering from operating losses driven by lower volume and higher conversion costs from appreciation of the Canadian dollar, allowed us to focus on our U.S. aluminum extrusions operations where we have more control over costs and profitability. The business was classified as held for sale at the end of December 2007 when it became probable that the business would be sold. All historical results for this business have been reflected as discontinued operations; however, cash flows for discontinued operations have not been separately disclosed in the consolidated statements of cash flows.

We recognized losses of $1.1 million ($430,000 after taxes) in the first quarter of 2008 and $207,000 ($207,000 after taxes) in the second quarter of 2008, which were in addition to the asset impairment charges recognized in 2007, to adjust primarily for differences in the carrying value of assets and liabilities and related tax benefits associated with the business sold since December 31, 2007. We also recognized $225,000 in the fourth quarter of 2008 for additional income tax benefits relating to the worthless stock deduction for the business. The remaining after-tax loss for discontinued operations in 2008 of $293,000 relates to the loss recognized in the first quarter from operations up through the date of sale.

The statements of income for 2008 for the aluminum extrusions business in Canada are shown below:

Aluminum Extrusions Business in Canada

Statements of Income

 

(In Thousands)

   Jan. 1, 2008 to
Feb. 12, 2008
 

Revenues

   $ 18,756   

Costs and expenses:

  

Cost of goods sold

     17,913   

Freight

     744   

Selling, general and administrative

     490   

Asset impairments and costs associated with exit and disposal activities

     1,337   
        

Total

     20,484   
        

Income (loss) before income taxes

     (1,728

Income taxes

     (1,023
        

Net income (loss)

   $ (705
        

 

77


Table of Contents
18 SELECTED QUARTERLY FINANCIAL DATA

 

Tredegar Corporation and Subsidiaries

(In Thousands, Except Per-Share Amounts)

(Unaudited)

 

     First
Quarter
    Second
Quarter
     Third
Quarter
     Fourth
Quarter
 

2010

                          

Sales

   $ 174,981      $ 185,031       $ 197,518       $ 182,945   

Gross profit

     29,664        29,958         33,802         32,909   

Net income

   $ 5,782      $ 4,960       $ 8,968       $ 7,317   
                                  

Earnings per share:

          

Basic

   $ .17      $ .15       $ .28       $ .23   

Diluted

   $ .17      $ .15       $ .28       $ .23   

Shares used to compute earnings per share:

          

Basic

     33,344        32,260         31,779         31,806   

Diluted

     33,515        32,450         31,995         32,348   

2009

                          

Sales

   $ 153,066      $ 158,115       $ 175,662       $ 161,770   

Gross profit

     24,579        28,630         35,191         27,195   

Net income (loss)

   $ (28,817   $ 6,487       $ 10,996       $ 9,981   
                                  

Earnings (loss) per share:

          

Basic

   $ (.85   $ .19       $ .32       $ .30   

Diluted

   $ (.85   $ .19       $ .32       $ .29   

Shares used to compute earnings per share:

          

Basic

     33,866        33,876         33,878         33,825   

Diluted

     33,866        33,971         33,922         33,871   

 

78


Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

TREDEGAR CORPORATION

(Registrant)

Dated: March 4, 2011   By  

/s/ Nancy M. Taylor

    Nancy M. Taylor
    President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on March 4, 2011.

 

Signature

      

Title

/s/ Nancy M. Taylor

    President, Chief Executive Officer and Director
     (Nancy M. Taylor)     (Principal Executive Officer)

/s/ Kevin A. O’Leary

    Vice President, Chief Financial Officer and Treasurer
     (Kevin A. O’Leary)     (Principal Financial Officer)

/s/ Frasier W. Brickhouse, II

    Controller
     (Frasier W. Brickhouse, II)     (Principal Accounting Officer)

/s/ R. Gregory Williams

    Chairman of the Board of Directors
     (R. Gregory Williams)    

/s/ N. A. Scher

    Vice Chairman of the Board of Directors
     (Norman A. Scher)    

/s/ Austin Brockenbrough, III

    Director
     (Austin Brockenbrough, III)    

/s/ Donald T. Cowles

    Director
     (Donald T. Cowles)    

 

79


Table of Contents

/s/ John D. Gottwald

    Director
     (John D. Gottwald)    

/s/ Richard L. Morrill

    Director
     (Richard L. Morrill)    

/s/ George A. Newbill

    Director
     (George A. Newbill)    

 

80


Table of Contents

EXHIBIT INDEX

 

      3.1

   Amended and Restated Articles of Incorporation of Tredegar (filed as Exhibit 3.1 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

      3.2

   Amended and Restated Bylaws of Tredegar (filed as Exhibit 3.2 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed December 15, 2009, and incorporated herein by reference)

      3.3

   Articles of Amendment (filed as Exhibit 3.3 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

      4.1

   Form of Common Stock Certificate (filed as Exhibit 4.1 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

      4.2

   Amended and Restated Rights Agreement, dated as of June 30, 2009, by and between Tredegar and National City Bank, as Rights Agent (filed as Exhibit 1 to Amendment No. 2 to Tredegar’s Registration Statement on Form 8-A/A (File No. 1-10258) filed on July 1, 2009, and incorporated herein by reference)

      4.3

   Credit Agreement, dated as of June 21, 2010, among Tredegar Corporation, as borrower, the lenders named therein, JPMorgan Chase Bank, N.A., as administrative agent, SunTrust Bank, as syndication agent, and Bank of America, N.A., HSBC Bank USA, National Association and U.S. Bank National Association, as co-documentation agents (filed as Exhibit 4.3 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed June 22, 2010, and incorporated herein by reference)

    10.1

   Reorganization and Distribution Agreement dated as of June 1, 1989, between Tredegar and Ethyl (filed as Exhibit 10.1 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

  *10.2

   Employee Benefits Agreement dated as of June 1, 1989, between Tredegar and Ethyl (filed as Exhibit 10.2 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

    10.3

   Tax Sharing Agreement dated as of June 1, 1989, between Tredegar and Ethyl (filed as Exhibit 10.3 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

    10.4

   Indemnification Agreement dated as of June 1, 1989, between Tredegar and Ethyl (filed as Exhibit 10.4 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

  *10.5

   Tredegar Industries, Inc. Retirement Benefit Restoration Plan (filed as Exhibit 10.7 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

  *10.5.1

   Amendment to the Tredegar Retirement Benefit Restoration Plan (filed as Exhibit 10.7.1 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

  *10.6

   Tredegar Industries, Inc. Savings Plan Benefit Restoration Plan (filed as Exhibit 10.8 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

  *10.6.1

   Resolutions of the Executive Committee of the Board of Directors of Tredegar Corporation adopted on December 28, 2004 (effective as of December 31, 2004) amending the Tredegar Corporation Retirement Savings Plan Benefit Restoration Plan (filed as Exhibit 10.9.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on December 30, 2004, and incorporated herein by reference)

  *10.7

   Tredegar Industries, Inc. Amended and Restated Incentive Plan (filed as Exhibit 10.9 to Tredegar’s Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2005, and incorporated herein by reference)

  *10.8

   Tredegar Corporation’s 2004 Equity Incentive Plan as Amended and Restated Effective March 27, 2009 (filed as Annex 1 to Tredegar’s Definitive Proxy Statement on Schedule 14A (File No. 1-10258) filed on April 14, 2009 and incorporated herein by reference)

  *10.9

   Transfer Agreement, by and between Old Therics and New Therics, dated as of June 30, 2005 (filed as Exhibit 10.17 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed July 1, 2005, and incorporated herein by reference)

    10.10

   Intellectual Property Transfer Agreement, by and between Old Therics and New Therics, dated as of June 30, 2005 (filed as Exhibit 10.18 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed July 1, 2005, and incorporated herein by reference)

 

81


Table of Contents

    10.11

   Unit Purchase Agreement, by and between Old Therics, New Therics and Randall R. Theken, dated as of June 30, 2005 (filed as Exhibit 10.19 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed July 1, 2005, and incorporated herein by reference)

    10.12

   Payment Agreement, by and between Old Therics and New Therics, dated as of June 30, 2005 (filed as Exhibit 10.20 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed July 1, 2005, and incorporated herein by reference)

  *10.13

   Form of Notice of Stock Award and Stock Award Terms and Conditions (filed as Exhibit 10.1 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on February 16, 2011, and incorporated herein by reference)

  *10.14

   Form of Notice of Stock Unit Award and Stock Unit Award Terms and Conditions (filed as Exhibit 10.2 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on February 16, 2011, and incorporated herein by reference)

  *10.15

   Form of Notice of Nonstatutory Stock Option Grant and Nonstatutory Stock Option Terms and Conditions (filed as Exhibit 10.3 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed on February 16, 2011, and incorporated herein by reference)

  *10.16

   Form of Notice of Stock Award and Stock Award Terms and Conditions (filed as Exhibit 10.18 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed February 19, 2009, and incorporated herein by reference)

  *10.17

   Severance Agreement, effective as of January 31, 2010, between Tredegar Corporation and Nancy M. Taylor (filed as Exhibit 10.19 to Tredegar’s Current Report on Form 8-K (File No. 1-10258), filed March 5, 2010, and incorporated herein by reference)

+*10.18

   Summary of Director Compensation for Fiscal 2010

  +21

   Subsidiaries of Tredegar

  +23.1

   Consent of Independent Registered Public Accounting Firm

  +31.1

   Section 302 Certification of Principal Executive Officer

  +31.2

   Section 302 Certification of Principal Financial Officer

  +32.1

   Section 906 Certification of Principal Executive Officer

  +32.2

   Section 906 Certification of Principal Financial Officer

 

* Denotes compensatory plans or arrangements or management contracts.
+ Filed herewith

 

82